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ABSTRACT 
 
MECHANISTIC STUDY OF HEME PROTEIN-MEDIATED NITRIC OXIDE 
DIOXYGENATION USING PHOTOLYTICALLY PRODUCED NITRIC OXIDE 
 
by 
Karl Koebke 
The University of Wisconsin-Milwaukee, 2015 
Under the Supervision of Professor A. Andy Pacheco 
 
 
The previously reported NO precursor [Mn(PaPy2Q)(NO)]ClO4 (1), where 
(PaPy2QH) is N,N-bis(2-pyridylmethyl)-amine-N-ethyl-2-quinoline-2-carboxamide, was 
synthesized and proven capable of producing as much as 180 µM NO when irradiated by 
a single 3 mJ 500nm laser pulse, in a 0.15 cm path cell, without the need for additional 
sacrificial reductants or oxidants.  Species 1 was first used to study the reaction of nitric 
oxide with oxy-myoglobin (oxyMb) to form ferric myoglobin (metMb) and nitrate.  This 
reaction had long been assumed to proceed via the same iron-bound peroxynitrite 
intermediate (metMb(OONO)) as the metMb-catalyzed isomerization of peroxynitrite to 
nitrate.  Recent research showed that the metMb-catalyzed isomerization of peroxynitrite 
to nitrate produces detectable amounts of nitrogen dioxide and ferryl myoglobin 
(ferrylMb).  This suggested a “caged NO2” mechanism for peroxynitrite isomerization.  
The presence of free NO2 and ferrylMb products revealed that small amounts of NO2 
escape from myoglobin’s interior before recombination can occur, and these should also 
be generated in the reaction of oxyMb with NO, if the common intermediate 
metMb(OONO) is formed.  However, in time resolved UV/Vis spectroscopy experiments 
reported herein no ferrylMb was detected when oxyMb and NO reacted.  The sensitivity 
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of the methodology is such that as little as 10% of the ferrylMb predicted from the 
experiments with metMb and peroxynitrite should have been detectable.  These results lead 
to the conclusion that the oxyMb + NO and metMb + ONOO− reactions do not proceed via 
a common intermediate as previously thought.  The conclusion has significant implications 
for researchers that propose a possible role of oxyMb in intracellular NO regulation, 
because toxic NO2 and ferrylMb are not generated during NO oxidation by this species.  
Nitric oxide precursor 1 was then used for investigating the interaction between NO 
and the protein truncated hemoglobin N (trHbN) from the pathogen Mycobacterium 
tuberculosis.  Oxy-trHbN is exceptionally efficient at converting NO to nitrate, with a 
reported rate constant of 7.45108 M1 s1 compared to 4107 M1 s1 for oxyMb.  This 
work analyzed the NO dioxygenation kinetics of wild type trHbN and a set of variants, as 
well as the nitrosylation kinetics for the reduced (red-trHbN) forms of these proteins.  The 
NO dioxygenation reaction was remarkably insensitive to mutations, even within the active 
site, while nitrosylation was somewhat more sensitive.  Curiously, the most profound 
change to the rate constant for nitrosylation was effected by deletion of a 12 amino acid N-
terminal sequence.  The deletion mutant exhibited first-order kinetics with respect to NO, 
but was zero-order with respect to protein concentration; by contrast all other variants 
exhibited second-order rate constants greater than 108 M1s1.  TrHbN boasts an extensive 
tunnel system that connects the protein exterior with the active site, and is likely the main 
contributor to the protein’s impressive NO dioxygenation efficiency.  The results herein 
suggest that N-terminal deletion abolishes a large-scale conformational motion, in the 
absence of which NO can still readily enter the tunnel system, but is prevented from binding 
to the heme for an extended period of time. 
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Chapter 1 
Introduction 
1.1. Overview of nitric oxide’s physiological roles 
Nitric oxide is what most would call a “late bloomer”.  It was discovered by Joseph 
Priestley in 1772 under the name nitrous air, but it wasn't until 1988 that the small molecule 
would finally enter the limelight.1,2  Research by Furchgott and Zawadzki into the effects 
of various factors on vascular endothelial linings in isolated blood vessels led to the 
discovery of a compound then called “endothelium-derived relaxing factor” (EDRF), 
which was released by the vascular endothelial lining in response to acetylcholine (Fig. 
1.1).3-5  Several clues hinted at the idea that EDRF might actually be nitric oxide or a similar 
compound.  Evidence included work that demonstrated the inactivation of EDRF by 
superoxide,6 with which nitric oxide has known reactivity,7,8 and inhibition of EDRF's 
effects in vitro by hemoglobin,9 a well-established target for nitric oxide ligation.10  A third 
piece of evidence was the fact that EDRF's effects were mediated by cyclic GMP, whose 
synthesis was in turn catalyzed by soluble guanylate cyclase,11 an enzyme known to be 
activated by nitric oxide.12  Final proof for nitric oxide's role in physiology came in 1987 
from the work of two independent groups.13,14  The first group confirmed the identity of 
EDRF as nitric oxide by comparing the UV/Vis signature of hemoglobin interacting with 
the EDRF with the known spectrum of nitrosylated hemoglobin.13  The second group 
compared the chemiluminescences of EDRF and NO reacting with ozone, and 
demonstrated that these were identical.14 
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Figure 1.1. Illustration of the original experiment that led to the discovery of the 
endothelium-derived relaxing factor (EDRF; illustration reproduced with permission from 
the original creator, Prof. Michael Palmer of the University of Waterloo). 
 
Since the original discoveries endogenous nitric oxide has been found in multiple 
tissues,15 and over- or under-abundances of NO have been implicated in pathological 
conditions in numbers that are sometimes difficult to believe.  Indeed, with the modern 
understanding of nitric oxide it is difficult to name a pathological condition that doesn't 
involve this gaseous compound in some way.  Examples include tumor angiogenisis, 
neurological disorders such as Alzheimer's and autism, and cardiovascular pathologies 
such as diabetes and septic shock.  Whether the noted changes in nitric oxide concentration 
are a cause or effect, however, has not always been clear.16-21  It's a testament to how much 
research still lies ahead for the biomedical field that such a crucial and ubiquitous 
mammalian signaling molecule evaded detection for as long as it did.  
Nitric oxide’s physiological roles fall into two broad categories.  In nanomolar 
concentrations it is used for signaling; its function as the EDRF is one example of a 
signaling role, but there are many others.  At micromolar concentrations NO becomes toxic, 
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but then it can be effectively used for fighting off bacterial infections.22  In vivo NO is 
synthesized from L-Arginine in two consecutive reactions that are catalyzed by a class of 
enzymes known as nitric oxide synthases (NOS, Fig. 1.2).23,24  Two isoforms of NOS, 
eNOS (“endothelial”) and nNOS (“neuronal”) generate small quantities of NO for 
signaling, whereas a third isoform called iNOS (“inducible”) is used by the immune system 
to generate large quantities of NO for bactericidal purposes.  As implied by the name, iNOS 
is inducible and only synthesized at need.23,24 
 
 
 
 
Figure 1.2.  Outline of the key processes of endogenous nitric oxide biology, ranging from 
initial synthesis, through its role in signaling, to its elimination when no longer needed. 
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Given NO’s potency as a signaling molecule, and its potential toxicity at higher 
concentrations, its in-vivo concentration must be strictly controlled.  This is challenging 
because for a reactive molecule NO has a comparatively long half-life (~0.5 s), an 
impressive diffusion rate of 3.3105 cm2/sec, and the ability to pass through cell 
membranes unimpeded.  Based on these features one can estimate from computational 
studies that a single source of nitric oxide could affect an area as great as 200 micrometers.  
The central nervous system provides a particularly dramatic example of the challenges that 
this number poses, since 200 μm would correspond to as many as 2 million synapses within 
range of that one NO source!  This property has led to the use of the term volume 
transmitter for nitric oxide in the central nervous system.25-27  Several putative methods for 
NO control have been identified to date.  In most cases the primary control method may 
well be to position the recipient of the NO signal, soluble guanylate cyclase (sGC, Fig. 
1.2), near enough to the NOS source to ensure that it is the first target encountered.12  In 
blood it has been hypothesized that serum proteins such as albumin can buffer NO 
concentrations by forming S-nitroso adducts,28-31 while oxy-hemoglobin (oxy-Hb) can act 
as a terminal NO sink by mediating its oxidation to nitrate.  Oxy-myoglobin (oxyMb) may 
play a similar role in muscle tissue (Fig. 1.2),32-35 which will be one major topic of this 
dissertation. 
1.2. Heme and NO: from the cradle to the grave 
It seems rather fitting for nitric oxide's biological relevance to be discovered by 
Ignarro and colleagues via hemoglobin, as nitric oxide has a long history and ever-growing 
relationship to heme proteins.  Nitric oxide has been known as a ligand of hemoglobin 
since 1937,10 and since the initial EDRF studies heme proteins have been implicated in 
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nitric oxide synthesis, signaling cascades, and as NO sinks when they mediate NO 
oxidation: the three proteins shown in Fig. 1.2, NOS, sGC and oxyMb, are all heme 
proteins.12,24,36-41   
This work focuses on the interaction of NO with two heme proteins, myoglobin 
(Mb) from horse heart, and truncated hemoglobin N (trHbN) from the pathogenic 
bacterium Mycobacterium tuberculosis.  Myoglobin was chosen for study because it is by 
far the most researched protein capable of nitric oxide oxidation, and so can be used to 
answer very specific mechanistic questions by combining careful experimental design with 
judicious use of the prodigious amount of kinetic information already available on the 
protein.  A detailed review of the Mb properties relevant to NO oxidation is provided in 
Section 1.3, while the experiments performed in this project are described in Chapter 3.  
The remarkable feature of oxy-trHbN, on the other hand, is its phenomenal efficiency as 
an NO oxidant.  This is over an order of magnitude higher than that of Mb, and very near 
the theoretical limit imposed by the maximum rate at which two molecules can diffuse 
toward each other in solution.  TrHbN is reviewed in Section 1.4, and the new experiments 
with it are presented in Chapter 4. 
The high value of the rate constant for the reaction of oxy-trHbN with nitric oxide 
puts this reaction at the limit of those that can be studied by rapid mixing methods such as 
stopped-flow, so most reactivity studies done prior to the investigations described here 
involved steady-state experiments.  Chapter 2 describes the development and testing of a 
protocol for generating NO in situ by laser flash photolysis of a stable precursor.  By using 
a 5 ns pulsed laser to rapidly generate NO from the precursor, coupled with a rapid-
response UV/Vis spectrophotometer, the reactions of NO with oxy-trHbN could be directly 
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monitored with relative ease (Chapter 4).  The laser photo-generation of NO also proved 
useful in the investigation of the reaction of NO with oxyMb (Chapter 3).  
1.3. Myoglobin as a prospective NO sink 
Myoglobin’s role as an oxygen storage protein in tissues is widely accepted,42,43 
although studies demonstrate that myoglobin-deficient mice have apparently normal 
muscle function.44  Many researchers have suggested that the protein may also serve a 
variety of other physiological functions such as being a sink for NO.32-35  Oxy-myoglobin 
(oxyMb) reacts with NO to release nitrate, leaving the myoglobin in an aquated ferric state 
known as aquomet-myoglobin (metMb)  (Scheme 1.1).32,33,45  As mentioned earlier NO 
plays many important physiological roles as a signaling molecule,36,46 all of which take 
advantage of its transient nature.  Thus, the reaction of oxyMb with NO could serve to 
spatially limit the range of a NO signal within tissues that contain high concentrations of 
myoglobin, such as cardiac and skeletal muscles, and to keep the concentration of NO 
within the cell below toxic levels.32  
The commonly accepted first step in the reaction of oxyMb with NO is the 
formation of a transient peroxynitrite-bound intermediate (metMb(OONO)), as shown in 
Scheme 1.1,47,48 though such an intermediate has never been directly detected.  At alkaline 
pH an intermediate was detected by UV/Vis stopped-flow45 and rapid freeze-quench EPR49 
studies that at first was believed to be the peroxynitrite species.  However, an intermediate 
species with identical kinetic behavior was later detected in the reaction of ferrylMb with 
NO2, and identified as the metMb(ONO2) adduct (Scheme 1.1).50  This assignment was 
confirmed using rapid freeze-quench resonance Raman  
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 Scheme 1.1.  Proposed mechanisms for the reaction of NO with oxyMb, and of 
peroxynitrite with metMb, highlighting the proposed common pathways for the two 
processes. 
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spectroscopic analysis.51  One indirect piece of evidence for the intermediacy of 
metMb(OONO) is that metMb and related proteins can catalyze the isomerization of 
peroxynitrite to nitrate, presumably through the same intermediate, as shown in Scheme 
1.1.52-55  Model studies with synthetic porphyrins by Schopfer et al. provide additional 
indirect evidence.56   
While a peroxynitrite intermediate is generally agreed upon in the reaction of 
oxyMb with NO, there has been ongoing debate on the mechanism by which this 
intermediate rearranges to the nitrate adduct (metMb(ONO2)), with some researchers 
favoring a concerted rearrangement (Scheme 1.1, path 1),54,57 and others an O-O bond 
homolysis to generate a ferryl myoglobin (ferrylMb) intermediate and “caged” NO2, 
followed by a recombination in which the nitrogen of NO2 binds to the ferryl oxo group 
(Scheme 1.1, path 2).51,53,55,56  A series of experiments that followed the reaction of 
peroxynitrite with metMb have provided persuasive evidence that the metMb(OONO) 
adduct rearranges according to the path 2 homolysis model.  The culmination came in a 
recent paper where Su and Groves were able to directly detect the putative ferrylMb 
intermediate.55  This and earlier papers also reported the nitration of a specific tyrosine 
within Mb (Tyr103), presumably by NO2 generated from the peroxynitrite fragmentation, 
and lost through the cage escape pathway (Scheme 1.1, lower-right).53,55  With the 
chemistry of the metMb(OONO) species now fairly well established, the study described 
in Chapter 3 revisits the question of whether this species in fact represents a common 
intermediate when oxyMb reacts with NO, and when metMb reacts with peroxynitrite. 
 
 
9 
 
1.4. Truncated Hemoglobin N from Mycobacterium tuberculosis 
1.4.1. Nitric oxide dioxygenation limited by diffusion alone.  Mb’s activity as a 
NO sink may or may not be one of its main physiological roles, but there’s other evidence 
suggesting that NO dioxygenation is one of the hemoglobin family’s most ancient 
functions along with dioxygen scavenging and/or sensing of concentration gradients.58-60  
Flavohemoglobin is the poster child for the evolution of the hemoglobin family towards 
this function.  The flavohemoglobin-mediated oxidation of nitric oxide in Escherichia coli 
occurs with an incredible efficiency that few enzyme systems can match (a rate constant of 
~ 2.4  109 M1 s1) and, unlike Mb, flavoHbs can catalytically convert nitric oxide to 
nitrate in the presence of oxygen and FAD without an outside reductase.61  In 1999 trHbN 
was discovered in M. tuberculosis, and found to oxidize NO at rates similar to those 
displayed by flavoHb, an impressive feat for a single domain globin.62  The question arises: 
why does M. tuberculosis express trHbN, and how does such a simple protein achieve its 
remarkable efficiency for nitric oxide oxidation?   
M. Tuberculosis currently infects about a third of the global population, and 
according to the WHO Global Tuberculosis report of 2014 was the causative agent for 9 
million new cases of tuberculosis (TB) in 2013 alone, with 1.5 million deaths resulting.  
Furthermore, there were 480,000 new cases of multidrug resistant TB reported in 2013, 
with 210,000 deaths.63  Part of the difficulty of trying to eradicate TB is the large pool of 
otherwise healthy individuals who harbor the disease, but have not yet presented any 
symptoms.  Upon infecting a healthy individual M. tuberculosis' spread is stopped after 
initial infection and replication inside host macrophages.  The infected macrophages are 
surrounded by newly recruited healthy macrophages to create the “caseous granuloma”, an 
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environment characterized by low pH and low dioxygen concentration that simultaneously 
contains high concentrations of toxic reactive oxygen and nitrogen species such as nitric 
oxide.64  
M. tuberculosis' ability to survive in the harsh environment of the caseous 
granuloma is in part thanks to trHbN, a 30 kDa homodimeric heme protein.62  This protein's 
oxygenated form reacts with NO to form nitrate in a reaction analogous to that of oxyMb 
with NO (Section 1.3 and Chapter 3), but the rate constant for the reaction is over an order 
of magnitude higher (initially reported as 7.45108 M1 s1, which is near the diffusion 
limit, compared to 4107 M1 s1 for oxyMb).65,66  Nitrate is released from trHbN after 
oxygenation, and the nitric oxide is essentially detoxified.62,66  The overall reaction of nitric 
oxide oxidation is shown in Scheme 1.2.   
 
 
Scheme 1.2. Nitric oxide oxidation by oxy-trHbN; note that superficially the reaction is 
identical to that of NO with oxyMb (Scheme 1.1). 
 
1.4.2. Substrate tunnels, Phe62 gating, and active site amino acid effects.  
TrHbN’s remarkable efficiency for oxygenating NO, in addition to its exceedingly high 
affinity for oxygen (P50 ~ 0.015 mm Hg compared to 1 mm Hg for Mb62,67), has made the 
protein a target of considerable interest over the past fifteen years, and resulted in a number 
of publications that address these phenomena.68-82  A crystal structure of oxy-trHbN solved 
by Milani et al. (Fig. 1.3)69 showed an extensive tunnel system through the protein that was  
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Figure 1.3. Truncated Hemoglobin N structure illustrated using Pymol, with the tunnel 
system shown in blue.  (pdb 1idr) tunnel system calculated using the Caver 3.0.1 plugin85 
 
  
 
Figure 1.4. Active site of Truncated Hemoglobin N illustrated using Pymol, with relevant 
amino acids labeled. (pdb 1idr) 
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suitable for ligand diffusion to the active site.  This provides one obvious possible 
explanation for the high rate constant for NO oxygenation by this protein; by contrast Mb 
exhibits no obvious tunnels from the exterior to the active site.  Later molecular dynamics 
(MD) studies utilizing the “Caver” program to analyze transient tunnels found that two 
more tunnels (BE and EH) could be added to those seen in crystal structures (short and 
long).76  The oxy-trHbN crystal structure also exhibited an extended hydrogen bonding 
network between residues Y33, Q58 and the bound dioxygen (Fig. 1.4), and mutagenesis 
studies showed that this network is critical for the protein’s high dioxygen affinity.62,68,69 
Finally, the crystal structure together with computational studies also revealed an apparent 
gating residue into the active site in F62 (Fig. 1.4).73,81,83,84  The initial computational 
studies suggested that dioxygen binding to reduced protein induces a conformational 
change that opens the F62 gate and facilitates nitric oxide entry into the active site.73 
Further theoretical analysis revealed that Y33 and Q58, in addition to their roles in binding 
dioxygen, might also play a role in protein tunnel dynamics through their links with F62.74  
Later computational studies using a method known as “adiabatic reactive molecular 
dynamics” (ARMD) indicated that Y33 might play a more active role in the reaction 
mechanism, and a Y33A mutation was calculated to have a large effect on the reaction 
rate.78  In a fairly recent study the F62 gate residue was mutated to Ile, Trp, Ala, or Tyr, and 
the nitric oxide oxidation rate was monitored using a polarographic method.81  For all of 
the mutants the overall nitric oxide oxidation rate decreased by a factor of two to three, 
which confirmed a role for F62 in the protein's function.  
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1.4.3. The mysterious Pre-A region and its effect on nitric oxide dioxygenation.  
Away from the heme active site crystal structures of trHbN showed a unique motif on its 
N-terminus that serves no apparent structural purpose, as it protrudes out from the globin 
fold into the outside solvent.  Nevertheless, when Lama et al.77 tested the importance of 
this N-terminal motif by deleting it from trHbN, they found that this decreased the rate of 
nitric oxide oxidation in steady state and nitric oxide titration experiments by seven-fold.  
Further proof of the motif's crucial role in this reaction came from adding it to the N-
terminal end of a homologous HbN protein from Mycobacterium smegmatis where it was 
previously lacking, and observing a two-fold increased rate of nitric oxide oxidation in the 
new mutant HbN.  Molecular Dynamics simulations suggested that the importance of the 
N-terminal motif was linked to its effect on the long tunnel (Fig. 1.3), in particular a 
conformational change which forces the F62 gate into a closed position.77  However, recent 
NMR studies show that in solution this motif does not adopt an alpha helical structure as it 
does in crystal structures, and that its presence had no measurable effects on F62 
dynamics.79   
 1.4.4. Objectives of the trHbN investigations.  The methodology that is described 
in Chapter 2, for rapidly generating NO from an inert precursor using a laser pulse, is 
ideally suited for studying the extremely fast reaction of trHbN with NO.  Chapter 4 of this 
dissertation presents kinetic investigations of the interactions between NO, trHbN, and 
several variants of trHbN, that were made possible by using the laser-initiated 
methodology.  These studies were designed to directly monitor the roles of the putative F62 
gate, active site amino acids Y33 and Q58, N-terminal motif, and other protein features 
that prior studies had identified as important. 
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Chapter 2. 
Developing [Mn(PaPy2Q)NO]ClO4 (where PaPy2Q = N,N-bis(2-
pyridylmethyl)-amine-N-ethyl-2-quinoline-2-carboxamide) as a 
tool for investigating rapid reactions of proteins with nitric 
oxide 
 
2.1. Overview 
2.1.1. Background on metal-based NO photo-precursors.  The study of nitric 
oxide and its interaction with proteins has attracted great interest since the late 1980s due 
to the realization that this small molecule has many important physiological functions.  In 
particular it acts as an intracellular messenger when present in nanomolar concentrations, 
while acting as a highly cytotoxic host defense mechanism when produced in micromolar 
concentrations, due to its reaction with superoxide to form peroxynitrite.1  Nitric oxide’s 
high reactivity makes it difficult to handle, which has led to the creation of a large number 
of stable precursor compounds that release nitric oxide only under conditions readily 
controlled in the laboratory, such as the application of heat, a change in pH, or exposure to 
light.2,3  The interest of the Pacheco lab in reactions with nitric oxide that occur on 
relatively fast time-scales, reaching down to microseconds, has led to an exploration of 
precursors that release nitric oxide upon irradiation with short (nanosecond) laser pulses.  
This chapter will focus on the development of methodologies for using one such precursor 
in enzymatic studies. 
Photo-initiation of reactions has been a hallmark of studying fast timescale 
reactions and transient intermediates ever since the pioneering studies by Norrish and 
Porter.4-6  Caged nitric oxide compounds include organic compounds such as the CNO 
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family,7 as well as a large number of inorganic compounds based mostly on iron,8 or 
ruthenium.9,10  Many of these compounds were created as mimics of bioinorganic metal 
centers found in proteins of particular interest, and a review of these proteins that served 
as muses for particular classes of synthetic compounds makes for interesting and 
illuminating reading.  Design of the NO photo-precursor class that will be the subject of 
this chapter was inspired by a rigorous study of the non-heme iron enzyme nitrile hydratase, 
which showed some interesting and unique chemistry with nitric oxide.  This study will 
now be summarized. 
Nitrile Hydratases (NHase) are a class of metalloenzymes containing either Co or 
Fe which convert nitriles to carboximides.  Since its discovery in Arthrobacter sp. J-1,11 
NHase has been adapted successfully for the large-scale productions of acrylamide and 
nicotinamide, and the treatment of agricultural and industrial wastewater by the production 
of acrylonitrile.12-14 While Co(III) NHase dominates the industrial applications, the Fe(III)-
containing NHase from Rhodococcus sp. N-771 attracted particular interest because it is 
inactivated by nitric oxide, but can be reactivated if the NO is removed by photolysis.15  
This was the first experimental evidence for photo-reactivation utilizing nitric oxide in 
biology.16,17 
Crystallographic studies of the active form of NHase from Rhodococcus sp. R312, 
and of the inactive nitrosylated form of NHase from Rhodococcus sp. N-771, showed that 
in each case the Fe center was formed by two mainchain amide nitrogen atoms, two 
cysteine ligands post-translationally modified to sulfenic and sulfinic acids, and one 
unmodified cysteine.18-20  The sulfinic and sulfenic acid cysteine residues 112 and 114, 
along with Serine 113, were hypothesized to form a “claw” setting for nitric oxide and to 
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be important factors for nitric oxide binding to the metal center.  Calculations showed that 
light photolytically cleaved the Fe-NO bond by promoting an electron into an orbital with 
σ*(Fe-NO) character.17,21 
 Bioinorganic chemists became interested in NHase due to its unique metal center, 
which was the first example of a metalloenzyme that contained deprotonated carboxamido 
nitrogens, along with sulfur from cysteine in complex with a metal center, as well as 
sulfinic and sulfenic acid cysteine ligations.22  The exceptional photo-activation quantum 
yield of 0.48 found by laser photolysis also led to speculation that photo-reactive 
compounds could be modeled after this novel iron center of NHase.15,23  NHase synthetic 
models from a number of different groups gave insights into how the metal environment 
of NHase gives an Fe(III) that is more labile, and acts as a Lewis acid instead of 
participating in redox reactions.24,25  The presence of deprotonated carboxamido nitrogens 
ligated to the Fe(III) center of NHase garnered particular interest.26  Carboxamido N 
linkages to low-spin non-heme Fe with N or S coordination proved to stabilize the Fe(III) 
redox state over Fe(II), shifting the redox potential as much as 1 V to the negative and 
protecting the Fe against hydrolytic decomposition to a degree.25   
While studying the effects of ligating a single carboxamido nitrogen to Fe(III) in 
2002, Mascharak and co-workers reported nitric oxide photolability in the nitrosyl species 
[(PaPy3)Fe(NO)](ClO4)2 (Fig. 2.1, where PaPy3 is N,N-bis(2-pyridylmethyl)amine-N-
ethyl-2-pyridine-2-carboxamide: a pentadentate ligand with a built-in single carboxamide 
group).27,28  This compound, in which the metal center has {Fe(NO)}6 configuration,29 
correctly mimicked the photochemical characteristics of the nitrile hydratase active site.28  
Iron nitrosyls of this kind, however, proved unstable under biological conditions due to  
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Figure 2.1.  Chemical Structure of the PaPy3M(NO)+ complexes (Species 1 when M = 
Mn).  
 
 
 
 
  
Figure 2.2.  Chemical Structure of PaPy2QM(NO)+ (Species 2 when M = Mn). 
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reactions with oxygen,30-32 and NOx disproportionation.33  This led to the creation of 
ruthenium and manganese versions of the compound: [(PaPy3)Ru(NO)](BF4)2 and 
[(PaPy3)Mn(NO)]ClO4 (Fig. 2.1).34,35  These complexes were shown to be potent NO 
delivery systems, suitable for biological applications, when irradiated with UV (Ru 
complex) or visible (Mn complex) light.  Their physiological utility was demonstrated in 
studies of light-dependent activation of soluble guanylate cyclase in rat thoracic aortic ring 
models, while their applicability to the study of fast NO reactions was revealed in a study 
of NO binding to cytochrome c oxidase with an apparent lifetime of 77 µsec.35-37  
Attempts to increase the photo-activity of the ruthenium and manganese complexes 
led to the synthesis of a new ligand, PaPy2QH, where the pyridine directly connected to 
the carboxamido group in PaPy3H is replaced with a quinolone (Fig. 2.2).  The hope was 
that this would act as a light harvesting group directly ligated to the metal.  In support of 
this hypothesis, the ruthenium nitrosyl derived from PaPy2QH proved to have increased 
photo-activity at several wavelengths of incident light.38  Even more interesting was the 
related Mn derivative, which showed photo-activity upon illumination with near IR 
radiation with wavelengths as long as 900nm.39  This was the first metal nitrosyl with both 
biological stability and activation by light at such low energy wavelengths.40 
 Computational studies of MnPaPy3NO (1) and MnPaPy2QNO (2) were done to in 
an attempt to discover how these complexes were able to release nitric oxide using much 
lower energy light (500-800nm) than their Ruthenium-based counterparts.41,42  Early 
studies suggested that the ruthenium(III) complexes' nitric oxide photo-lability arose from 
symmetry-allowed charge transfer transitions from bonding to antibonding molecular 
orbitals within the metal-NO -backbond; the authors refer to such transitions as “dπ_π* 
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→ π*_dπ”.9,43  Merkle et al. subsequently explained why NO was photo-labilized by 400 – 
450 nm light in the Mn compounds, instead of UV light as in the Ru compounds, by 
invoking an admixing of metal(d) → L(Py_π*) charge transfer character into the dπ_π* → 
π*_dπ charge transfer transitions for the Mn complexes.41,42  This explanation, however, 
did not account for the ability of complexes 1 and 2 to be photo-labilized with wavelengths 
as long as 800nm.  At such low energies only dxy → L(Py/Q_π*) transitions are 
theoretically predicted, which disallows any direct excitation of  dπ_π* → π*_dπ 
transitions.  Furthermore, direct excitation of a dπ_π* → π*_dπ transition could not explain 
why NO photorelease is so much greater for species 2 than species 1, given that the dπ_π* 
→ π*_dπ transition is predicted to have very similar energies for both 1 and 2.  Taken 
together these facts suggest that nitric oxide release by 600 – 800 nm light must occur 
through a different mechanism than the direct mechanism described for ruthenium (III) 
complexes.  Merkle et al. suggested an indirect pathway by which photo-excitation first 
occurs via the dxy → L(Py/Q_π*) transition, which can then populate a low-lying dxy → 
π*_dπ excited state; the latter transition has zero oscillator strength and so can’t be directly 
induced by irradiation.  Once formed though, the dxy → π*_dπ excited state can undergo 
intersystem crossing into a dxy → π*_dπ triplet state, which has a weakened Mn-NO bond 
that makes it suited for photo-release of nitric oxide.41,42  Ligand effects on the energy of 
the dxy → L(Py/Q_π*) excited state, and the sizable extinction coefficients in the 600-
800nm range, make the manganese nitrosyl complexes highly tunable for NO photo-
release. 
 2.1.2. The problem of uncontrolled NO release.  Controlling nitric oxide 
concentration physiologically and in in vitro experiments means not only having a 
26 
 
procedure to generate it where and when it's needed, but also being able to eliminate it 
when necessary.  Compounds that irreversibly react with nitric oxide are sometimes called 
nitric oxide sinks, and physiologically these include proteins studied by the Pacheco lab 
such as myoglobin (discussed in Chapter 3),44 or truncated Hemoglobin N from 
Mycobacterium tuberculosis (discussed in Chapter 4).45  Ruthenium complexes have 
attracted attention as potential synthetic NO sinks because of the high stability of the Ru-
NO bond, which persists through a variety of redox and substitution reactions.46-48  
[RuIII(EDTA)H2O] (RuEDTA, Fig. 2.3) has shown particular promise due to its incredibly 
efficient and strong bonding to nitric oxide, displaying a 2nd order rate constant of 2.24107 
M1 s1, and binding constant greater than 108 M1.49  Investigations into the use of 
RuEDTA as a therapeutic agent gave hope for its utility in septic shock therapy,50 as well 
as tumor treatment.51  On the downside RuEDTA in aerobic aqueous environments is 
known to form μ-oxo RuIII-RuIV dimers,52 which may cause difficulties for physiolgical 
applications, since the bioavailability of this dimer is unknown.  Because of this researchers 
interested in therapeutic applications of NO scavengers have also investigated 
[RuIII(H3dtpa)Cl], which does not show a tendency to dimerize (most likely because of 
the pKa of the H2O molecule of 8.3).53  This compound has been tested for applications in 
treatment of inflammation 54, inflammatory cascade management during cardiopulmonary 
bypass,55 and cardiac allograft rejection.56  For in-vitro applications, those of interest in the 
Pacheco lab, the eventual dimerization of RuEDTA is of little consequence, so 
[RuIII(H3dtpa)Cl] will not be discussed further herein. 
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Crystallographic studies of RuEDTA show that the ruthenium is coordinated by two 
nitrogen atoms and three carboxylate groups of the EDTA, with H2O taking up the sixth 
position (Fig. 2.3).57  The fourth carboxylate group of EDTA is commonly referred to as 
the “pendant group”, does not directly coordinate to the ruthenium, and appears to be the 
cause of the high lability of water from this complex.  It has been suggested that the pendant 
group labilizes the water by interacting with it and creating a somewhat open area for an 
incoming nucleophile,58,59 though this hypothesis has not gone unopposed.  An alternative 
hypothesis suggests that activation for attack by the incoming nucleophile is a result of 
transient binding by the pendant group to the 
ruthenium itself.60  Whatever the specific 
mechanism, substitution of the pendant group 
significantly alters the rate at which RuEDTA binds 
to nitric oxide, and therefore its utility as a nitric 
oxide sink.61  In particular in RuMEDTA, where the 
pendant group is substituted with a methyl (Fig. 
2.3), the rate of nitric oxide binding is decreased by 
four orders of magnitude from 2.24107 M1 s at 
7.3 C for RuEDTA, to 3103 M1 s1 at 15 C for 
RuMEDTA.61 
 This chapter covers the synthesis of the 
photo-active nitric oxide donor [Mn(PaPy2Q)(NO)]ClO4 (2), as well as the NO scavengers 
RuEDTA and RuMEDTA, with particular attention to several difficult steps that have been 
under-described in the available literature.  The chapter also introduces the reader to the 
Figure 2.3.  Chemical Structures 
of RuEDTA and RuMEDTA: 
RuMEDTA, R = CH3; RuEDTA, 
R = CH2COO.
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photochemical properties of 2 that must be considered when designing experiments in 
which 2 is used to study rapid reactions of nitric oxide with proteins.  Two studies in which 
species 2 was actually used will be described in Chapters 2 and 3.  Finally, this chapter 
shows how RuMEDTA in particular can be used to capture nitric oxide slowly released 
from 2 prior to laser photo-initiation, which can interfere with particularly sensitive 
experiments.  Kinetic studies of RuMEDTA binding nitric oxide will also be presented.  
2.2. Materials and Methods 
2.2.1. General materials.  All reagents were purchased from Sigma-Aldrich or 
Fisher Scientific unless otherwise specified.  Methanol and ethanol were distilled over 
magnesium methoxide or magnesium ethoxide, respectively, under anaerobic conditions.  
Nitrogen, and argon gas were purchased from Airgas, while nitric oxide gas was purchased 
from Praxair and purified by bubbling through a 2M NaOH solution, and then drying over 
NaOH pellets before use.  The pH-change activated NO precursor 1-(N,N-
diethylamino)diazen-1-ium-1,2-diolate (DEANO) was prepared by the method of Drago 
and Paulik,62 and handled as described by Purwar et al.63 
 2.2.2. Instrumentation.  Routine UV/Vis spectra were obtained using a Cary 50 
spectrophotometer (Varian); an instrument installed in the glovebox was used for air-
sensitive measurements.  Photochemical fragmentation of 2 (Fig. 2.2) was initiated with 
10 ns, 500 nm pulses from an OPO tunable laser (Opotec Rainbow Vis).  An Olis RSM-
1000 Spectrophotometer measured the absorbance changes induced in solution by the laser 
pulse.  The configuration of the laser and spectrophotometer equipment was as described 
in general terms elsewhere 64,65, except that the laser pulse was transmitted by fiber optic 
cable instead of by mirrors.  Except where noted, in all experiments the solutions were held 
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in 1.5 mm  1.5 mm fluorometer submicro cuvettes (Starna).  The laser pulse was focused 
as a spot of ~5 mm diameter, which irradiated the entire cuvette window.  The laser pulse 
energies were measured before each day of experiments using a Scientech AC2501 
bolometer; typical pulse energies were 3 mJ/pulse.   
 Where needed the redox-active dyes indigo di-, tri- and tetrasulfonate were 
electrochemically reduced in a bulk electrolysis vessel, using a BASi Epsilon EC 
potentiostat to set the potential to 300mV, and a Ag/AgCl electrode (BASi, Model RE-
5B) as a reference.  Once reduced the reactions of the mediator dye solutions with putative 
oxidants could be monitored by UV/vis spectroscopy using one of the Cary 50 
spectrophotometers.  Cyclic voltammograms of methyl viologen were collected before 
setting the potential of the bulk electrolysis solution, and the calculated midpoint potentials 
were used to account for any drift in the reference electrode (the midpoint potential of 
methyl viologen was taken to be 0.449 V vs SHE).66   
NMR spectra were obtained on a Bruker DPX300 with a 5 mm broadband (BBO) 
probe. 
 2.2.3. Synthesis of species 2.  The NO photo-precursor 2 (Fig. 2.2) was synthesized 
using the procedure described by Eroy-Reveles et al;39 important details are provided 
below.  At each stage in the synthesis of the ligand N,N-Bis(2-pyridylmethyl)amine-N-
ethyl-2-quinolinecarboxamide (PaPy2QH), the intermediate product purities were 
confirmed by NMR.   
The synthesis of ethylquinaldate from quinaldic acid was straightforward and 
exactly as previously described,39 except that longer reflux times and addition of slightly 
                                                 
 Indigo disulfonate is more commonly referred to as “indigo carmine”. 
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more sulfuric acid slightly improved the yields (see Results and discussion). A mixture of 
1.83 g (9.09 mmol) of ethylquinaldate, 2.73 g (45.47 mmol) of ethylenediamine, and 1.4 
mL of pyridine was heated on a boiling water bath for 4 hours, after which the solvent was 
removed at reduced pressure, and the remaining oil was acidified to pH 5 with concentrated 
HCl.  After diluting with 30 mL of H2O, the aqueous solution was washed with CH2Cl2 (2 
 100 mL).  Concentrated NaOH was then added to the aqueous layer until no more 
precipitation occurred, or the pH of the solution was 11.  The desired product was extracted 
from the aqueous layer with CH2Cl2 (4  75 mL), after which the organic layer was dried 
over anhydrous MgSO4 and filtered.  Removal of the solvent afforded the product (N-(2-
aminoethyl)-quinolinecarboxamide) as a yellow oil.  After storage at 20 C overnight this 
oil solidified to a pale yellow solid that could be crushed to a powder, before further 
removal of solvent under a vacuum.   
 A mixture of 1.47g (6.83 mmol) of N-(2-aminoethyl)-quinolinecarboxamide, 22.24 
g (13.66 mmol) and 2-(chloromethyl)-pyridine hydrochloride (Picolyl Chloride), dissolved 
in 3.6 mL of deionized H2O and 2.8 mL of 10 M NaOH, was stirred at 70 C for 4 h.  At 
this point 45 mL of saturated NaOH solution was added to the mixture, and the desired 
product (PaPy2QH) was extracted into CH2Cl2 (4  75 mL); the first CH2Cl2 aliquots were 
brown, while the final one was pale yellow.  The pooled brown organic layer was washed 
successively with H2O adjusted to pH 5 using HCl (7  130 mL), saturated brine solution 
(3  100 mL), and 10 M NaOH solution (3  100mL).  Finally, the CH2Cl2 solution was 
dried over anhydrous MgSO4 and filtered.  Removal of the solvent afforded the ligand as 
a dark brown oil. 
 The synthesis of Mn(PaPy2Q)(OH)]ClO4 basically followed the procedure of Eroy-
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Reveles et al,39 but we found that it was critical to do the synthesis under rigorously dry 
and anaerobic conditions, in order to ensure that the desired product crystallized.  This in 
turn was essential for obtaining pure 2 in the subsequent step. 
Important note: the final synthesis of 2, and all subsequent manipulations of this 
species, must be carried out in as near as practicable to total darkness.  A batch of 100 
mg (1.6 mmol) Mn(PaPy2Q)(OH)]ClO4 was dissolved in 20 mL of a MeCN/MeOH 
mixture (2:18) and thoroughly degassed with argon.  The reaction vessel was then wrapped 
in aluminum foil to keep it dark, and nitric oxide gas was passed over the solution for 10 
minutes.  The maroon solution was stored under positive nitric oxide pressure overnight 
while stirring at room temperature.  The solution was then transferred to a 20 C freezer 
for at least 24 hours until green crystals of species 2 formed.  All manipulations of 2 in 
solution after its synthesis were done in dark rooms equipped with red lights that were kept 
as dim as possible. 
The Kinetics of the final reductive nitrosylation of Mn(PaPy2Q)(OH)]ClO4 were 
measured by running the reaction in a vessel that contained a port through which aliquots 
of the solution could be extracted using a gastight syringe.  Aliquots were taken from the 
mixture every forty minutes, diluted 1:100 in H2O, and examined by UV-Vis spectroscopy 
in the 200 – 800nm range.  Additional nitric oxide gas was added after every two 
measurements.  
 The concentration of nitric oxide produced by a laser flash was determined by time-
resolved UV/Vis spectrophotometry using the OLIS rapid scanning instrumentation 
described in Section 2.2.2.  The concentration could be calculated directly using the known 
extinction coefficient spectrum of 239 when 2 was present in high concentrations (200-800 
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µM), or indirectly by coupling the nitric oxide release to production of nitrosylated catalase 
when 2 was present at low concentrations (5-30 µM).  In these cases approximately 8 µM 
catalase were added to act as a reporter, and the spectral changes observed after photolysis 
in the 380 – 602 nm range were fit using the known extinction coefficient spectra of 
catalase and its nitrosylated derivative.63,67   
 2.2.4. Synthesis of RuMEDTA and RuEDTA.  [RuCl5H2O]K2, 
Methylethylenediaminetriacetate (MEDTA), [RuIII(EDTA)H2O] (RuEDTA), and 
[RuIII(MEDTA)H2O] (RuMEDTA) were synthesized following literature procedures.59,68-
70  One point of note is that it proved essential to synthesize [RuCl5H2O]K2 fresh in the lab 
using the method of Mercer et al;68 commercially available material did not produce the 
desired results.  Note that the UV/Vis extinction coefficients calculated for the synthesized 
RuEDTA and RuMEDTA products were lower than the literature values, suggesting that 
the products were contaminated by non-absorbing impurities.  The crude products were 
used for the preliminary studies described here. 
 2.3. Results 
 2.3.1. Synthesis of species 2.  The first three steps in the synthesis of photo-active 
species 2 required very few changes from the original published procedure of Eroy-Reveles 
et al.39  During ethyl quinaldate synthesis it wasn't uncommon to allow the solution to 
reflux for 48 hours instead of the prescribed 24 h, and add an extra 1 mL of sulfuric acid to 
the reaction mixture.  With such minor changes yields as high as 95% could be obtained.  
Also, it is important that when neutralizing with sodium bicarbonate the reaction mixture 
is poured into the sodium bicarbonate and not vice versa.  Due to the above, it proved 
convenient in this neutralization step to use 100 mL of saturated sodium bicarbonate 
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instead of the literature prescribed 20 mL.  
 The only notable change during the synthesis of N-(2-Aminoethyl)-2-
quinolinecarboxamide was a step in which the literature instructions were to make the 
reaction mixture basic by adding 30mL of pH 10 NaOH solution.  This proved ineffective, 
so in the current work the pH of the reaction mixture was adjusted to pH 11 with 
concentrated NaOH (~10M), or until additional precipitate no longer formed.  Using this 
procedure high yields of the desired product were obtained. 
 After obtaining the PaPy2QH ligand the literature gives two possible reaction 
pathways for the final two inorganic synthetic steps.39  A recent paper implies that species 
2 is best obtained from the intermediate Mn(PaPy2Q)(H2O)]ClO4;41 however, the original 
reference of Eroy-Reveles et al. cautions that this species is air-sensitive, and recommends 
making 2 from the stable intermediate Mn(PaPy2Q)(OH)]ClO4.39  The latter procedure was 
used in this work.  Synthesis of Mn(PaPy2Q)(OH)]ClO4 followed the published procedure, 
but care was needed to keep the reaction dry and anaerobic, or the product didn’t 
crystallize.  Most likely exclusion of water was the critical parameter, but this was most 
readily accomplished by blanketing the reaction mixture with dry argon, which excluded 
oxygen as well. 
 The published final step in the synthesis of 2 appears straightforward, but in 
practice product purification after the fact proved difficult.  At first no green crystals would 
form, but an impure brown powder could be obtained by adding 30 mL of ether to the 20 
mL reaction solution.  Later studies showed that this impure product contained oxidizing 
equivalents of uncharacterized Mn(III) compounds (see Section 2.3.4), which could 
complicate its use for certain experiments.  To obtain crystalline 2 it was essential to use 
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crystalline Mn(PaPy2Q)(OH)]ClO4 as starting material. 
 2.3.2. A kinetic study of the formation of 2 from Mn(PaPy2Q)(OH)]ClO4.  The 
realization that Mn(III) species could be contaminating non-crystalline preparations of 2 
immediately raised the possibility that one such species could be unreacted 
Mn(PaPy2Q)(OH)]ClO4 starting material.  To determine if enough time was being allowed 
for the reductive nitrosylation of Mn(PaPy2Q)(OH)] a new reaction vessel was designed 
that would allow aliquots of the reacting solution to be removed for analysis without 
introducing air into the vessel.   
Figure 2.4a shows the UV/Vis absorption spectra taken during the reductive 
nitrosylation of Mn(PaPy2Q)(OH)]ClO4 for the synthesis of 2.  Spectra of reaction mixture 
aliquots diluted 1:100 with water were taken every 40 minutes.  Figure 2.4b is an 
absorbance vs. time slice taken at 500 nm through the spectra of Fig. 2.4a.   This plot shows 
that the absorbance at 500 nm increases linearly for about 300 min (6 h), then plateaus.   
The nitrosylation step was usually allowed to proceed for at least 8 h, which should be 
enough under the reaction conditions of Fig. 2.4.  Note however that Fig. 2.4b shows the 
nitrosylation to be essentially zero-order in Mn(PaPy2Q)(OH)]ClO4.  Therefore, if the 
amount of starting material were to be doubled in future syntheses, the time allowed for 
the reaction should also be doubled. 
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Figure 2.4. (a) UV-Vis absorption spectra taken every 40 minutes for 8 hours during the 
reductive nitrosylation of 100 mg (1.6 mmol) Mn(PaPy2Q)(OH)]ClO4 using reaction 
mixture aliquots diluted 1:100 in H2O.  (b) Absorbance vs time slice taken at 500 nm 
through the spectra of (a). 
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2.3.3. Nitrosative properties of NO photo-precursor 2.  Figure 2.5 shows the 
amount of NO that was generated after irradiating a pH 7 solution initially containing 20 
M 2 and 8.7 M catalase in a 0.3 cm pathlength fluorescence cell, with a 500 nm laser 
pulse.  The amount of NO produced was calculated from the known extinction coefficient 
difference spectrum catNO – cat.63,67  Under these conditions the initial pulse produced 
about 2.5 M NO, after which the amount of NO present increased linearly at a rate of 
about 24 nM/s.  The linear increase is attributable to NO photolysis caused by the 
spectrophotometer probe beam.  This experiment was repeated with concentrations of 2 
varying from 5 to 30 µM to determine how the concentration of NO released depended on 
the concentration of 2 initially present.  Similar experiments were also done with solutions 
initially containing 200 – 800 µM 2.  At the higher concentrations of photo-precursor the 
amount of NO generated could be determined directly from the spectral change arising 
from denitrosylation of 2, sample spectral changes associated with these experiments are 
provided in Chapter 3. 
 In Fig. 2.6 the data obtained in the presence and absence of catalase are combined 
to show how the amount of NO generated by the laser pulses varied as a function of [2].  
This is seen to initially increase as [2] increases, but then to level off.  The data were fit 
using Equation 2.1, which is an empirical equation that seeks to take into account self- 
[ ][ ] [ ] bNO a e   22   Eq. 2.1 
screening by the photo-precursor.  Thus, at very low concentrations of 2 the amount of NO 
generated is predicted to increase roughly linearly with a slope a as predicted by Beer’s  
                                                 
 The experiments in the presence of catalase were carried out by Jennifer McGarry of the Pacheco group. 
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 Figure 2.5.  Concentration of nitric oxide produced after a solution initially containing 20 
µM of photo-precursor 2 and 8.7 µM catalase in a 0.3cm pathlength cell was irradiated by 
a single ~3 mJ laser pulse of 500 nm light.  Red line: linear fit to the data, which yielded a 
y-intercept of 2.4920.002 µM and a slope of 24.23  0.07 nM/s.  Reaction conditions: 50 
mM HEPES buffer adjusted to pH 7; see text for details. 
 
 Figure 2.6.  Amount of NO released in solutions containing varying amounts of photo-
precursor 2, housed in 0.3cm  0.3cm pathlength fluorescence cells, by irradiation with 
single 500 nm, ~3 mJ laser pulses.  Red trace: least-squares best fit to Eq. 2.1. 
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law.  However, as the concentration of 2 increases solution near the cuvette window begins 
to screen the laser pulse from the solution deeper inside the cuvette, which is the solution 
sampled by the spectrophotometer probe beam.  At this point the increase in NO photo-
generated departs from linearity and levels off.  Presumably the amount of NO released 
would actually decrease at even higher concentrations of 2. 
 The experiments summarized in Fig. 2.6 were done using a 0.3 cm  0.3 cm 
pathlength fluorescence cuvette, which in retrospect is not optimal when self-screening is 
an issue.  In later experiments the Pacheco group has switched to 0.15 cm  0.15 cm cells.  
Though the decreased pathlength for the probe beam decreases sensitivity, decreasing the 
depth that the laser pulse must penetrate roughly doubles the maximum concentration of 
nitric oxide that can be produced per pulse; with the shorter pathlength NO concentrations 
as high as 160 µM have been generated (see for example Chapter 3). 
 2.3.4. Oxidative properties of non-crystalline preparations of species 2.  Crude 
preparations of 2 were found to be oxidizing agents in experiments where they were added 
to solutions of reduced redox-active dyes.  In preparation for these experiments a solution 
containing 150 µM each of the reduced dyes indigo di-, tri and tetrasulfonate, in 1 M NaCl, 
50 mM HEPES buffer adjusted to pH 7,  was prepared as described in Section 2.2.2.  One 
aliquot of this solution was then mixed with one equivalent of buffer to give a solution with 
a concentration of 75 µM/mediator, and the subsequent spectral changes were monitored 
by UV/Vis spectroscopy in a glovebox every 15 s for 30 min (Fig. 2.7).  The slow 
absorbance increase with time seen at 616 nm is due to re-oxidation of the dyes in the 
absence of any added oxidizing agents.  Presumably the small amount of oxidation 
observed is due to residual oxygen in the glovebox, so this experiment serves as a control  
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for the experiments below. 
 Figure 2.8a shows the spectral changes observed after mixing an aliquot of the 
reduced dye solution 1:1 with a solution containing NO formed from the precursor 
DEANO.63  The mixed solution contained roughly 150 µM NO in addition to 75 µM of 
each of the dyes.  Figure 2.8b shows an absorbance vs. time slice through the Fig. 2.8a 
spectra taken at 616 nm.  The peak with maximum absorbance at 616 nm now grows in 
more rapidly than in Fig. 2.7, demonstrating that NO can oxidize the reduced dyes.  The 
red trace in Fig. 2.8b is an exponential least-squares best fit to the data, and it shows that 
the dyes are being oxidized with a half-life of about 6.7 min (400 s). 
Figure 2.7.  UV/Vis spectral changes observed after 
mixing 300 µL of a solution containing 150 µM each of 
reduced indigo tetra-, tri-, and disulfonate, and 1 M NaCl 
in 50mM HEPES buffer adjusted to pH 7, with 300 µL of 
NaCl-free HEPES buffer (final concentrations of 75 µM 
fer each of the mediators, and 0.5M NaCl).  After mixing 
UV/Vis spectra were taken every 15 seconds for 30 
minutes. 
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Figure 2.8. (a) UV/Vis spectral changes observed after mixing 300 µL of a solution 
containing 150 µM each of reduced indigo tetra-, tri-, and disulfonate, and 1 M NaCl in 
50mM HEPES buffer adjusted to pH 7, with 300 µL of a solution containing NO generated 
from the precursor DEANO.  The mixed solution contained roughly 150 µM NO in 
addition to 75 M of each reduced dye.  Spectra were taken every 15 seconds for 30 
minutes.  (b) Absorbance vs time slice taken from (a) at 616 nm; the red trace is the least-
squares best fit with an exponential function.  
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Figure 2.9 shows the spectral changes observed after mixing an aliquot of the 
reduced dye solution 1:1 with a solution of Mn(PaPy2Q)(OH)]ClO4 to give a final 
concentration of 143 µM of the complex.  In this case there is an immediate oxidation of 
the dyes within the deadtime of the experiment, presumably by the Mn(III).  Note however 
that, over time, the amplitude of the 616 nm signal in Fig. 2.8 surpasses that of Fig. 2.9, 
indicating that eventually the presence of NO leads to a greater extent of dye oxidation.  A 
possible explanation of this would be if the midpoint potential of Mn(PaPy2Q)(OH)+ is 
comparable to those of the mediators (30 mV, 80 mV and 125 mV for the tetra- tri- and 
disulfonate, respectively), so that an equilibrium is established between oxidized and 
reduced species. 
Figure 2.9.  UV/Vis spectral changes observed after mixing 300 µL of a 
solution containing 150 µM each of reduced indigo tetra-, tri-, and 
disulfonate, and 1 M NaCl in 50mM HEPES buffer adjusted to pH 7, with 
300 µL of a solution containing Mn(PaPy2Q)(OH)]ClO4.  The mixed 
solution contained 143µM Mn(PaPy2Q)(OH)]ClO4 in addition to 75 M 
of each reduced dye.  Spectra were taken every 15 seconds for 30 
minutes. 
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Figure 2.10. (a) UV/Vis spectral changes observed after mixing 300 µL of a solution 
containing 150 µM each of reduced indigo tetra-, tri-, and disulfonate, and 1 M NaCl in 
50mM HEPES buffer adjusted to pH 7, with 300 µL of a solution containing the NO 
precursor species 2 from a crude preparation.  The mixture nominally contained 900 µM 
of 2 in addition to 75 M of each reduced dye. Spectra were taken every 15 seconds for 30 
minutes.  (b) Absorbance vs time slice taken from (a) at 616 nm; the red trace is the least-
squares best fit with a combined exponential and linear function (Eq. 2.2). 
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Figure 2.10a shows the spectral changes observed after mixing an aliquot of the 
reduced dye solution 1:1 with a solution containing NO precursor species 2 from a crude 
preparation, so that the mixture nominally contained 900 µM of 2.  Figure 2.10b shows an 
absorbance vs. time slice through the Fig. 2.10a spectra taken at 616 nm.  The spectra of 
Fig. 2.10a look different from those of Figs 2.7 – 2.9 because species 2 absorbs in the 500 
nm – 800 nm range, and contributes to them.  Nevertheless one can still distinguish the 
characteristic signal at 616 nm from the indigo dyes growing over the underlying signal 
from species 2.   The spectral changes can be modeled with a combined exponential and 
linear function (Eq. 2.2; red trace Fig. 2.10b).  The exponential phase has  
0
616 616 (1 )ktA A Amp e b t        Eq. 2.2 
a half-life of about 90 s, which is about 4.5 shorter than that seen in Fig. 2.8b for dye 
oxidation by large amounts of NO generated from DEANO.  This suggests that the 
exponential oxidation phase may be caused by the presence of other oxidants, such as 
Mn(III) species, in addition to NO released during sample preparation but before mixing.  
The amplitude of the exponential phase is 0.017 absorbance units, or about 4% of that 
observed in Fig. 2.8b in the presence of 150 M NO.  The linear oxidation phase seen in 
Fig. 2.10b is most likely due to NO released from 2 by photolysis with the 
spectrophotometer probe beam, as seen also in Fig. 2.5.  Finally, note that the 616 nm signal 
at t = 0 is non-zero in Fig. 2.10, even after correcting for the contribution from species 2.  
This could be due to “instantaneous” oxidation comparable to that seen in the presence of 
143 µM Mn(PaPy2Q)(OH)]ClO4; however, a non-zero absorbance at t0 is also observed in 
Fig. 2.8, where NO was generated from DEANO, and even in Fig. 2.7 where no oxidant 
was specifically added.  Thus, some dye oxidation appears to occur within the stock upon 
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standing, so the t0 absorbance in these experiments is not a meaningful parameter. 
 2.3.5. Estimate of latent nitric oxide release.  The results shown in Fig. 2.10 
suggest that even in highly pure solutions of 2, some NO release may be occurring ahead 
of laser photo-initiation.  Figure 2.11 shows the results of an experiment designed to 
quantify the extent of such pre-release of NO.  In this experiment 10.0 µM of met-
myoglobin (metMb) was reduced using 100 µM indigo tetrasulfonate, in a solution that 
also contained 600 M pure 2.  The solution was then transferred to a cuvette and 
illuminated with a 500 nm, ~3 mJ laser pulse.  Fig. 2.11a shows the UV/Vis spectra taken 
before and after the laser pulse, while Fig. 2.11b shows the difference between these 
spectra.  The red trace in Fig. 2.11b is the least-squares best fit of the difference spectrum 
using the independently obtained extinction coefficient spectra of reduced myoglobin 
(Mbred), nitrosylated myoglobin (MbNO), and 2.  From the absorbance change attributed 
to photolysis of 2 one can estimate that about 60 M NO were released by the laser pulse, 
well in excess of the amount required to nitrosylate 10 M Mbred.  However, the absorbance 
change in Fig. 2.11b attributable to Mbred nitrosylation is only 5.4 M, which indicates that 
4.6 M was already nitrosylated prior to the laser pulse.  This can also be seen qualitatively 
from inspection of the absolute spectra in Fig. 2.11a.  Thus, it appears that species 2 is 
sufficiently photo-active that over time it can release about 1% of its NO prior to laser 
irradiation, even when handled only under very dim, dark-room-red illumination. 
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Figure 2.11.  (a) UV/Vis spectra of a solution initially containing10 µM Mbred, 100 µM 
indigo tetrasulfonate, and 600 µM 2, before (black trace) and after (red trace) illumination 
with a 500 nm laser pulse.  (b)  Black trace: difference spectrum obtained from the traces 
from (a); red trace: least-squares best fit of the difference spectrum using the independently 
obtained extinction coefficient spectra of Mbred, MbNO and 2. 
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 2.3.6. RuMEDTA as a nitric oxide sink.  For the experiments reported in Chapters 
3 and 4 of this dissertation the protein reacting with NO was always in large excess, so 
small amounts of NO released prior to laser irradiation were not a problem.  However, in 
other studies it is sometimes necessary to photo-generate from 2 an amount of NO in excess 
of the protein with which it is reacting.  In such experiments even a small amount of NO 
leakage prior to laser pulse irradiation can become a major problem.  A possible solution 
to this difficulty is to add an NO scavenger to the stock solution of 2; in this section the 
suitability for this purpose of the complex RuMEDTA is explored.  RuMEDTA reacts with 
NO relatively slowly (the reported rate constant is 3000 M1s1), but binds it strongly.61  
The expectation was that such a species would keep the solution NO concentration very 
low in stock solutions prior to mixing in the protein of interest, but that after the pulse 
RuMEDTA would react with newly photo-generated NO too slowly to compete with the 
reaction between NO and the intended protein.  This hypothesis was tested in two 
experiments that used catalase as the test protein.  Catalase (Cat) binds NO rapidly and 
strongly with a binding constant of 8.7106, and the rate constants for both NO binding 
(1107 M1s1) and dissociation (1.6 s1) are known,63 with the former being 4300 larger 
than the reported rate constant for NO binding to RuMEDTA.61 
Figure 2.12a tracks the amount of nitrosylated catalase (CatNO) present at various 
times following laser pulse irradiation of a solution initially containing 23.5 µM Cat, 125 
µM 2, and nominally 210 µM of RuMEDTA.  The concentration of CatNO was calculated 
from the independently obtained UV/Vis extinction coefficients at 434 nm of Cat and 
CatNO.  As expected the NO generated by the laser pulse initially reacts rapidly with Cat 
to generate CatNO, in a reaction phase that is complete within a few milliseconds.  Over  
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Figure 2.12. (a)  Concentration of nitrosylated catalase (CatNO) present at various times 
following 500 nm laser pulse irradiation of a solution initially containing 23.5 µM Cat, 125 
µM 2, and nominally 210 µM of  RuMEDTA.  The concentration of CatNO was calculated 
from the independently obtained UV/Vis extinction coefficients at 434 nm of Cat and 
CatNO.  (b) Same (a), but the solution initially contained nominally 840 µM RuEDTA.  
Buffer: 50mM HEPES, 0.5 mM EDTA adjusted to pH7.  Red traces: least-squares best fits 
using Eq. 2.3. 
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the next 60 s or so the concentration of CatNO in solution decreases as NO is transferred 
to RuMEDTA.  However, [CatNO] does not decrease to zero, indicating that the NO 
ultimately equilibrates between Ru- and Cat-bound species.   
 
 
 
 
Scheme 2.1 shows the relevant reactions, from which one can derive the differential 
equation 2.3.  Conveniently, values are available in the literature for all of the parameters  
22
2 2
[CatNO][RuMEDTA][Cat][RuMEDTA(NO)]d[CatNO]
dt [Cat] [RuMEDTA] [Cat] [RuMEDTA]
offon
on on
k kk k
k k k k
    Eq. 2.3 
in Eq. 2.3 except k2,61,63 while all the concentrations are either obtained directly from the 
spectral changes, or calculated from stoichiometric considerations.  The red trace in Fig. 
2.12a was obtained from a least-squares fit of the data to Eq. 2.3, using a k2 value of 0.034 
s1 , and a k2 value of 30,000 M1s1; surprisingly the literature value of k2 = 3,000 M1s1 
could not be made to give even modestly reasonable fits, while 30,000 M1s1 gave a robust 
minimum in the sum of squares.  This suggests the possibility of a typographical error in 
the original reported value,61 but a more thorough investigation will be needed to validate 
this possibility.  From the values of k2 and k2 one can calculate the binding constant for 
the interaction between NO and RuMEDTA to be 8.8105 M1. 
 Figure 2.12b shows the results of a second experiment in which all the reaction 
conditions were kept the same as in the experiment of Fig. 2.12a, except that nominally 
Scheme 2.1.  Competition for NO between catalase 
(Cat) and RuMEDTA 
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840 M of RuMEDTA were used instead of 210 M.  Qualitatively the results of Fig. 2.12b 
are as expected: the concentration of CatNO after the laser pulse decreases more rapidly, 
and the net equilibrium predicted by Scheme 2.1 lies further to the right, in the presence of 
the higher RuMEDTA concentration.  However, attempts to fit the data using the 
parameters obtained from the Fig. 2.12a fit were unsuccessful.  The red trace in Fig. 2.12b 
was obtained using a k2 value of 5103 s1 (~10 smaller than obtained from the Fig. 2.12a 
fit) and by artificially inflating the RuMEDTA concentration to 1.01 mM from the nominal 
840 M value.  Such large deviations from the expected values show that a more extensive 
study will be needed to quantitatively characterize the reactivity of RuMEDTA with NO.  
2.4. Discussion 
2.4.1. The challenge of obtaining crystalline species 2.  The experiments 
described in Section 2.3.4 show that Mn(PaPy2Q)(OH)]ClO4 is a reasonably strong 
oxidizing agent, and demonstrate the importance of ensuring that neither this starting 
material or other Mn(III) species are left in the final preparations of 2, if this compound is 
to be used in experiments that are sensitive to oxidation.  The kinetic study described in 
Section 2.3.2 shows that the conversion of Mn(PaPy2Q)(OH)]ClO4 to 2 is zero-order in 
starting reagent (Fig. 2.4), so one must be careful to increase the reaction time in proportion 
with the amount of 2 being prepared.  One should also be careful to ensure that enough NO 
is provided: 0.1 g (1.6 mmol) of Mn(PaPy2Q)(OH)]ClO4 will require at least 2 equiv (3.2 
mmol) NO, which in a closed system at 1 Atm and 298 K, will require the reaction vessel 
to have 80 mL or greater capacity.   
The published procedure for obtaining crystalline 2 is to simply leave the reaction 
mixture in a freezer overnight;39 however, in our hands this method gave low yields, 
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typically 3-6 mg (3-6 %) of crystalline product, even when dry and anaerobic technique 
was used in both this step and in the synthesis of the precursor Mn(PaPy2Q)(OH)]ClO4.  
The low yield is more than enough for many applications given that very little product is 
needed for photochemistry, but some future optimization is warranted if 2 is to be 
extensively used.  One alternative method that was tried was to add 15 mL of ether as 
precipitant for every 10 mL of the reaction mixture in MeCN/MeOH, which basically 
combined elements from the current procedure with a step from the synthesis of 2 from 
Mn(PaPy2Q)(H2O)]ClO4.39  This method did afford crystals at a high yield (26mg or 28%) 
for one trial, but the result proved difficult to repeat.  The use of dry anaerobic ether and 
rigorous Schlenk technique seemed to be essential, but even so later trials always yielded 
an impure solid upon ether addition.   
 2.4.2. The use of RuMEDTA as a sink for prematurely released NO.  The 
experiments summarized in Fig. 2.12 confirm that RuMEDTA has the desired properties 
for a NO scavenger that specifically targets NO prematurely released from 2.  Such a 
scavenger should bind NO tightly and reasonably fast, but much more slowly than the 
proteins being investigated using the laser photo-initiation method.  Our results suggest 
that the rate constant k2 (Scheme 2.1) for the interaction between RuMEDTA and NO may 
be 10 higher than previously reported (30,000 M1s1 instead of 3,000 M1s1),61 but is 
still orders of magnitude smaller than the rate constants for NO binding to proteins such as 
catalase, or other heme proteins of interest to the Pacheco group.  Consequently, Fig. 2.12 
shows that in the presence of as much as 800 M RuMEDTA, essentially all of the NO 
generated by the laser pulse will react initially with the protein of interest.  Competition 
between the protein and the RuMEDTA can occur over longer time scales if NO 
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dissociation from the protein under consideration is appreciable, but for many applications 
this is not a complication; indeed, it may be used to obtain information, such as the 
magnitude of the protein’s NO dissociation rate constant.   
 In contrast to RuMEDTA, the more extensively investigated RuEDTA has a rate 
constant greater than 107 M1s1.71  This is in the same ballpark as the NO associative rate 
constants of many heme proteins such as catalase (1.3107 M1s1),63 so RuEDTA would 
directly compete for NO on the timescale of interest.  One could still envision using 
RuEDTA as a scavenger in low concentrations, in experiments where very large quantities 
of NO were being photo-generated.  Under such conditions a certain amount of the photo-
generated NO would indeed react with the scavenger, but plenty more would still be 
available for interacting with the protein of interest.  Thus RuMEDTA could be used as an 
NO sink in the stock concentration of 2, but a small amount of RuEDTA would be added 
along with the protein of interest to ensure that no NO reacted with the protein of interest 
until the laser pulse created more NO than there was RuEDTA, and the excess would then 
react with the intended protein.  This system would allow the researcher to completely 
avoid NO reacting with the intended protein until the laser pulse occurred.  RuEDTA has 
been synthesized for this purpose, but requires further characterization before use. 
 NO doesn’t bind RuMEDTA as tightly as it does RuEDTA (Kb ~ 9105 M1 
compared to > 107 M1 for RuEDTA),71 but this binding should be sufficiently tight for 
many applications.  Fortuitously the difference in binding constants seems to be about 10 
smaller than the difference in associative rate constants. This is because the rate constant 
governing dissociation of NO from RuMEDTA actually appears to be smaller than that 
governing dissociation of NO from RuEDTA; thus we estimate the half-life for NO 
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dissociation from RuMEDTA to be ~22 s, whereas it would be ~3 s for RuEDTA.71  It may 
be that the pendant carboxylate in RuEDTA, which is believed to help open a binding site 
for NO to occupy,61,71 also contributes to the labilization of NO once bound.  
 
   
Scheme 2.2.  An alternative NO photo-precursor used in earlier studies of NO – protein 
interactions. 
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2.4.3. Comparison of species 2 with an earlier NO photo-precursor.  Prior to 
using species 2 as a photo-active precursor for NO, the Pacheco group had used the organic 
compound N,N′-bis(carboxymethyl)- N,N′-dinitroso-1,4-phenylenediamine (species 3, 
Scheme 2.2) in a series of protein studies,64,72,73 and published three papers on the 
properties of this species.64,65,74  It is thus worthwhile to consider the relative merits of the 
two photo-precursors as NO delivery vehicles.   
Photolysis of species 3 is initiated by a UV laser pulse (308 nm), which sets in 
motion the reactions shown in Scheme 2.2.  In the first step the laser pulse causes 3 to 
fragment, yielding NO and the radical species 4.  This radical can recombine with NO, or 
it can dissociate a second NO to give the stable species 5 (step 2).  When producing very 
low concentrations of nitric oxide the rate of the back-reaction in step 1 is negligible 
compared to step 2, and 2 equivalents of NO are obtained for every equivalent of 3 
photolyzed.  However, as more of species 3 is photolyzed the second-order back-reaction 
between NO and 4 begins to dominate the first-order decomposition of 4 to 5, and the 
amount of NO generated per laser pulse levels off.  In practice this limits the amount of 
NO that can be photo-generated to the low micromolar range.64,74  The amount of NO 
generated can be increased significantly in the presence of a sacrificial electron donor that 
reduces 4 to the stable species 6 (step 3, Scheme 2.2),65,74 but this strategy must be used 
with caution as the resulting perturbation of the solution potential can complicate data 
interpretation.  
Species 2 has several advantages over the older photo-precursor 3 for our purposes.  
First, it can be activated with visible light instead of UV.  Second, in contrast to the first 
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step in Scheme 2.2 the initial photolysis of 2 is effectively irreversible, and the Mn(II) 
photoproduct has proved to be inert in studies performed so far (the net reaction is shown 
in Scheme 3.1 of the next chapter).  Third, though the yields from the initial photolysis of 
both 2 and 3 are very high, the irreversibility of species 2 photolysis allows yields above 
100 M to be obtained in optimized systems (see Chapter 3).  By contrast the maximum 
yields from photolysis of 3 are in the low micromolar range, unless a sacrificial electron 
donor is added to the solution.  One of the advantages of species 2 is also its principal 
disadvantage: its extreme photosensitivity throughout the visible spectrum means that it 
releases NO when exposed to even the very low-level red light used during sample 
preparation. 
2.4.4. Summary.  [Mn(PaPy2Q)(NO)]ClO4 (2) was successfully synthesized and 
tested for use as a photo-activated precursor of nitric oxide in fast timescale UV/Vis 
absorption experiments with catalase or other proteins that react rapidly with NO.  The 
study represents the first instance of this compound being used for microsecond timescale 
kinetic studies.  The maximum amount of nitric oxide produced from 2 photolysis to date, 
using a 3 mJ 500nm laser pulse, and irradiating solution contained in a 0.15 cm path cell, 
was 180 µM.  This vastly exceeds the amount of NO that could be generated from species 
3 (Scheme 2.2). Premature nitric oxide release from 2 prior to the laser pulse was observed 
using nitrosylation of Mb, and was quantified as ~1% of the caged nitric oxide available in 
the solution.  This led to the synthesis of RuEDTA and RuMEDTA, and the successful 
testing of RuMEDTA as a potential nitric oxide sink, that would take prematurely released 
NO out of solution when necessary. 
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Chapter 3 
 
Does the oxidation of nitric oxide by oxy-Myoglobin share an 
intermediate with the met-Myoglobin-catalyzed isomerization 
of peroxynitrite? 
 
3.1. Overview 
 The reaction of nitric oxide with oxy-myoglobin (oxyMb) to form ferric myoglobin 
(metMb) and nitrate, and the metMb-catalyzed isomerization of peroxynitrite to nitrate, 
have long been assumed to proceed via the same iron-bound peroxynitrite intermediate 
(metMb(OONO), Scheme 1.1, also shown as Scheme 3.1 in this chapter for easy 
reference).1-5.  More recent research showed that the metMb-catalyzed isomerization of 
peroxynitrite to nitrate produces detectable amounts of nitrogen dioxide and ferryl 
myoglobin (ferrylMb).6  This suggests a mechanism in which the peroxynitrite binds to the 
metMb, ferrylMb is transiently generated by dissociation of NO2, and nitrate is formed 
when the NO2 nitrogen attacks the ferrylMb oxo ligand.  The presence of free NO2 and 
ferrylMb products reveals that small amounts of NO2 escape from myoglobin’s interior 
before recombination can occur.  Free NO2 and ferrylMb should also be generated in the 
reaction of oxyMb with NO, if the common intermediate metMb(OONO) is formed.  
However, this chapter presents a series of time resolved UV/Vis spectroscopy experiments 
in which no ferrylMb was detected when oxyMb and NO reacted.  The mechanistic 
implications of this observation will be discussed. 
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Scheme 3.1. Proposed mechanisms for the reaction of NO with oxyMb, and of 
peroxynitrite with metMb, highlighting the proposed common pathways for the two 
processes (see also Scheme 1.1). 
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3.2. Materials and Methods 
All reagents were purchased from Sigma-Aldrich or Fisher Scientific unless 
otherwise specified.  The light-activated NO precursor [Mn(PaPy2Q)NO]ClO4 (Scheme 
3.2, species 1, where PaPy2Q is the pentadentate ligand N,N-bis(2-pyridylmethyl)-amine-
N-ethyl-2-quinoline-2-carboxamide), and the pH-jump activated NO precursor 1-(N,N-
diethylamino)diazene-1-ium-1,2-diolate (DEANO),7 were prepared by the methods of 
Eroy-Reveles et al. 8 and Drago and Paulik,9,10 respectively.  Horse-heart myoglobin as 
obtained from Sigma was in the metMb form.   This was reduced in a glove box using an 
excess of electrolytically-generated methyl viologen monocation radical11 to generate 
ferromyoglobin (Mb), which could in turn be converted to oxyMb by exposure to ambient 
air.  FerrylMb was generated by exposing metMb to excess hydrogen peroxide, which was 
then removed by adding ~10−8 M catalase, as previously described.6  Nitrosylated metMb 
(metMbNO) and Mb (MbNO) were prepared by exposing metMb and Mb, respectively, to 
NO gas generated in situ from DEANO.9,10  Extinction coefficient spectra were obtained 
for all the above-mentioned forms of myoglobin. 
 
 
Scheme 3.2. Photolytic cleavage of 1 to produce an aquo species and free NO. 
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All experiments described herein were carried out in solutions buffered at pH 7.4 
using 2-[4-(2-hydroxyethyl)-piperazin-1-yl]ethanesulfonic acid (HEPES) sodium salt, and 
made using 18 M purified water.  Stock solutions of most reagents were made up in 50 
mM HEPES.  In the case of ascorbate, a 1.25 M stock solution was made by dissolving 5.5 
g of ascorbic acid and 7.45 g of HEPES sodium salt in 50 mL water, and then adjusting the 
pH to 7.4 with NaOH or HCl, as appropriate.  Reaction mixtures were made by combining 
appropriate volumes of the stock solutions.  Routine UV/Vis spectra were obtained using 
CARY 50 spectrophotometers (Varian); an instrument installed in the glovebox was 
available for air-sensitive measurements.   Photochemical fragmentation of species 1 was 
initiated with 10 ns, 500 nm, laser pulses generated using an OPO tunable laser (Opotec 
Rainbow Vis).  An OLIS RSM-1000 spectrophotometer was used to monitor the 
absorbance changes induced in the reaction mixture by the laser pulse.  The configuration 
of the laser and spectrophotometric equipment was as described in general terms 
elsewhere,12,13 except that the laser pulse was transmitted via an optical fiber instead of by 
using mirrors.  Reactions with lifetimes of less than 2 ms were monitored with the OLIS 
RSM-1000 in fixed wavelength mode. Data arrays that tracked the changes in the complete 
spectra as a function of time were then constructed from multiple absorbance vs. time traces 
collected for the same reaction at varying wavelengths.  For reactions with lifetimes higher 
than 2 ms data were collected with the OLIS RSM-1000 in rapid-scanning Average 1 mode, 
which provides 62 scans/s (1 scan every 16 ms).  After verifying that no significant changes 
were occurring on the ms timescale, the raw spectra were further averaged to obtain spectra 
spaced 160 ms apart.  For all experiments the solutions were held in 1.5mm × 1.5mm 
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fluorometer sub-micro cuvettes (Starna).  The laser pulse was focused as a spot of ~5mm 
diameter which irradiated the entire cuvette window.  The laser pulse energies were 
measured before and after each day’s experiments using a Scientech AC2501 bolometer; 
typical pulse energy intensities at the cuvette were ~ 15-18 mJ/cm2. 
All data were analyzed using programs written within the commercially available 
software packages Origin version 6.0 (Microcal Software) or Mathcad 13 (PTC Software).  
The analysis strategies used in our laboratories have been previously described;7,13-16 
details specific to this work are provided in Appendix 1. 
3.3. Results 
In this study NO was generated photochemically by irradiating the photoactive 
manganese nitrosyl complex 1 (Scheme 3.2).8  When species 1 is irradiated with a 500 nm, 
10 ns laser pulse it fragments in less than 1 μs to release free NO and an aqua-substituted 
product of 1, as shown in Scheme 3.2.  This is a very convenient way of generating NO in 
an aerobic solution of oxyMb, because under the reaction conditions free NO is in contact 
with free oxygen for less than 0.5 ms before it is all consumed in the reaction with oxyMb.2  
Thus unwanted side-reactions, particularly the formation of NO2 from direct interaction 
between NO and O2, are easily avoided.  For the purposes of the present study species 1 is 
superior to other known NO photo-precursors for two reasons.  First, the NO can be 
generated in large quantities (as high as 150 μM in the present study) using long-
wavelength light (500 nm or longer); other high-yield NO photo-precursors that were used 
in the past by this research group require UV laser pulses.13  Second, the aquated 
photoproduct of 1 is not very reactive on the timescales being investigated, as is verified 
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in experiments described below.  Many other NO photo-precursors fragment to yield 
products that are either strong oxidants 13 or strong reductants,17,18 which can take part in 
side-reactions on the timescales of interest, thus complicating their use in experiments. 
 
 
 
Figure 3.1. Difference spectrum obtained immediately after 
irradiating a solution of 316 μM oxyMb and 1.66 mM 1 with a 500 nm 
laser pulse. Solid blue trace: experimentally obtained data. Dashed red 
trace: calculated by least-squares fit using the extinction coefficient 
spectra of oxyMb, metMb, ferrylMb, and 1. Dashed green trace: same as 
red trace but using the Mb extinction coefficient spectrum instead of the 
ferrylMb one. The fitted experimental spectrum was the average of the 
first 20 raw spectra collected every 16 ms using the Olis 
spectrophotometer (absorbance remained essentially constant throughout 
this time period, which allowed for signal averaging). 
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3.3.1. Experiments with no ascorbate added.  Figure 3.1 shows the difference 
spectrum obtained immediately after irradiating a solution of 316 μM oxyMb and 1.66 mM 
1 with a 500 nm laser pulse.  The Fig. 3.1 difference spectrum can be fitted reasonably well 
using the independently known extinction coefficients of metMb, oxyMb, 1 and ferrylMb 
(Fig. 3.1, red dashed trace).  Based on this fit, the changes in concentrations of the various 
species are calculated to be ΔCmetMb = 81 μM, ΔCoxyMb = ΔC1 = −86 μM, and ΔCferrylMb = 
5 μM.  Note however that this method is quite insensitive, and a similar fit can be obtained 
using the extinction coefficients of metMb, oxyMb, 1 and Mb (Fig. 3.1, green dashed 
trace).  In this case the calculated concentrations of the species are ΔCmetMb = −ΔC1 = 82 
μM, ΔCoxyMb= −86 μM, and ΔCMb = 4 μM.  Neither fit is improved by adding in 
contributions from the extinction coefficient spectrum of MbNO.  The presence of either 
ferrylMb or Mb is mechanistically plausible: if a peroxynitrite intermediate is formed from 
the reaction of oxyMb with NO, then ferrylMb is an expected product.6  On the other hand, 
the rapid reaction of oxyMb with NO also consumes O2, thus perturbing the equilibrium 
between oxyMb, free Mb and dissolved O2.
If one accepts the hypothesis that the same metMb(OONO) intermediate is 
generated in the reaction of oxyMb with NO and in the metMb-catalyzed isomerization of 
peroxynitrite (Scheme 3.1), then it is possible to estimate the expected final product 
distribution using only kinetic parameters available in the literature.2,6,19-22  The relevant 
reactions, together with the associated kinetic parameters and the source references, are 
shown in Scheme 3.3.   Su and Groves estimated that the rate for in-cage recombination of 
NO2 and ferrylMb to form metMb(ONO2) is ~10× that of cage escape by NO2 (kr/ke ~ 10 
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in Scheme 3.1).6  For the reaction that gave rise to the Fig. 3.1 results, in which ~86 μM of 
oxyMb reacted with an equivalent amount of photogenerated NO, this would mean that 
initially about 8 μM ferrylMb, 8 μM free NO2 and 78 μM metMb should have been 
generated.  This estimate of ferrylMb generated is about twice that calculated in the red 
trace analysis of Fig. 3.1, but doesn’t take into account the subsequent fate of the NO2, 
which can itself react with oxyMb, ferrylMb and NO as shown in Scheme 3.3.19,20  Using 
the literature values of the rate constants for the Scheme 3.3 reactions it is straightforward 
to predict the expected product distributions as a function of time (see Appendix 1).  Figure 
3.2 shows the calculated time evolution of all the species in Scheme 3.3, assuming initial 
concentrations [oxyMb] = 316 M and [NO] = 86 M, where the NO concentration is 
taken as equal to the amount of 1 photolyzed, as calculated from the Fig. 3.1 fit.  Notice 
that the Fig. 3.2 calculations predict that, under the given experimental conditions, the 
reactions of NO2 with the various Mb species will themselves result in a net increase in the 
ferrylMb concentration, so that after 10 ms the ferrylMb will reach ~16 M.  Thus, the 5 
M ferrylMb calculated in the red trace analysis of Fig. 3.1 is less than a third that predicted 
for the reaction of oxyMb with NO, if one assumes that the reaction goes via the same 
intermediate as the metMb-catalyzed peroxynitrite isomerization.6 
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 Figure 3.2.  Time evolution of reactant and product concentrations that is expected 
following the reaction of 85.6 µM NO with 316 µM oxyMb (initial concentrations in the 
Fig. 3.1 data), if one assumes a metMb(OONO) intermediate in common with the metMb 
+ ONOO− reaction.  Concentrations were calculated using numerical integration of the 
corresponding rate equations, and the known rate constants given in Scheme 3.3, as 
described in Appendix 1.  Panel (a) shows major species, panel (b) minor ones. 
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3.3.2. Experiments in the presence of ascorbate.  The result presented above 
places an upper bound on the amount of ferrylMb produced when NO is photogenerated  
from 1 in the presence of a large excess of oxyMb, but leaves open the question of whether 
any ferrylMb is in fact produced.  This is because the Fig. 3.1 spectrum is equally well 
fitted if one assumes that Mb is a minority species instead of ferrylMb.  Furthermore, the 
minor features in the residual trace of Fig. 3.1 allow for the possibility that minority species 
Scheme 3.3.  Known reactivities of NOx species with various Mb 
forms expected to be relevant on the timescale of milliseconds.  
Rate constants for each reaction were either experimentally 
determined in this work or available from literature.  References 
for the rate constants are as follows: (a) Ref 35; (b) Ref 19; (c) Ref. 
21; (d) Ref 18; (e) Ref 17.  
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other than Mb or ferrylMb are also contributing to the Fig. 3.1 spectrum, and one can’t 
assess the significance of such species from analysis of single spectral traces such as Fig. 
3.1.   
In order to more precisely quantify the amount of ferrylMb produced in the reaction 
of photogenerated NO with excess oxyMb, the Fig. 3.1 experiment was repeated in the 
presence of varying amounts of ascorbate, with continued monitoring of the reaction 
solution over tens of seconds.  FerrylMb reacts with ascorbate in a second-order process 
governed by a rate constant of 2.7±0.8 M−1s−1,23 which should generate a readily 
detectable, ascorbate concentration-dependent kinetic fingerprint with a many-second 
lifetime.  When a solution containing 272 M oxyMb, 1.66 mM 1 and 200 mM ascorbate 
was irradiated with a 500 nm laser pulse, an analysis analogous to that of Fig. 3.1 above 
showed initial product distributions of either ΔCmetMb = 96 μM, ΔCoxyMb = ΔC1 = −100 μM, 
and ΔCferrylMb = 4 μM, or ΔCmetMb = −ΔC1 = 97 μM, ΔCoxyMb= −100 μM, and ΔCMb = 3 μM 
(see Appendix 1).  The experiment was then followed for an additional 45s after the initial 
laser pulse, and double-difference spectra were generated by subtracting the first difference 
spectrum from every subsequent one.  Figure 3.3a shows a number of these double-
difference spectra, collected at selected times after the laser pulse, and refined using 
singular value decomposition (see Appendix 1).24,25  Figure 3.3b shows corresponding ΔAλ 
vs time traces at selected wavelengths.  The complete set of double-difference spectra, 
collected at varying times and wavelengths, can be fitted empirically using a model that 
builds the spectra from the known extinction coefficients of Mb, metMb, oxyMb and 
species 1, and accounts for the time dependence of ΔA at each wavelength using Eq. 3.1.   
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Figure 3.3. Spectral changes that follow irradiation of a solution initially containing 
272 μM oxyMb, 1.72 mM 1 and 200 mM ascorbate with a 500 nm laser pulse.  (a) Double-
difference spectra obtained by subtracting the first difference spectrum (equivalent to the 
Fig. 1 spectrum) from all subsequent difference spectra that followed the laser pulse.  The 
representative spectra shown here were collected 0, 2, 4, 6, 8, 10, 20, 30, and 45s after the 
initial spectrum.  Theoretical traces (dashed red lines) were calculated as described in 
Appendix 1.  Arrows indicate regions where spectral changes are monotonic, while stars 
indicate regions in which ΔA first increases and then decreases.  (b)  ΔA vs t slices at 
selected wavelengths, corresponding to the data shown in (a).  The short orange trace shows 
the absorbance change at 596 nm that would accompany the reduction of 4 μM ferrylMb 
to metMb by 0.2 M ascorbate 
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The detailed fitting procedure is described in Appendix 1.  Equation 3.1 shows that at any 
given wavelength two components contribute to the total absorbance change, one varying 
linearly and the second exponentially with time.  The parameter m represents the rate of 
change of the linear component (in AU/s), while Ainf and k represent the final 
amplitude and rate constant, respectively, for the exponential component.  The calculated 
spectra and time traces are overlaid on the experimental data of Figs. 2.3a and 2.3b.  From 
the fitting procedure the changes in concentration with time of Mb, metMb, oxyMb and 
NO (indirectly obtained from the concentration change of 1) were calculated; these are 
plotted in Fig. 3.4.  In addition, the value of the rate constant governing the exponential 
part of Eq. 3.1 was calculated to be k = 0.133±0.005 s−1. 
     
Given the 2.7 M−1s−1 rate constant for the reaction of ferrylMb with ascorbate,23 any 
ferrylMb present immediately after the laser pulse should have subsequently been reduced 
by the 200 mM ascorbate in a pseudo-first order process with kobs = 0.54 s−1, which 
translates to a half-life of 1.3 s.  The Fig. 3.3 kinetic data show no evidence for such a 
kinetic process.  If 4 M of ferrylMb had in fact been present immediately after irradiating 
the reaction solution, as suggested by spectral analysis analogous to that which produced 
the red trace of Fig. 3.1 (Appendix 1), it should then have reacted with ascorbate to generate 
metMb, giving rise to a detectable spectral signature with maximum amplitude at 596 nm.  
Figure 3.3b compares the absorbance change expected from the reduction of ferrylMb to 
metMb with that actually observed at 596nm.  Though the predicted change is small, it 
should have been clearly resolvable given the low noise of the data obtained on this  
Eq. 3.1 
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Figure 3.4.  (a) Changes in concentration of the myoglobin species that gave rise to the 
spectral changes of Fig. 3.2, calculated as described in Appendix 1.  Also shown is the 
increase in [NO] with time that was effected by photolysis of 1 in the spectrophotometer 
probe beam.  This was calculated from the absorbance change that accompanied the 
denitrosylation of 1.  (b) Similar to (a), this plot shows the total myoglobin reduced from 
the Fe(III) to the Fe(II) state as a function of time. 
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timescale (a conservative estimate suggests that 1-2 M ferrylMb should have been 
detectable by the applied method.  Furthermore, the theoretical analysis of Scheme 3.3 and 
Fig. 3.2 predicts a spectral change that is ~3-4× larger.  On the basis of the Fig. 3.3 analysis 
one can therefore conclude that ferrylMb is not present in detectable quantities (> 1-2 M) 
by the time the first post-laser flash spectra are collected, 16 – 160 ms after the laser pulse.  
Other minor species, such as Mb (e.g.: green trace, Fig 3.1), may be present at this point. 
 
 
Scheme 3.4.  Expected reactions between various forms of Mb, dioxygen and ascorbate.  
Here AH− is ascorbate, and A−● is the ascorbyl radical.  Two equivalents of H2O are 
generated in step 3, one of which binds to Fe(III) in the metMb.  
 
The results presented in Figs. 3.3 and 3.4 can be qualitatively explained on the basis 
of NO formed by photolysis of 1 in the spectrophotometer probe beam, and of the known 
reactivity of ascorbate with oxyMb and metMb that is outlined in Scheme 3.4.6,23,26  The 
linear increase in NO concentration shown in Fig. 3.4 (ΔCNO/Δt = 4.7×10−7 Ms−1)  arises 
from photolysis of 1 by the spectrophotometer probe beam, as can be verified by submitting 
solutions of pure 1 to the same treatment (Appendix 1).  The NO so generated will 
immediately react with oxyMb to produce metMb, thus contributing to the concentration 
changes of these two species.  Step 3 of Scheme 3.4 is a second process that results in a net 
oxidation of oxyMb to metMb.26  In this process one equiv. of ascorbate first reacts with 
oxyMb to generate metMb and H2O2.26  The metMb and H2O2 then react to give ferrylMb 
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cation radical (ferrylMb+, formally Mb with Fe(V)),26,27 which is rapidly reduced by two 
equiv. of ascorbate back to metMb.  The net process of step 3 Scheme 3.4 results in the 4-
electron reduction of O2 to give 2 equivs. of H2O (one of which binds to the Fe of oxidized 
myoglobin), with 3 of the necessary electrons coming from ascorbate and 1 equivalent from 
the myoglobin Fe(II).  The 3 equivs. of ascorbyl radicals generated in the process 
subsequently disproportionate.23,26  Counteracting the net oxidation of oxyMb to metMb 
by NO and by step 3 of Scheme 3.4 is the reduction of metMb by ascorbate (step 1, Scheme 
3.4).  From experiments with metMb and ascorbate under anaerobic conditions the second-
order rate constant for this reaction is calculated to be 0.053 ± 0.002 M−1s−1 at pH 7.4 
(Appendix 1).  This step initially generates Mb, but in the presence of O2 the Mb is in 
equilibrium with oxyMb (step 2, Scheme 3.4). 
Figure 3.4b shows that over the time period monitored there was a net reduction of 
Fe(III) (metMb) to Fe(II) (oxyMb and Mb), but that the rate of reduction slowed over time.  
Immediately after the laser pulse the reaction mixture contains roughly 97 M metMb, 3 
M Mb and 172 M oxyMb (as determined by analysis analogous to that which produced 
the green trace of Fig. 3.1; Appendix 1).  Presumably, as metMb is subsequently consumed 
and reduced myoglobin is generated, the rates of the net oxidizing and net reducing 
processes move towards a dynamic equilibrium, beyond which no further changes in 
concentration would be observed.  The distribution of reduced species also changes with 
time as seen in Fig. 3.4a.  Step 3 of Scheme 3.4 consumes oxygen, as does the reaction of 
oxyMb with NO, and in the small cuvette employed for the experiments the oxygen is not 
rapidly replaced by diffusion from the surroundings.  Thus, over time, the concentration of 
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oxyMb decreases and that of Mb increases.  Experiments with solutions containing only 
oxyMb and ascorbate in the same type of cuvette showed the same general reactivity 
(Appendix 1), though the exact reaction conditions couldn’t be reproduced in the absence 
of the laser pulse that rapidly consumed an initial quantity of O2. 
In addition to the experiment described above (Figs. 3.3-3.4) similar experiments 
were also performed in the presence of 100 M and 300 M ascorbate (see Appendix 1).  
In all of these experiments the time-resolved spectra lacked the kinetic fingerprint that 
would be expected if ferrylMb had been generated in the reaction of oxyMb with NO, but 
were otherwise consistent with the expected reactivity of the reaction mixtures, as outlined 
in Scheme 3.4.  Finally, to ensure that the reaction of ferrylMb with ascorbate is not altered 
under the specific reaction conditions employed in this study, authentic ferrylMb was 
reacted with ascorbate in the presence and absence of 1, oxyMb or Mb.  In all cases the 
same rate constant was obtained, which in turn agreed with the literature values (see 
Appendix 1).6,23 
 
 
77
 
3.3.3. Stability of ferrylMb in the presence of species 1, with and without laser 
irradiation.  The experiments presented above demonstrate conclusively that no ferrylMb 
is detectable 16 ms after irradiating solutions of oxyMb and 1 with a 500 nm laser pulse.  
However, they do not preclude the possibility that detectable amounts of ferrylMb were 
generated on the µs timescale, but consumed prior to 16 ms in reactions specific to the 
conditions employed.  In order to test for this possibility, several experiments were 
performed with authentic ferrylMb and 1. 
Figure 3.5 shows the spectral changes observed at 409 nm after mixing 4.2 M 
ferrylMb with 238 M 1.  The absorbance at 409 increases exponentially, indicating that 
the ferrylMb is being reduced to metMb with an apparent rate constant of 1.7×10−3 s−1.  
Figure 3.5. Spectral changes observed at 409 nm after mixing 4.2 μM 
ferrylMb with 238 μM 1. Blue circles: experimental data. Red curve: 
theoretical fit to an exponential function. 
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When the experiment was repeated in the presence of half the concentration of 1 the 
apparent rate constant also decreased by half, showing that the reduction is first order in 
[1], and second order overall.  The value of the true second-order rate constant for reduction 
of ferrylMb in the presence of 1 is therefore ~ 7 M−1 s−1.   In the experiments with oxyMb 
and 1 described above the concentration of 1 was typically between 1.5 and 2 mM, 
therefore one expects any ferrylMb generated under those conditions to be reduced with a 
half-life of ~ 50 – 65 s.  This reaction is too slow to eliminate ferrylMb before it could be 
detected in the experiments of the previous sections; in particular it would not compete 
with the reaction of ferrylMb with 200 mM ascorbate, which is predicted to occur with a 
half-life of 1.3 s. 
As shown in Scheme 3.3, NO reacts rapidly with ferrylMb.  Thus, the spectral 
changes seen in solutions containing ferrylMb and 1 (Fig. 3.5) could simply be due to the 
reaction between ferrylMb and NO photogenerated from 1 in the spectrometer probe beam.  
Alternatively, the Mn(PaPy2Q)H2O+ that is co-generated from photolysis of 1 could also 
contribute to ferrylMb reduction.  These possibilities were addressed in kinetic and 
stoichiometric studies.  In the kinetic experiments species 1 was photolyzed in the presence 
of varying amounts of ferrylMb, and the subsequent reactions were monitored on the s 
timescale (Fig. 3.6).  These experiments were carried out under pseudo-first order 
conditions, such that the concentration of ferrylMb greatly exceeded the amount of NO 
photo-generated in every experiment. The change in absorbance at 409 nm with time was 
exponential at all ferrylMb concentrations (Fig. 3.6a), and plots of kobs vs [ferrylMb] were 
linear (Fig. 3.6b), showing that the reaction was first-order in [ferrylMb] and second-order  
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Figure 3.6. (a) Spectral changes observed at 409 nm after irradiating a solution containing 
50 μM ferrylMb and 40 μM 1 with a 500 nm laser pulse. Blue trace: experimental data. 
Red trace: data fitted to a single exponential. (b) Dependence of the observed rate constant 
on [ferrylMb] when the experiment of part (a) was repeated with varying initial ferrylMb 
concentrations. In all cases, [NO]generated  [ferrylMb]0. 
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overall.  The true second-order rate constant for the reaction was calculated to be 
(1.4±0.1)×107 M−1s−1 from the slope of the Fig. 3.6b line, a value that is close to that 
previously reported in the literature for the reaction between NO and ferrylMb (Scheme 
3.3).21 
The agreement between the rate constant calculated from Fig. 3.6b and that reported 
earlier by Herold and Rehman 21 demonstrates that NO is the fastest reducing agent present 
in photolyzed mixtures of ferrylMb and 1.  If it weren’t, the rate constant calculated from 
Fig. 3.6b would have been higher than Herold and Rehman’s.  The close agreement does 
not, however, exclude the possibility that Mn(PaPy2Q)H2O+ also reduces ferrylMb at rates 
comparable to, or lower than NO.  To address this possible alternative the amount of 
ferrylMb reduced and the amount of NO generated by photolysis of a given amount of 1 
were determined independently, in a set of experiments that are described in Appendix 1.  
In these experiments only one equivalent of ferrylMb was reduced per equivalent of 1 
photolyzed, which shows that NO is the sole reducing agent generated in the photolysis.  If 
Mn(PaPy2Q)H2O+ were also capable of reducing ferrylMb on the sub-second timescale, 
two equivalents of ferrylMb would have been reduced per equivalent of 1 photolyzed in 
these experiments.  Therefore, in the experiments in which solutions of oxyMb and 1 were 
irradiated to generate NO, free ferrylMb generated by homolytic fragmentation of a 
metMb(OONO) intermediate should have still been present 16 ms after photolysis, and 
thus detectable.  
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3.3.4. Evaluation of the Scheme 3.3 model.  Given that ferrylMb was not 
generated in detectable quantities in the present experiments, contrary to the predictions of 
earlier reports as outlined in Scheme 3.3, it is now necessary to assess the sensitivity of the 
Scheme 3.3 conclusions to possible errors in the published kinetic parameters.  One 
question that immediately arises is whether Su and Groves could have overestimated the 
amount of cage escape (Scheme 3.1) that occurred in their experiments; the values of k11 
and k12 in Scheme 3.3 are based directly on this estimate.6  When the numerical simulation 
that they used to obtain the kr/ke estimate of 10 was repeated, this estimate was found to be 
very insensitive to even large variations in the inputted initial concentrations of metMb and 
peroxynitrite.  Therefore, Su and Groves’ estimate for initial ferrylMb generation via cage 
escape cannot be very far off.   
Next to be examined were the possible effects that uncertainties in the Scheme 3.3 
rate constants might have on the predicted time evolution of the ferrylMb concentration.  
Of all the parameters in Scheme 3.3 the one with the greatest reported uncertainty is k6, for 
which the literature value is given as a range (104 M−1s−1 – 107 M−1s−1).20  For the 
calculations that yielded Fig. 3.2 the upper bound was arbitrarily chosen (Appendix 1), but 
a smaller value of k6 is unlikely to change the conclusions; if ferrylMb+ reacts more slowly 
with oxyMb, then it is almost certainly still converted to ferrylMb by other competing 
processes, such as reduction by ascorbate.   
The fact that (k11+k12) and k2 are within 20% of the reported values2,21 was 
independently verified herein (Appendix 1 and Fig. 3.6).  Of the remaining parameters, k3 
and k7 prove to be too small to have any real impact on the outcome of the simulations, 
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given the reaction conditions being modeled.  This leaves k4, k5, k8, k−8 and k9 as parameters 
that could significantly affect the predicted time evolution of [ferrylMb]. 
The parameters k4, k5, k8, k−8 and k9 all govern the fate of the NO2 that putatively 
escapes the protein cage.  Any increase in the ratio k5/k4 will lead to greater net 
recombination of ferrylMb with NO2, thus decreasing the final amounts of both species.  
However, in practice it would take a huge error in the literature derived value of this ratio 
(0.267 from Scheme 3.3) to have any significant effect on ferrylMb survival under the 
reaction conditions being modeled, where at all times the oxyMb concentration far 
exceeded any ferrylMb that might be generated.  Thus, for example, if the value of k4 is 
decreased to 5×106 M−1s−1 and that for k5 is increased to 108 M−1s−1 (both these numbers 
are well outside the reported uncertainties for the respective parameters), a simulation still 
predicts the presence of ~10 M ferrylMb 10 ms after the laser pulse.  A k5 value of 108 
M−1s−1 for ferrylMb reaction with NO2 would make it by far the largest known rate constant 
for the reaction of NO2 with a biomolecule,20 while the k4 value of 5×106 M−1s−1 would be 
at the low end of values reported for the interaction of small gas molecules with either 
oxyMb or Mb.2,20,28,29  And yet, much greater changes in the input rate constants would be 
needed to decrease the ferrylMb concentration below 1-2 M (the estimated detection limit 
for these experiments).   
The processes governed by k8, k−8 and k9 determine the rate at which NO2 is 
consumed independently of ferrylMb.  The value of k8 for reaction of NO with NO2 is at 
the diffusion limit, and so is unlikely to be underestimated.  However, if k−8 is 
overestimated and/or k9 is underestimated in Scheme 3.3, then all else being equal the Fig. 
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3.2 analysis would be overestimating the amount of ferrylMb that is eventually generated 
by reaction of NO2 with oxyMb.  Note however that even in the extreme case whereby 
none of the NO2 resulted in additional ferrylMb formation, one would still see the 10% 
ferrylMb generated by the initial NO2 cage escape, if this were occurring.   
To summarize, even if one assumes much larger uncertainties in the kinetic 
parameters of Scheme 3.3 than are provided with the literature values, ferrylMb is predicted 
to accumulate to concentrations 5 – 10× above the detection limit in the experiments 
presented herein, if the reactions of oxyMb with NO and metMb with peroxynitrite share 
a common metMb(OONO) intermediate, as proposed in Scheme 3.1. 
3.4. Discussion 
3.4.1. No common intermediate between metMb peroxynitrite isomerization 
and oxyMb reaction with NO.  Investigations by the Groves group and others over the 
past decade have shown fairly convincingly that, during metMb-catalyzed isomerization 
of peroxynitrite, some nitration of Tyr103 from the metMb takes place, and ferrylMb builds 
up as a transient but detectable intermediate.5,6,30  These results are consistent with the 
mechanism of Scheme 3.1 path 2, whereby peroxynitrite first binds the Fe heme center to 
produce a metMb(OONO) intermediate, which then rapidly cleaves homolytically to form 
ferrylMb and caged NO2.  The NO2 can then either recombine with the ferrylMb to release 
nitrate, or escape the cage; the latter path gives rise to the ferrylMb that is transiently 
detectable, and to the observed Tyr103 nitration.  In an early report the extent of cage 
escape was estimated to be as high as 20%,30 but this was later revised downward to ~10%.6 
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It has been widely assumed until now that the reaction between oxyMb and NO 
proceeds through the same metMb(OONO) intermediate as the reaction between metMb 
and peroxynitrite (Scheme 3.1); however, if this assumption is correct, then under 
appropriate conditions one should be able to detect the ferrylMb side product due to 10% 
cage escape of NO2, as Groves’ group did when reacting peroxynitrite with metMb.6  The 
fact that this intermediate was not detected in any of the experiments presented herein calls 
the assumption into question.  In this regard the key experiments are those performed in 
the presence of ascorbate (Figs. 3.3, 3.4 and Appendix 1).  Single spectrum analyses such 
as that given in Fig. 3.1 are of limited use because all of the components contributing to 
such a spectrum may not be known.  However, the kinetic analyses of the ascorbate 
experiments are substantially more sensitive to ferrylMb concentration, and relatively 
insensitive to the effects of unknown parameters.  No matter what species are contributing 
to the overall spectra, any spectral changes due to conversion of ferrylMb to metMb should 
have been readily detectable if ferrylMb concentrations greater than 1-2 M had been 
produced from the reaction between oxyMb and photo-generated NO.  This is clear from 
inspection of the short orange trace in Fig. 3.3b, which shows the spectral change at one 
representative wavelength that would be associated with the conversion of 4 M ferrylMb 
to metMb in the presence of 200 mM ascorbate.  However, 4 M is only the largest amount 
of ferrylMb consistent with analysis of the t0 spectrum for the data set (the analogue of the 
Fig. 3.1 spectrum; see Appendix 1).  If the reaction of oxyMb with NO had produced 10% 
ferrylMb, as predicted from the experiments with metMb and peroxynitrite, the amplitude 
of the Fig. 3.3 short orange trace should have been at least twice as large, and according to 
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the extended analysis based on Scheme 3.3 it could have been as much as 4× greater.  
Furthermore, the short orange trace of Fig. 3.3 is only for one wavelength.  The analysis 
presented herein was a global one, and the expected kinetic signature for ferrylMb 
reduction to metMb was absent from the entire monitored spectral region (480 nm – 620 
nm).  The same was true in experiments with 100 mM and 300 mM ascorbate (see 
Appendix 1). 
The experiments with ferrylMb and 1 (Figs. 3.5,3.6 and Appendix 1) show that 
neither 1 nor its photoproduct Mn(PaPy2Q)H2O+ will react with ferrylMb in less than 1s, 
so if this species had been generated from oxyMb and NO it should have persisted long 
enough to react with ascorbate on the timescale of seconds.  Furthermore, the experiments 
with ferrylMb and ascorbate show that the kinetics of this crucial reaction were unaffected 
by the specifics of the reaction conditions (see Appendix 1).  Together, the experiments 
with ferrylMb confirm that this transient species should have been detectable if it had been 
generated in the quantities predicted from experiments with metMb and peroxynitrite,6,30 
via path 2 of Scheme 3.1. 
3.4.2. Possible mechanism for the reaction of NO with oxyMb without a 
peroxynitrite intermediate.  Scheme 3.5 proposes one reaction mechanism for oxyMb + 
NO that would yield a product distribution different from that obtained in the reaction 
between metMb and peroxynitrite.  In this scenario NO directly inserts into the oxyMb O-
O bond, thus completely bypassing the metMb(OONO) intermediate.  Some model studies 
with synthetic iron porphyrin complexes support the hypothesis that different mechanisms 
may operate in reactions of ferric porphyrins with peroxynitrite and in reactions of 
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oxyferrous porphyrins with NO.  For example, Kurtikyan and Ford recently reported 
careful studies in which synthetic complexes with the formula Fe(Por)(NH3)(O2), sublimed 
in vacuo onto liquid nitrogen-cooled CaF2 or KBr surfaces, were exposed to NO gas.31  
Even in these low-temperature studies the first detectable intermediate as the surface 
warmed up was invariably the metMb(ONO2) adduct.  From these studies Kurtikyan and 
Ford concluded that if peroxynitrite intermediates actually formed, subsequent barriers for 
their isomerization to nitrate species were at most ~7 kcal/mol.31  By contrast Lee et al. had 
shown earlier that some water soluble Fe(III)porphyrins react with peroxynitrite to generate 
very long lived oxoFe(IV) species and NO2, that only slowly recombine.32  The Kurtikyan 
and Lee experimental conditions are very different (hydrophobic porphyrins adsorbed on 
surfaces vs. water-soluble porphyrins in aqueous solution), and this alone could explain the 
different product distributions.  Alternatively it is also possible that the Kurtikyan and Ford 
reactions proceeded via a mechanism akin to Scheme 3.5, while those of Lee et al. followed 
path 2 of Scheme 3.1.  It should be noted that Kurtikyan and co-workers did, very recently, 
detect the cobalt equivalent of a peroxynitrite-bound species, and later NO2, when they 
reacted synthetic oxy-coboglobin models with NO, using the surface deposition 
methodology summarized above.33  Also, Schopfer and coworkers have reported indirect 
evidence that synthetic Fe(Por)(NH3)(O2) complexes can react with NO via a pathway akin 
to that shown in Scheme 3.1, path 2.  When tetrahydrofuran (THF) solutions containing 
tyrosine mimic 2,4-di-tert-butylphenol, and oxyMb mimic (THF)(F8)FeIII(O2+) [where F8 
= tetrakis(2,6-difluoro-phenyl)porphyrinate(2-)], were exposed to NO, the nitrated product  
2,4-di-tert-butyl-6-nitrophenol was recovered, as would be expected if free NO2 was being 
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formed from fragmentation of a peroxynitrite intermediate.34 Schopfer et al. did not directly 
observe such an intermediate, but their experiments show that the question is far from 
settled. 
3.4.3. Possible mechanism for the reaction of NO with oxyMb that still allows 
for a peroxynitrite intermediate Scheme 3.6 suggests an alternative to Scheme 3.5 that 
would also allow the reaction mechanism for oxyMb + NO to deviate from that of metMb 
+ peroxynitrite, but wouldn’t preclude a metMb(OONO) transient species in either case.  
In this scenario the metMb(OONO) moiety itself  is formed in both reactions, and 
fragments homolytically to release NO2 into the immediate surroundings of the heme, but 
the conformation of the protein surrounding the heme center is assumed to be significantly 
different in the two cases.  This is depicted in Scheme 3.6 by representing the Fe(II)-derived 
protein conformation by a rectangle surrounding the heme moiety, and that for Fe(III) by 
an ellipse.  If the conformation of the protein derived from metMb were “leakier” than that 
derived from oxyMb (ke2 >> ke1 in Scheme 3.6), this would explain why ferrylMb and NO2 
are produced in the former case and not the latter.  Using the most conservative estimate 
of the detection limit in the ascorbate experiments (~2 M), this mechanism would predict 
that ke2 in Scheme 3.6 is at least 10× greater than ke1.   
The fact that the reaction of oxyMb with NO gives different product distributions 
than that of metMb with peroxynitrite has important implications for researchers 
investigating the possible physiological role of myoglobin and related molecules as NO 
sinks.  Path 2 of Scheme 3.1, which has now been identified as the likely mechanism for 
metMb-catalyzed isomerization of peroxynitrite,6 allows a significant amount of free NO2 
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to escape the protein, and concomitantly results in formation of ferrylMb.  If NO 
dioxygenation by oxyMb were to follow exactly the same path, then removal of the reactive 
NO would be accompanied by generation of NO2 and ferrylMb, which in many ways are 
at least as reactive.  In contrast, the results of this investigation show that oxyMb converts 
NO to NO3− without generating any detectable ferrylMb side product.  This makes a 
physiological role for myoglobin’s NO dioxygenase activity that much more plausible. 
3.5. Material provided in Appendix 1 
 Determination of the rate constant for the reaction of metMb with ascorbate; The 
reaction of oxyMb with ascorbate; The reaction of ferrylMb with ascorbate; Laser photo-
initiated fragmentation of species 1 in the absence of protein; Expected result of mixing 
100 M NO with 272 M oxyMb, if the reaction of oxyMb with NO shared an intermediate 
with the metMb-catalyzed isomerization of peroxynitrite: a numerical simulation of the 
product distribution’s evolution during the first 3 ms; Laser photo-initiated reaction of NO 
with excess oxyMb in the presence and absence of ascorbate: analysis of the data; 
Monitoring the reaction of oxyMb with NO on the microsecond timescale; Stability of 
ferrylMb in the presence of species 1 after laser irradiation: stoichiometric analysis. 
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Chapter 4 
Truncated Hemoglobin N from Mycobacterium tuberculosis: NO 
dioxygenation at the diffusion limit 
 
4.1. Overview 
Mycobacterium tuberculosis, the causative agent for the disease tuberculosis, is 
thought to infect a third of the world wide population.1  This is at least in part due to the 
nitric oxide dioxygenation activity of a small dimeric heme protein known as Truncated 
Hemoglobin N (trHbN) and its impressive efficiency (second-order rate constant of 
7.45108 M1 s1 compared to 4107 M1 s1 for oxygenated myoglobin (oxyMb)).2,3  This 
reactivity protects M. tuberculosis from the NO produced by the host’s immune system by 
converting the toxic substance into benign nitrate.3,4  The simplest explanation for the 
superior efficiency of trHbN relative to myoglobin is the existence of a tunnel system 
connecting the active site to the surface of trHbN which is not seen in myoglobin (Fig 4.1 
and Section 1.4.2); however, over the past 15 years a large number of theoretical and 
experimental studies have expanded on this explanation and provided some possible 
alternatives.5-19   
The high value of the rate constant for the reaction of oxy-trHbN with nitric oxide 
puts this reaction at the limit of those that can be studied by rapid mixing methods such as 
stopped-flow or flash photolysis, so most reactivity studies done to date have involved 
steady-state experiments.  The laser photo-initiation method of generating nitric oxide in 
situ that was presented in Chapter 2, and used to study the interaction of oxyMb with nitric 
oxide (Chapter 3 and ref. 20), is ideally suited for investigating fast reactions of nitric oxide.   
93 
 
 
 
This chapter presents kinetic investigations of the conversion of nitric oxide to nitrate by 
oxy-trHbN (Scheme 4.1), as well as the binding of nitric oxide to reduced trHbN (red-
trHbN, Scheme 4.2), for the wild type protein and a series of mutants.  In particular these 
studies were designed to directly monitor the roles of the putative F62 gate, active site 
amino acids Y33 and Q58, N-terminal motif, and the sensitivity of the dioxygenase activity 
to the heme's midpoint potential (see overview in Section 1.4).  Kinetics for the reaction of 
wild type red-trHbN with NO are also compared to those previously measured for red-
trHbN reaction with dioxygen (kon = 2.5107 M1 s1)4 to gain insight into the proposed 
ligand discriminatory functions of the tunnel system in trHbN. 
Figure 4.1.  Crystal structure of trHbN showing the positions of the 
heme, the two major tunnel systems that presumably allow small 
molecules access to the active site, the putative gating amino acid  
Phe62, and the short -helical N-terminal domain referred to as the 
“pre-A region” (see text for details). 
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Scheme 4.1. Nitric oxide oxidation by oxy-trHbN. 
 
 
 
 
Scheme 4.2. Nitric oxide binding to red-trHbN 
 
4.2. Materials and Methods 
 4.2.1. General materials.  All reagents were purchased from Sigma-Aldrich or 
Fisher Scientific unless otherwise specified.  The light-activated NO precursor 
[Mn(PaPy2Q)NO]ClO4 (species 1, where PaPy2Q is the pentadentate ligand N,N-bis(2-
pyridylmethyl)-amine-N-ethyl-2-quinoline-2-carboxamide) was prepared by the method 
of Eroy-Reveles et al.21 with slight alterations detailed in Chapter 2 
4.2.2. Protein expression, purification and handling.  The gene for Truncated 
Hemoglobin N (trHbN) from M. tuberculosis was synthesized for optimal codon usage by 
Genscript before cloning into a pET19 vector and transforming into BL21(DE3) 
Escherichia coli for expression.  Mutants were either produced in the lab by phusion site-
directed mutagensis PCR (Thermo Scientific Phusion Site-Directed Mutagenesis Kit) or 
purchased from Integrated DNA technologies as a gBlock gene fragment, before restriction 
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and ligation into pET19.  Bacterial cultures were grown overnight at 37 C in LB media, 
after which the cells were concentrated and lysed using a sonic dismembrator (model CL-
334) to release the cell contents, and the resulting suspension clarified by addition of 
streptomycin sulfate to a final concentration of 1% and centrifugation.   
Protein was purified using a two-step purification procedure.  In the first step the 
clarified cell lysate was loaded onto a 50 mL anion exchange Q-Sepharose column (GE 
Healthcare) using a loading buffer consisting of 10 mM 2-[4-(2-hydroxyethyl)-piperazin-
1-yl]ethanesulfonic acid (HEPES) sodium salt, 5104 M ethylenediaminetetraacetic acid 
disodium salt (EDTA), pH 7 (Buffer A).  The protein mixture was then eluted using 500 
mL of a linear gradient starting with Buffer A and ending with Buffer B, which contained 
0.2 M NaCl in Buffer A.  In the second purification step the trHbN-containing fraction 
from step 1 was concentrated to ~1-2 mL and passed through a 500 mL Sephacryl S-100 
Size Exclusion Column (GE Healthcare) using a buffer consisting of 50 mM 
tris(hydroxymethyl)aminomethane hydrochloride salt (Tris/HCl), 5104 M EDTA, and 0.1 
M NaCl adjusted to pH 8.  At each stage of the purification protein purity was assessed by 
monitoring the ratio of A416/A280 in the UV/Vis spectrum, the ultimate goal being to get 
ratios of 3 or higher.  The final purity of the trHbN was assessed by SDS-PAGE gel 
electrophoresis.  The concentration of each purified protein stock solution was determined 
by use of the pyridine hemochrome assay.22  All reported concentrations are for trHbN 
monomer, which is equivalent to the concentration of heme found by the above pyridine 
hemochrome assay. 
TrHbN stock was reduced in an anaerobic glovebox using a slight excess of 
electrolytically produced methyl viologen monocation radical, with Catalase (~1108M) 
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added to avoid the accumulation of hydrogen peroxide from reduction of oxygen in the 
solution.  The reduced solution was then either brought into air to make the oxygen bound 
variant (oxy-trHbN), or used directly from the glovebox without contacting air for 
experiments on the reduced form itself (red-trHbN).  The Q58V Y33F double mutant of 
trHbN required a preliminary step involving oxidation with excess potassium ferricyanide 
trihydrate to clear a bound carbon monoxide from its heme, and clearing out the potassium 
ferricyanide trihydrate from the buffer using 10 kDa MWCO centrifugal filters (centricon); 
after this initial step the protein was treated as above. 
Solutions for the kinetics experiments contained either oxy-trHbN or red-trHbN, 
and the NO photo-precursor 1, in mole ratios ranging from 2:1 to 1:2.  Unless otherwise 
stated the buffer was 50 mM Tris/Cl, 5104M EDTA, pH 8.  Based on previous 
experiments the laser pulse used for these experiments typically released ~10% of the 
possible nitric oxide from a given solution of 1.  Thus, the stated experimental conditions 
were chosen so that the solution NO concentration after the laser pulse would be about 
10% of protein concentration, in order to maintain pseudo-first-order conditions.   
4.2.3. Equilibrium and time-resolved spectroscopic analysis.  Routine UV/Vis 
spectra were obtained using a Cary 50 spectrophotometer (Varian); an instrument installed 
in the glovebox was used for air-sensitive measurements.  Photochemical fragmentation of 
photoactive species 1 was initiated with 10 ns, 500 nm pulses from an OPO tunable laser 
(Opotec Rainbow Vis).  An Olis RSM-1000 spectrophotometer was used to measure the 
absorbance changes induced in solution by the laser pulse.  The configuration of the laser 
and spectrophotometer equipment was as described in general terms elsewhere 23,24, except 
that the laser pulse was transmitted by fiber optic cable instead of by mirrors.   For all 
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experiments the solutions were held in 1.5 mm  1.5 mm fluorometer submicro cuvettes 
(Starna).  The laser pulse was focused as a spot of ~5 mm diameter which irradiated the 
entire cuvette window.  The laser pulse energies were measured before each day of 
experiments using a Scientech AC2501 bolometer; typical pulse energies were 3 mJ/pulse.  
Reactions with lifetimes of less than 10 ms were monitored with the Olis RSM-1000 in 
fixed wavelength mode.  Single wavelength experiments were fit using Origin 6.0 
(Microcal Software) with one- or two-exponential equations.  The apparent rate constants 
obtained from four or more separate experiments, in which protein concentrations were 
varied while keeping the amounts of NO generated sufficiently low to ensure pseudo-first 
order conditions, were then re-plotted against protein concentrations, and the true first- or 
second-order rate constants were obtained from the resulting linear fits.  Complete time-
resolved spectra for reactions with short lifetimes were constructed by combining 
individual time traces collected at specific wavelengths as described above.  The time traces 
were collected in random order relative to the collection wavelength.  The reconstructed 
time-resolved spectra were subjected to Singular Value Decomposition (SVD) to determine 
the number of spectral components and smooth out noise, after which the processed spectra 
were fit to appropriate exponential models using programs custom-built in Mathcad 15 
(PTC Software).  The analysis strategies used in our laboratories have been previously 
described.24-28 
UV/Vis spectro-potentiometric titrations of trHbN were performed using a BASi 
Epsilon EC potentiostat to set the potential, and a CARY Bio 50 UV/Vis spectrophotometer 
to obtain the spectra at each applied potential.  The complete apparatus was housed in an 
anaerobic glove box.  Controlled potentiometric electrolysis of the solution was performed 
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in an optically transparent thin-layer electrode (OTTLE) cell similar to one used in earlier 
experiments by this group28 and others.29,30  In preparation for experiments a solution 
containing oxy-trHbN (106 µM wild-type or 144 µM V80A mutant) and 100 µM each of 
Indigo Tetrasulfonate, Indigo Carmine, and Gallocyanin as mediators, was prepared in a 
buffer containing 50 mM HEPES and 200 mM NaCl, adjusted to pH 7.0.  The oxy-trHbN 
so prepared was then reduced to red-trHbN by controlled-potential electrolysis at 200 mV 
applied potential, using a bulk electrolysis cell rather than the OTTLE cell.  Spectro-
potentiometric titrations were then performed in one of two ways.  In the first method the 
red-trHbN generated by bulk electrolysis was transferred to the OTTLE cell, where UV/Vis 
spectra in the range from 250 – 800 nm were collected at applied potentials ranging from 
200 mV to +100 mV (vs. SHE) in 10 – 20 mV intervals.  The second method was similar 
except that the red-trHbN was fully oxidized to the met-trHbN form in the bulk electrolysis 
cell at +100 mV applied potential, and then subjected to potentials from +100 mV to 200 
mV (vs. SHE) in the OTTLE cell.  The midpoint potentials obtained by the two methods 
were then averaged to account for any biases arising from the OTTLE cell design.  An 
Ag/AgCl electrode (BASi, Model RE-5B) was used as a reference.  Cyclic voltammograms 
of methyl viologen were collected before assembling the spectropotentiometric datasets, 
and the calculated midpoint potentials were used to account for any drift in the reference 
electrode (the midpoint potential of methyl viologen was taken to be 0.449 V vs SHE31).  
Datasets were also collected with identical mediator solutions in the absence of trHbN, and 
these were subtracted from the corresponding trHbN data sets to account for any spectral 
changes during the titration that arose from mediators.  The corrected datasets were 
analyzed using programs written within the commercially available software package 
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Mathcad 15 (PTC Software).  Data analysis broadly followed the methodology used 
previously by this group;28 details specific to this work are provided in the Results. 
4.3. Results 
4.3.1. Single wavelength UV/Vis time-resolved studies.  Figure 4.2a shows the 
spectral changes observed at 422 nm after exposing a 50 mM tris pH 8 solution initially 
containing 28.1 M oxy-trHbNY33F+Q58A mutant and 15 µM of the photoactive NO species 
1 to a 500 nm, 10 s laser pulse.  After an initial ~30 µsec artifact caused by the laser pulse 
over-saturating the voltage output of the photomultiplier tubes, an absorbance decrease due 
to the reaction of the protein with NO (Scheme 4.1)4 is clearly visible; this was fit using an 
exponential decay equation (red trace, Fig. 4.2) to obtain an apparent first-order rate 
constant, kobs.  The experiment was repeated using concentrations of oxy-trHbNY33F+Q58A 
varying from 9.4 to 56.4 µM, each time adjusting the amount of 1 so that the amount of 
NO generated by the laser pulse was ~0.1 the protein concentration (to maintain pseudo-
first-order conditions).  A re-plot of kobs as a function of the oxy-trHbNY33F+Q58A 
concentration was linear (Fig. 4.2b), and yielded a second-order rate constant for the 
reaction of protein with NO of k = (7.50.7)108 M1s1.   
Experiments comparable to those shown in Fig. 4.2 were performed using red-
trHbNY33F+Q58V in place of the oxygenated protein.  Once again individual experiments 
using protein concentrations in 5-10 excess of the [NO] generated could be fit using 
exponential functions, and a plot of the apparent first-order rate constants so obtained as a 
function of the red-trHbNY33F+Q58V concentrations was linear (Fig. 4.3).  From these results 
the second-order rate constant for the reaction of red-trHbNY33F+Q58V with NO (Scheme 
4.3) was determined to be (92)108 M1s1.  Note that the experiments with  
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Figure 4.2. (a) Spectral changes at 422nm that accompany 500 nm laser pulse irradiation 
of a solution initially containing 28.1 µM oxy-trHbNY33F+Q58A mutant and 15 µM NO 
photo-precursor 1 in a 50 mM Tris, 0.5 mM EDTA buffer adjusted to pH 8.  Red trace: 
single exponential fit of the data.  Under these conditions the apparent rate constant kobs for 
the spectral change was 25,7001,300 s1.  From the total change in absorbance amplitude 
one could also estimate that the laser pulse generated ~1.5 µM nitric oxide.  (b) 
Dependence of kobs on the concentration of oxy-trHbNY33F+Q58V mutant; concentrations of 
photo-precursor 1 were varied from experiment to experiment so that the amount of NO 
generated was always ~0.1 that of oxy-trHbNY33F+Q58V.  From the linear fit to the data the 
second-order rate constant for reaction of NO with oxy-trHbNY33F+Q58V was determined to 
be (7.50.7)108 M1s1. 
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red-trHbNY33F+Q58V were more technically challenging than those with the oxygenated 
protein because the full sample preparation had to be done in the glovebox and in the dark.  
As a result less protein concentrations were used for these experiments. 
 
 
  
 
In addition to the experiments shown in Figs. 4.2 and 4.3, similar experiments were 
performed to determine the reactivities with NO of oxygenated and fully reduced wild type 
trHbN, and of a series of variants.  The results are summarized in Fig. 4.4.  As was the case 
for the oxy-trHbNY33F+Q58V double mutant, the reactions of the other oxygenated variants 
with NO were first-order with respect to NO and protein concentrations, and second-order 
overall.  The red bars in Fig. 4.4 show the calculated second-order rate constants for each 
of the variants.  Error estimates range from less than 10% to about 20% of the calculated 
rate constants, which are reasonable given that some of the faster reactions monitored 
approached the time resolution limit of our instrumentation (see for example Fig. 4.2a).  
The reactions of the red-trHbN variants with NO were also first order with respect to NO 
and protein concentrations, with the exception of a variant in which the N-terminal pre-A 
motif (Fig. 4.1) was deleted (hereafter referred to as trHbNdelN).  For this variant the 
reaction with NO was first-order in NO concentration but zero-order in protein  
Scheme 4.3.  Reaction sequence that could explain the lack of 
dependence on protein concentration of the interaction between red-
trHbNdelN and NO.  In species B NO is within the protein tunnel 
system, but not bound to the heme. 
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Figure 4.3.  Dependence of kobs on the concentration of red-trHbNY33F+Q58V mutant; 
concentrations of photo-precursor 1 were varied from experiment to experiment so that the 
amount of NO generated was always ~0.1 that of red-trHbNY33F+Q58V.  From the linear fit 
to the data the second-order rate constant for reaction of NO with red-trHbNY33F+Q58V was 
determined to be (92)108 M1s1. 
 
  
Figure 4.4.  A graphical summary of the second order rate constants for the reactions with 
NO of the oxygenated and fully-reduced forms of the trHbN variants presented herein.  
WT: wild type trHbN; DM:  Y33F+Q58V double mutant; delN: deletion mutant lacking 
the pre-A motif (Fig. 4.1).  A tabular form of this data is provided in Appendix 2. 
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concentration (Fig. 4.5).  Thus, Fig. 4.5 shows that the apparent rate constant in fact 
remained invariant at 33001200 s-1 as the red-trHbNdelN concentration was increased from 
~5 M to 35 M.  
 So far this section has focused on the fastest UV/Vis spectral changes observed 
after exposing wild type trHbN and several variants to laser photo-generated NO.  
However, further inspection also revealed spectral changes on longer timescales following 
the reactions of both oxy-trHbN and red-trHbN with NO.  Figure 4.6 shows an example in 
which a solution initially containing 21.2 μM red-trHbNWT and 40 μM photo-precursor 1 
was irradiated with a laser pulse.  Figure 4.6a shows the initial absorbance change 
occurring on the s timescale, but Fig. 4.6b shows an additional change that occurred over 
Figure 4.5.  Dependence of kobs on protein concentration for the reaction with 
NO of the mutant lacking the short pre-A helix (red-trHbNdelN, Fig. 4.1).  Notice 
that in this case kobs appears to be a true first-order rate constant that is invariant 
with changes in protein concentration.  The solid red line shows the average 
value of kobs, while the dashed lines are placed at one standard deviation to 
either side.  
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tens of ms.  As with the rapid absorbance change this slower change could be fit with a one 
exponential decay function.  However, whereas the kobs for the fast phase exhibits linear 
dependence on protein concentration as discussed earlier, the kobs for the slower phase 
shows no dependence on protein concentration (Fig. 4.6c). Taking the average of the kobs 
values from Fig. 4.6c yields 130  25 s1 as the value of a true first-order rate constant.  
Slower time scale UV/Vis absorption changes were also seen when oxy-trHbN was 
reacted with photo-generated NO (Scheme 4.1).  Figure 4.7 shows an example in which a 
solution containing 10.7 μM oxy-trHbNWT and 20 μM photo-precursor 1 was irradiated 
with a 500nm laser pulse to produce ~2 μM NO.  The time trace of Fig. 4.7a (plotted on a 
logarithmic scale) was fitted to two exponentials.  When the experiment was repeated with 
varying concentrations of oxy-trHbN the apparent rate constant for the second (slow) 
kinetic event was found to be roughly invariant with protein concentration (Fig. 4.7b); 
however, the 2-exponential fits were not as good at higher protein concentrations because 
the faster absorbance changes came progressively closer to the deadtime of the 
instrumentation as the concentration increased past ~30 μM.  Furthermore, the average first 
order rate constant obtained for the slow phase (250  92 s1) displayed a large degree of 
scatter (Fig. 4.7b).   
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Figure 4.6.  Spectral changes observed after a solution initially containing 21.2 μM red-
trHbNWT and 40 μM photo-precursor 1 was irradiated with a 500 nm laser pulse to produce 
~4 μM NO.  (a) Changes observed on the s timescale; (b) changes observed on the ms 
timescale.  (c) Dependence of the apparent rate constant for the slower process shown in 
(b) on protein concentration. 
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 The single wavelength experiments described thus far provide no insight into the 
possible origins of the slow exponential phases observed upon exposure of red-trHbN and 
oxy-trHbN to NO.  Indeed, in attributing the fast exponential phases to the processes of 
Schemes 4.1 and 4.2, one is implicitly relying on previous studies where these processes 
were observed, since single-wavelength studies provide no spectral cues that can be 
assigned to specific chemical changes.  In order to gain more insight into the nature of the 
slow processes the reactions of red-trHbN and oxy-trHbN with NO were investigated in 
two global UV/Vis time-resolved experiments, in which the spectral changes were  
Figure 4.6.  Spectral changes observed after a solution initially containing 21.2 
μM red-trHbNWT and 40 μM photo-precursor 1 was irradiated with a 500 nm 
laser pulse to produce ~4 μM NO.  (a) Changes observed on the s timescale; 
(b) changes observed on the ms timescale.  (c) Dependence of the apparent rate 
constant for the slower process shown in (b) on protein concentration. 
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Figure 4.7.  (a) Spectral changes at 430 nm that follow laser pulse irradiation of a solution 
initially containing 10.7 µM oxy-trHbN and 20 µM photo-precursor 1 (which produced ~2 
µM NO).  Red trace: best non-linear least-squares fit to a 2-exponential model.  (b) 
Dependence of kobs for the slow phase of (a) on concentration of oxy-trHbN. 
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monitored as a function of probe wavelength as well as time.  These experiments are 
described in the next section. 
 4.3.2 Global UV/Vis time-resolved studies.  Complete time-resolved spectra for 
selected reactions of oxy-trHbN or red-trHbN with NO were constructed by combining 
multiple individual time traces, collected at different wavelengths, but under identical 
conditions.  The reconstructed time-resolved spectra were subjected to Singular Value 
Decomposition (SVD) to determine the number of spectral components and smooth out 
noise, after which the processed spectra were fit to appropriate exponential models.   
In one experiment the spectral changes observed after irradiating samples 
containing 19.3 μM red-trHbN and 20.4 μM of photo-precursor 1 were monitored in the 
range from 400 – 450 nm.  SVD analysis revealed two spectral components above the noise 
level, though one of these showed systematic time dependence but not wavelength 
dependence (See Appendix 2).  The SVD-processed data were fit to the 2-exponential 
equation 4.1, where At is the absorbance change at wavelength  and time t; 1 and 2 
are the amplitudes of components 1 and 2, respectively at wavelengths ; and k1obs 
1 2, 1 2(1 ) (1 )obs obsk t k ttA e e            Eq. 4.1 
and k2obs are the apparent first-order rate constants for the respective exponential processes.  
Figure 4.8a shows spectra collected at selected times after the laser pulse, and the 
corresponding calculated least-squares fits, while Fig. 4.8b shows the A vs time trace 
obtained at 420 nm, one of the wavelengths at which the magnitude of A was largest.  The 
associated values of kobs were determined to be 6800 s1 and 97 s1, respectively; the 
spectral components 1 and 2 are provided in Appendix 2.  It is important to note that 
although 1 and 2 were allowed to vary independently in the fit, they have very nearly  
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Figure 4.8.  (a) UV/Vis spectral changes observed at selected times after irradiating a 
solution of 19.3 μM red-trHbN and 20.4 μM photo-precursor 1 with a 500 nm laser pulse.  
The blue traces were obtained at 120 s intervals starting at 80 s, while the green ones 
were obtained at 10 ms intervals starting at 1 ms.  The red dashed traces are least-squares 
best fits to Eq. 4.1.  (b)  Blue trace: A vs time slice through the spectra from (a) obtained 
at 420 nm; Red trace: least-squares best fit at this wavelength.  The values obtained for kobs 
were 6800 s1 and 97 s1 for the fast and slow phases, respectively. 
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identical shapes, with maximal positive deflections around 420 nm and maximal negative 
deflections near 440 nm.  That this must be so is evident from the fact that all of the 
representative spectra in Fig. 4.8a have similar shapes.  The result is consistent with the 
observation that only one of the SVD components shows systematic wavelength 
dependence (Appendix 2), and suggests that any apparent differences between the two 
components are simply a result of differing admixtures of noise.  The spectral changes 
shown in Fig. 4.8a, both on the s and ms timescales, are those expected for nitrosylation 
of red-trHbN.  Thus it appears that heme nitrosylation occurs in two phases: the first rapid 
phase has first-order dependence on [red-trHbN] while the second is independent of protein 
concentration; both phases have first-order dependence on [NO].   
Figure 4.9 shows the spectral changes that were observed when solutions 
containing 30.6 μM oxy-trHbN and 73.8 μM photoprecursor 1 were irradiated with laser 
pulses, and the resulting A vs time traces obtained at varying wavelengths were combined 
to produce complete time-resolved spectra.  In this case SVD analysis revealed three 
spectral components that showed systematic time dependence, but only one that showed 
clear wavelength dependence (Appendix 2).  In contrast to the results shown in Fig. 4.8 for 
the reaction of red-trHbN with NO, the difference spectra in Fig 4.9 first increase in 
amplitude but then decrease (this is clearly seen in the A404 vs t slice of Fig. 4.9b).  To 
account for this the SVD-processed data were fit to the 3-exponential equation 4.2, where 
At is the absorbance change at wavelength  and time t; 1 – 3 are the amplitudes of 
components 1 – 3, respectively, at wavelengths ; and k1obs – k3obs are the apparent first-
order rate constants for the respective exponential processes.  The negative signs in front  
1 2 3, 1 2 3(1 ) (1 ) (1 )obs obs obsk t k t k ttA e e e                Eq. 4.2 
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Figure 4.9.  (a) UV/Vis spectral changes observed at selected times after irradiating a 
solution of 30.6 μM oxy-TrHbN and 73.8 μM photo-precursor 1 with a 500 nm laser pulse.  
The blue traces were obtained at 40 s intervals starting at 60 s, while the green ones were 
obtained at 5 ms intervals starting at 1 ms.  The red dashed traces are least-squares best fits 
to Eq. 4.2.  Note from the associated arrows that the spectral amplitude increases for the 
early blue traces, but decreases for the later green traces (b)  Blue trace: A vs time slice 
through the spectra from (a) obtained at 404 nm; Red trace: least-squares best fit at this 
wavelength.  The values obtained for kobs were 3.33104 s1, 910 s1 and 55 s1 for the three 
kinetic phases, respectively. 
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of 2and 3 make these into spectral components that are subtracted from the difference 
spectra at longer timescales (Appendix 2).  The rate constants calculated from the fitting 
procedure were 3.3104 s1, 900 s1, and 55 s1 for k1obs – k3obs, respectively.   
As was the case for the red-trHbN experiment, the Fig. 4.9 time-resolved difference 
spectra share very similar shapes, which in this case are characteristic of the difference 
between the oxy-trHbN and met-trHbN spectra.  Thus we surmise that 1 – 3are really 
all the same spectral component, but that they contain differing admixtures of noise.  This 
interpretation suggests that, after NO oxidizes oxy-trHbN to met-trHbN, a fraction of the 
aquomet species is converted back to oxy-trHbN by an as-yet unknown process.  It is not 
clear why three exponential functions are required to fit the time-resolved spectra of Fig. 
4.9, whereas two exponentials suffice to fit absorbance vs. time traces obtained at a single-
wavelength (Fig. 4.7a).  The magnitude of the 2component is rather small (Appendix 2), 
and it is possible that this feature is an artifact of reconstructing the Fig. 4.9 spectrum from 
multiple individual absorbance vs. time traces.  Further studies will be needed to address 
these questions. 
4.3.3. Spectropotentiometric studies.  Figures 4.10 and 4.11 compare the 
electrochemical properties of trHbNWT with those of the trHbNV80A mutant.  Figure 4.10a 
shows the spectral changes at 435 nm observed for a solution initially containing red-
trHbNWT (106 µM), as an applied potential was increased stepwise in 10 mV increments 
from 200 mV to 100 mV.  Figure 4.10b shows the comparable data obtained when a 
solution initially containing met-trHbNWT (106 µM) was exposed to applied potentials that 
decreased in 10 mV decrements from 100 mV to 200 mV.  The red traces in Fig. 4.10 are 
least-squares fits to the exponential form of the Nernst Equation 28, which yielded midpoint 
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potentials of 11mV and 30mV, respectively from (a) and (b).  The calculated average 
midpoint potential for reduction of met-trHbNWT is therefore 2011 mV.  When the 
experiments of Fig. 4.10 were repeated using the trHbNV80A mutant (144 µM, Fig. 4.11), 
an analogous analysis (red traces) showed that the average midpoint potential for the 
mutant was 3510 mV, or 15 mV more negative than the wild type.  Given the 
uncertainties of the measurements, this difference was not deemed very significant. 
4.4. Discussion 
 4.4.1. Effects of active site mutations on trHbN’s reactivity with NO.  Mutations 
to active site amino acids had relatively small effects (Fig. 4.4) on the reactions of oxy-
trHbN and red-trHbN (Schemes 4.1 and 4.2, respectively) with NO.  Oxy-trHbNWT has an 
impressive 1.4109 M1 s1 second-order rate constant for reaction with NO according to 
our measurements.  Active site amino acid mutations Q58A and Y33F+Q58V decreased 
this rate constant by about half (to 5.8108 M1 s1 and 7.1x108 M1 s1, respectively), while 
the Y33A mutation had essentially no effect.  This shows that Q58 plays a more meaningful 
role in tuning the enzyme’s dioxygenase activity than does Y33; however, halving a rate 
constant so near the diffusion limit is a relatively small effect.  Tyrosine 33 is critical to 
trHbN’s exceptionally high oxygen affinity,4 but previous studies have left its effect on NO 
dioxygenation less certain.  Mutation of a comparable Tyr group in the closely related 
flavohemoglobin from E. coli leads to an 80-fold decrease in the protein’s NO dioxygenase 
activity,32 and a similar outcome was predicted for trHbN on the basis of this result; early 
whole-cell assays appeared to support the prediction.3  More recently Mishra and Meuwly 
presented a theoretical study using a method called adiabatic reactive molecular dynamics 
(ARMD) that predicted significant retardation of NO dioxygenation in Y33A mutants, and 
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Figure 4.10. Spectral changes at selected wavelengths of a solution initially containing 106 
μM trHbN in 50 mM buffer containing Tris/Cl adjusted to pH 8, and a mixture of 
electrochemical mediators containing 100 μM Indigo Tetrasulfonate, Indigo Carmine, and 
Gallocyanine.  (a) Applied potential initially set at 200 mV, then increased in 10 or 20 
mV steps until reaching 100 mV; (b) Reverse of (a): applied potential initially set at 100 
mV, then decreased in 10 or 20 mV steps until reaching 200 mV.  Black squares: 
experimental data; red lines: least-squares fits to the exponential form of the Nernst 
Equation,28 which yielded midpoint potentials of 11mV and 30mV, respectively from 
(a) and (b).  The calculated average midpoint potential for reduction of met-trHbN is 
2011 mV. 
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Figure 4.11. Spectral changes at selected wavelengths of a solution initially containing 
~144 μM trHbNV80A mutant in 50 mM buffer containing Tris/Cl adjusted to pH 8, and a 
mixture of electrochemical mediators containing 100 μM Indigo Tetrasulfonate, Indigo 
Carmine, and Gallocyanine.  (a) Applied potential initially set at 200 mV, then increased 
in 10 or 20 mV steps until reaching 100 mV; (b) Reverse of (a): applied potential initially 
set at 100 mV, then decreased in 10 or 20 mV steps until reaching 200 mV.  Black squares: 
experimental data; red lines: least-squares fits to the exponential form of the Nernst 
Equation,28 which yielded midpoint potentials of 25mV and 45mV, respectively from 
(a) and (b).  The calculated average midpoint potential for reduction of met-trHbN is 
3510 mV. 
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a somewhat smaller retardation for mutations in Gln 58.15  In contrast to these reports, a 
2005 QM-MM theoretical study by Crespo et al. predicted exactly what we observed here: 
little or no direct effect on NO dioxygenase activity upon mutation of Tyr 33, and a modest 
decrease in activity accompanying mutation of Gln 58.10  The report by Crespo et al. did 
also suggest a greater indirect role for Tyr 33 and Gln 58 in modulating the NO dioxygenase 
rate constant, which involved triggering a conformational switch in Phe 62, an amino acid 
that appears to control ligand passage via the long diffusion tunnel that connects the active 
site to the protein exterior (Fig. 4.1).10  This hypothesis was further elaborated in two later 
articles,33,34 and is discussed more extensively in the next section. 
The rate constant for reaction of red-trHbNWT with NO was calculated to be 2.2108 
M1 s1, but increased to 9.3108 M1 s1 for the red-trHbNY33F+Q58V double mutant, and 
4.6108 M1 s1 for red-trHbNY33A mutant.  The rate constant for the red-trHbNQ58A mutant 
was essentially unchanged (2.6108 M1 s1).  These results parallel those seen by Ouellet 
et al. for the reactions of O2 and CO with red-trHbNWT and comparable active site variants: 
for both gases the Tyr 33 variant rate constants were substantially higher than those of the 
wild type, and approached the diffusion limit.35  A series of laser flash photolysis studies 
with the NO adducts of the met-trHbN variants, together with molecular dynamics 
simulations of the red-trHbN variants, provided persuasive evidence that displacement of 
a non-coordinated distal site water molecule, held in place by tight interaction with Tyr 33, 
provides the main barrier to ligand binding.35  Notably, the rate constant for NO binding to 
red-trHbNWT (2.2108 M1 s1) was 4 – 10 times higher than that for O2 binding to the wild 
type protein, which was determined to be between (2.5 – 5.6) 107 M1 s1 in stopped-flow 
and flash photolysis studies.3,35  This difference is levelled in the Tyr 33 mutants, which 
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display near-diffusion limit rate constants for all three gases, NO, O2 and CO. 
4.4.2. The role of Phenylalanine 62.  Crystal structures of trHbN showed that Phe 
62, which is situated at the junction between the active site and the long tunnel that connects 
the active site with the protein exterior (Fig. 4.1), can adopt two possible conformations: 
one of these blocks the tunnel, and the other leaves the tunnel open.6-8  Later theoretical 
studies showed that this “gate” in the long tunnel was controlled to a great extent by Tyr 
33 and Gln 58.10,33,34  For example, molecular dynamics simulations showed that the Phe 
62 gate spends most of its time closed in red-trHbN, but most of its time open in oxy-
trHbN, due to conformational changes triggered in Tyr 33 and Gln 58 after dioxygen 
binding. 33,34  Furthermore, the simulations also predicted that in Y33F or Q58A mutants 
the Phe 62 gate would stay closed regardless of the presence or absence of dioxygen at the 
active site.34  These results led to the hypothesis of a “dual-path mechanism” for trHbN 
whereby dioxygen migration into red-trHbN proceeds exclusively via the short tunnel 
(since the long tunnel is blocked in the deoxy form of the protein), but that NO transport 
proceeds via the long tunnel once dioxygen binding opens this pathway up.33 
 The results discussed in the previous section showed that the reaction of NO with 
oxy-trHbN was only marginally affected by mutation of Q58, and completely unaffected 
by changes to Y33.  Assuming that the theoretical studies are correct, and that the long 
tunnel of Q58 or Y33 variants is stuck in a closed position, these findings demonstrate that 
there is no barrier to NO entering the active site of oxy-trHbN through the short tunnel.  In 
apparent contradiction with this conclusion a very recent article noted that in four F62 
mutants of trHbN the steady-state NO dioxygenase activity of the protein decreased from 
30% – 50%, whereas the association rate constant for CO with the red-trHbN mutants was 
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unaffected; the protein’s oxygen affinity was likewise unaffected.18  From these results the 
authors concluded that F62 plays a key role in controlling NO’s access to oxy-trHbN, but 
does not affect gas binding to red-trHbN, in agreement with the dual path mechanism.  In 
this present study two gate mutants, oxy-trHbNF62A and oxy-trHbNF62W, were both found 
to have rate constants for NO dioxygenation that were lower than the wild type (Fig. 4.4): 
4.7108 M1 s1 (34% WT) for oxy-trHbNF62A, and 6.8108 M1 s1 (52% WT) for oxy-
trHbNF62W.  These results are in rough agreement with the steady-state results of Oliveira 
et al, though in the latter trHbNF62W was found to have lower activity than trHbNF62A (30% 
vs 50% of WT, respectively).18  However, what seems most remarkable about the combined 
results of the two studies is not the absolute magnitudes of the changes in reactivity.  Rather 
it is the fact that a reactivity decrease was observed for both trHbNF62W, in which 
phenylalanine was replaced with a bulkier side chain, and trHbNF62A, in which the 
replacement side chain should have been small enough to leave the long tunnel 
permanently open.33  This suggests that the mutations to F62 disturb gas access to the active 
site in a complex way that can’t be readily correlated with a simple gate which affects 
passage through the long tunnel.  A more likely explanation for the observed reactivity 
decrease in the mutants, also suggested by Oliveira et al, is that F62 plays an important role 
in preventing collapse of the B and E helices that control ligand accessibility to the active 
site.18  Finally note that, whereas the rate constant for CO binding to red-trHbN mutants 
was the same as for the wild type,18 our results show (Fig. 4.4) that the rate constants for 
mutant nitrosylation are lower than for the wild type: 1.2108 M1 s1 (52% WT) for oxy-
trHbNF62A, and 1.6108 M1 s1 (70% WT) for oxy-trHbNF62W.  Again this result can’t be 
neatly incorporated into a simple dual path mechanism in which access to oxy-trHbN and 
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red-trHbN are distinct.  
4.4.3. The role of the pre-A motif on the reactivity of trHbN.  As mentioned in 
Section 1.4.3, in a recent paper Lama et al. showed that when the first 12 amino acids (the 
“pre-A sequence”) were deleted from the N-terminus of trHbN, the resulting trHbNdelN 
mutant exhibited a drastic decrease in its NO dioxygenase activity.14  An equally intriguing 
result was that when a pre-A sequence was added to a trHbN orthologue from 
Mycobacterium smegmatis, which lacks its own pre-A sequence and shows minimal NO 
dioxygenase activity, the augmented mutant now displayed increased activity.14  Taken 
together these results clearly demonstrate that the pre-A sequence plays a key role in 
providing trHbN with NO dioxygenase activity, despite its remoteness from the active site.  
On the basis of molecular dynamics simulations Lama et al. proposed that thermal 
fluctuations in the highly flexible pre-A region influence backbone motion of the protein, 
which in turn influences the conformational state of the Phe 62 gate residue (see previous 
section); in trHbNdelN the simulations showed that the gate was stuck in a closed position.14  
Recent NMR studies disagreed with the concept of the pre-A motif having an effect on the 
dynamics of Phe 62; however, the question of what caused the dramatic loss of NO 
dioxyganese activity observed by Lama et al. upon deletion of this motif remained.16    
The results of the present work are inconsistent with the explanation of Lama et al, 
given that the rate constant for reaction of NO with oxy-trHbN is not significantly affected 
by the removal of the pre-A sequence (Fig. 4.4; the value of the rate constant for trHbNdelN 
was (1.00.1)109 M1 s1, compared with (1.40.1)109 M1 s1 for the wild type).  
Instead our results show that it is ligand association with red-trHbN that is most profoundly 
affected by deletion of the pre-A region.  The reaction of red-trHbNdelN with NO is no 
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longer second-order overall, now being independent of protein concentration, and 
governed by a rate constant of 3300  1200 s1 (Fig. 4.5).  Presumably the reactions of 
dioxygen and carbon monoxide with red-trHbNdelN would be affected similarly to NO, 
though this will have to be confirmed in future experiments.  In that case it is the change 
in the oxygenation rate of red-trHbNdelN that is responsible for the profound difference in 
NO dioxygenase activity between trHbNdelN and trHbNWT in steady state assays, not the 
oxygenated proteins’ relative ability to oxidize NO.  This hypothesis does not explain the 
dramatically decreased rate for the reaction of NO with trHbNdelN compared to trHbNWT 
reported by Lama et al. for NO titration experiments;14 however, this rate difference 
disappeared when we tested for it using our more rigorous photo-initiated NO delivery 
system (see Appendix 2). 
The overall first-order kinetics observed for the reaction of red-trHbNdelN with nitric 
oxide can be understood in terms of Scheme 4.3, where red-trHbNdelNNO represents an 
NO adduct in which the gas has entered the protein through the substrate tunnels but has 
not bound to the iron, while red-trHbNdelN(NO) represents the iron-nitrosylated protein.  
Thus, according to this model nitric oxide is able to enter the tunnel system without notable 
impedance, but once ensnared in the tunnels it is in some way prevented from immediately 
binding the active site as it normally would in red-trHbNWT. 
As mentioned in Section 1.4.2, in addition to the long and short tunnels seen in the crystal 
structure,6 a theoretical study by Daigle et al. recently identified two additional tunnels that 
open only transiently (the “BE” and “EH” tunnels).13  The authors proposed that these 
tunnels could temporarily store NO or dioxygen within the protein.  These two tunnels, in 
addition to the permanent “long” tunnel visible in the crystal structure that appears to open 
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or close according to circumstances (Fig. 4.1),10,33,34 are promising candidates for locations 
within trHbN where NO could be temporarily trapped in the trHbNdelN variant.  Presumably 
the decreased backbone mobility in key regions of trHbN that accompanies the pre-A 
deletion, as found in the calculations of Lama et al,14 disturbs some kind of unlocking 
mechanism present in the wild type (this is discussed further below).  It should be noted 
however that this decreased backbone mobility was not observed in NMR studies of the 
cyanide bound trHbNdelN variant.16 
Under pseudo-first-order conditions with red-trHbNdelN in excess, Scheme 4.3 leads 
to a single-exponential rate law in which the apparent rate constant kobs has hyperbolic 
dependence on total protein concentration (Eq. 4.3; see Appendix 2).  Such a rate law is 
only consistent with the results of Fig. 4.5 (where kobs is independent of protein 
concentration) if [HbNtotal] (~ [red-HbNdelN]) >> K11 for all the protein concentrations 
sampled.  These ranged from 5 M to 35 M (Fig. 4.5), from which one can estimate that 
K11 can be at most 5107 M, or K1 must be at least 2106 M1 according to the mechanism  
   Eq. 4.3 
of Scheme 4.3.  Such a value is entirely reasonable given what is known about trHbN.  One 
can assume that entry to the tunnel system (k1 in Scheme 4.3) will be diffusion limited 
(~109 M1s1), so if K1 ~ 2106 M1 then k1 would have to be ~500 s1, which corresponds 
to a half-life of ~1.4 ms for tunnel residence. 
 Two molecular-level explanations that could give rise to Scheme 4.3 build directly 
on the known chemistry of trHbN that has been discussed here.  The first is that the closed 
putative Phe 62 gate residue traps NO in the long or EH tunnels of the delN mutant, and 
2 total
obs 1
1 total
k [HbN ]k K [HbN ] 
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only slowly allows access to the reduced heme center.  The second is that motions in the 
N-terminus play a crucial role in displacing the non-coordinated distal site water molecule 
that is held in place by tight interaction with Tyr 33, and which has been proposed to 
provide the main barrier to ligand binding to red-trHbNWT as discussed earlier.35  Given the 
results above that reveal no barrier to NO oxidation by oxy-trHbNdelN despite 
computational evidence that its long tunnel is also blocked by Phe 62, we tentatively favor 
the second mechanism.  However, some involvement of Phe 62 is also possible, and other 
molecular-level mechanisms could be proposed.  An obvious and important follow-up 
experiment will be to test the nitrosylation kinetics of a red-trHbNdelN+ Y33F+Q58V mutant: if 
the only role of the pre-A region is to help mobilize the non-coordinated distal site water 
molecule, then eliminating the Tyr 33 that holds the water in place should boost the rate 
constant for heme nitrosylation to the diffusion limit, as it does for red-trHbNY33F+Q58V.  
This experiment is planned for the near future. 
 
  
 
Scheme 4.4.  Resonance forms used to describe oxy-hemes. 
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4.4.4. V80A: a mutant designed to affect the trHbN midpoint potential.  The 
final mutant synthesized and tested in this project was V80A.  Valine 80 is a surface amino 
acid that helps make up a wall near the proximal side of the trHbN heme.  The mutation 
V80A was meant to decrease the steric bulk at that point, thus increasing the accessibility 
of solvent to the heme, which in turn was expected to decrease its midpoint potential.36,37  
Oxy-hemes can be understood in terms of three resonance forms (Scheme 4.4), whereby 
the dominant resonance form is expected to vary with changes to the protein 
environment.38,39  Recent studies indicate that the character of the bound oxygen may affect 
its proclivity for the nitric oxide dioxygenation reaction to occur.40  The ultimate goal of 
this experiment was to determine the effect of a midpoint potential shift, and corresponding 
change in the nature of the coordinated heme, on its reactivity with NO. 
Spectroelectrochemical experiments to determine the heme midpoint potentials of 
trHbNWT and trHbNV80A were performed going from oxidized protein to reduced, as well 
as going from reduced protein to oxidized (see Results Section 4.3).  This was required 
since the design of the spectroelectrochemical cell can introduce different biases in the 
measured potentials depending on which direction the applied potential is changed in.  The 
results show that the differences in calculated midpoint potentials were consistently around 
20 mV, which is an acceptable uncertainty for the current needs.  The reported midpoint 
potentials, 2011 mV for trHbNWT and 3510 mV for the trHbNV80A mutant, were 
obtained as the averages of the midpoint potentials obtained when changing the applied 
potentials in opposing directions. 
 Kinetic experiments using the 15 mV downshifted V80A mutant showed that the 
rate constants for the reaction of nitric oxide with oxygenated protein (1.99109 M1 s1) 
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and the binding of nitric oxide to reduced protein (4.74108 M1 s1) were increased relative 
to the wild-type values by similar degrees (Fig. 4.4).  Since both reduced and oxygenated 
protein kinetics are affected to roughly the same extent, it seems more likely that the effect 
of the V80A mutation is to somehow increase the accessibility of nitric oxide to the active 
site, rather than to tune the bound oxygen’s reactivity. 
 The effect of the V80A mutation on the heme midpoint potential proved to be fairly 
minor (a shift of 15 mV), and it’s possible that in mutants showing greater changes to the 
midpoint potential the reactivity of oxy-trHbN would be more profoundly affected.  To date 
no other electrochemical mutations have been prepared, but this is a promising avenue for 
further research.  Future investigators will have to be cautious though, because a too drastic 
change in the heme midpoint potential would lead to a heme incapable of binding dioxygen. 
 4.4.5. The slow phase in red-trHbN nitrosylation.  Figures 4.6 and 4.8 
demonstrate that nitrosylation of red-trHbN occurs in two phases: a fast phase that depends 
on both NO and protein concentrations, and a slow phase that depends only on NO 
concentration.   Scheme 4.5 suggests one possible mechanistic explanation for this  
 
 
 
1
2
red-trHbN NO red-trHbN(NO) [red-trHbN NO]
[red-trHbN NO] red-trHbN(NO)
k
k
   
 
B CA
C B
Scheme 4.5.  Reaction sequence that could explain the presence of two 
exponential phases during nitrosylation of red-trHbN.  The rate constant 
k1 is second order and governs the encounter between free NO and protein, 
but produces two species B and C.  In species C NO is within the protein 
tunnel system, but not bound to the heme.  It then slowly finds its way to 
the active site in a process governed by the first-order rate constant k2. 
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behavior.  According to this mechanism after NO enters red-trHbN it can either take a direct 
path to the heme center (Scheme 4.5, species B), or it can become momentarily trapped in 
a remote site within the protein (Scheme 4.5, species C), and only slowly make its way to 
the active site.  The conversion of species C to species B would be governed by the first-
order rate constant k2, and would depend only on the concentration of C.  Under pseudo-
first-order conditions with protein in excess this process would appear to depend only on 
the concentration of NO generated by the laser flash, as is observed experimentally.  This 
mechanism is reminiscent of that proposed in Scheme 4.3 for the red-trHbNdelN mutant, 
and once again several structure-based explanations for it can be proposed on the basis of 
the known trHbN structure.  For example, one could propose that the fast phase arises from 
NO that enters the trHbN short tunnel, whereas the slow phase is due to NO that enters the 
long tunnel and is momentarily trapped behind the Phe 62 gate.10,33,34  A more general 
explanation is that the NO can be trapped in any one, or all of the transient BE and EH 
tunnels recently identified by Daigle et al,13 as well as in the long tunnel (see Section 4.4.4 
above). 
  
 
 
Initially an alternative mechanism shown in Scheme 4.6 was considered as an 
explanation of the kinetics for the reaction of NO with red-trHbN, but this was 
subsequently ruled out as will now be described.  In the Scheme 4.6 mechanism red-trHbN 
Scheme 4.6.  Alternate explanation for the presence of two exponential 
phases during nitrosylation of red-trHbN, which was ruled out by the 
experimental evidence (see text for details). 
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exists in two conformational states, one of which provides direct access to the active site 
([red-trHbN]open in Scheme 4.6), and the other which can bind NO, but in which direct 
access to the heme is blocked ([red-trHbN]closed in Scheme 4.6).  According to this 
mechanism exchange between the isomers is slow compared to the rate of NO binding to 
either isomer, and NO trapped in the closed isomer has no way of reaching the active site.  
Under pseudo-first-order conditions with protein in excess all of the photogenerated NO 
would rapidly bind to the protein, but only that which bound to any available “open” 
conformer would immediately give rise to red-trHbN(NO).  Then, after the initial rapid 
nitrosylation phase, further nitrosylation would be governed by the slow isomerization of 
[red-trHbN]closed to [red-trHbN]open.  The Scheme 4.6 mechanism predicts that in a series 
of experiments where the protein concentration is kept constant but the amount of 
photogenerated NO is increased, the ratio of amplitudes for the fast and slow phases should 
stay roughly constant as NO is increased up to the initial concentration of [red-trHbN]open, 
but thereafter should decrease because additional NO will only be able to bind to the [red-
trHbN]closed.  This experiment was done using the F62A mutant for which the fast phase 
was slow enough that both phases could be monitored in a single experiment (Fig. 4.12a).  
As seen in Figs. 4.12b and 4.12c, the ratios of amplitudes for the fast and slow phases 
remained constant at 42 as the amount of photogenerated NO was increased, which is 
consistent with the Scheme 4.5 but not the Scheme 4.6 mechanism.  Finally, note that in 
Scheme 4.5 NO binding to red-trHbN is shown as irreversible.  If NO can escape into the 
solvent from the red-trHbNNO blind tunnels more rapidly than it can reach the active site, 
then the Scheme 4.5 kinetics would become indistinguishable from those of Scheme 4.6.  
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4.4.6. The slow phases in the reaction of NO with oxy-trHbN.  As is the case 
for the reaction of red-trHbN with NO, Figures 4.7 and 4.9 reveal multiple phases for the 
reaction of oxy-trHbN with NO, this time a total of three kinetic phases (Fig. 4.9).  Once 
again the slow phases show no dependence on protein concentration, and first-order 
dependence on [NO].  However, in the reaction of oxy-trHbN with NO the slow phases 
reverse the initial protein reaction: the spectra of Fig. 4.9 reveal that met-trHbN is being 
slowly converted back to oxy-trHbN.  At present we have no explanation for this 
observation, though it is entirely reproducible and was observed for all of the trHbN 
variants investigated in this study.  One likely possibility is that the phenomenon is an 
artifact of the experimental procedure.  As described in the Materials and Methods 
section, prior to kinetic studies stock trHbN was first reduced to the red-trHbN form with 
methyl viologen monocation radical to eliminate any met-trHbN that might have formed; 
this was especially important for variants that held oxygen more weakly than the wild 
type.  For the experiments with oxy-trHbN the methyl viologen-reduced red-trHbN was 
then brought out of the glovebox and exposed to air to generate the oxygenated form.  It 
is possible that excess methyl viologen monocation radical generated an as-yet 
uncharacterized reductant capable of reducing the met-trHbN generated in the reaction of 
oxy-trHbN with NO.  Such a reductant would have to survive the initial exposure to 
oxygen (which the monocation radical would not), but be capable of reducing met-trHbN 
on the observed timescales.  To test this hypothesis, future studies should carefully 
control the amount of methyl viologen monocation radical used to prepare the oxy-trHbN 
for the experiments.  
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Figure 4.12.  (a) Spectral changes at 440 nm following irradiation by a 500 nm laser pulse 
of a solution initially containing 21.7 µM red-trHbNF62A mutant and ~80 M NO photo-
precursor 1 (enough to produce ~8 µM nitric oxide).  Red trace: least-squares fit using a 
two exponential model.  (b) Effect of varying the NO concentration on the amplitudes of 
the two exponential phases shown in (a) above; (c) Ratios of the calculated amplitudes for 
the two exponential phases plotted in (b) above.  Red solid line: average value; dashed lines 
are one standard deviation from the average. 
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 Though for now the results of Figs. 4.7 and 4.9 stand as empirical observations 
without obvious mechanistic explanations, the results of Fig. 4.9 in particular do serve to 
rule out one possible complicating reaction that might have been expected upon exposing 
oxy-trHbN to a laser pulse.  In the past ligand dissociation from both oxy-trHbN and the 
red-trHbN(CO) has been effected with 530 nm laser pulses,35 and one might have expected 
similar chemistry in the present studies.  However, Fig. 4.9 shows no evidence of oxygen 
dissociation, so either the process does not occur upon irradiation with 500 nm laser pulses, 
or it occurs to an extent too small to be detected by our methods.  A possible reason for this 
is that 500 nm is near an absorbance minimum for oxy-trHbN, whereas 530 nm (the laser 
Figure 4.12.  (a) Spectral changes at 440 nm following irradiation by a 500 nm 
laser pulse of a solution initially containing 21.7 µM red-trHbNF62A mutant and 
~80 M NO photo-precursor 1 (enough to produce ~8 µM nitric oxide).  Red 
trace: least-squares fit using a two exponential model.  (b) Effect of varying the 
NO concentration on the amplitudes of the two exponential phases shown in (a) 
above; (c) Ratios of the calculated amplitudes for the two exponential phases 
plotted in (b) above.  Red solid line: average value; dashed lines are one standard 
deviation from the average. 
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irradiation wavelength used in previous studies) sits on the shoulder of the protein’s 545 
nm absorbance maximum. 
 4.4.7. Summary.  Perhaps the most striking feature about the rate constant 
governing the reaction of oxy-trHbN with NO is how little it is affected by mutations to 
the protein (Fig. 4.4).  For all of the mutants investigated the observed rate constant lay 
near the theoretical diffusion limit, and the difference between the largest and smallest rate 
constants was at most a factor of four.  The results demonstrate that NO access to the active 
site heme is only minimally affected by any of the mutations, and are consistent with the 
2005 computational studies of Marti et al. that predicted only modest effects on NO 
oxidation rates by mutations to active site amino acids such as Tyr 33 and Gln 58.10  Later 
studies noted how Phe 62 can block the long and EH tunnels that connect the heme to the 
protein surface,33-35 but clearly NO can access the active site via the short or BE tunnels 
which remain open.6,35 
 Changes in the reactivity of red-trHbN with NO were for the most part also modest, 
spanning the range from (0.2 – 1.0)109 M1s1.  The fastest nitrosylation rates were 
observed for the trHbNY33A+Q58A double mutant, which supports the hypothesis of Ouellet 
et al. that these residues hold in place a non-coordinating water, the displacement of which 
provides the main barrier to ligand binding to the reduced protein.35  The red-trHbNdelN 
variant provides a dramatic exception to the otherwise modest effects of trHbN mutations.  
For red-trHbNdelN the rate constant for nitrosylation is much lower than that of other 
variants, and is first-order rather than second-order.  This shows that the pre-A N-terminal 
sequence plays a critical role in opening the heme iron to NO binding, and suggests that 
dioxygen binding to red-trHbNdelN would be similarly affected.  Future studies are planned 
131 
 
for testing this important conjecture.  The work of Lama et al. first demonstrated that NO 
dioxygenase activity of trHbNdelN is greatly decreased relative to the wild type,14 but our 
results (Fig. 4.4) show that the reaction of oxy-trHbNdelN with NO is not affected by the 
mutation.  If dioxygen binding to red-trHbNdelN is affected to the same extent as NO binding 
is, that would explain the decreased activity observed under steady-state conditions. 
 A final observation from this study that is worth noting is the fact that the rate 
constant for reaction of red-trHbNWT with NO (2.2108 M1 s1) is 5 – 10  greater than 
previously reported for the reaction of dioxygen with red-trHbNWT (2.5107 M1 s1 from 
stopped flow, or 5.6107 M1 s1 from laser flash photolysis).4,35  This seems surprising 
since one would expect trHbN to have evolved to bind dioxygen more rapidly in order to 
maximize formation of the active oxy-trHbN form in a mixture of both NO and dioxygen.  
The observation does however lend some credence to a recent conjecture made by Cazade 
and Meuwly, who proposed that the native state of trHbN is red-trHbN(NO), and that the 
bound NO must be replaced by oxygen before reaction can occur.17  Future studies on this 
interesting protein should further explore this possibility. 
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Chapter 5 
Conclusions and suggestions for further study 
5.1 Concluding Remarks  
The three primary accomplishments of this dissertation were to develop a method 
for generating over 100 M of nitric oxide in situ on the sub-microsecond timescale, and 
then using this method to obtain important new insights on the interaction of NO with the 
heme-containing proteins myoglobin (Mb) and truncated hemoglobin N (trHbN).  The 
complex Mn(PaPy2Q)(NO)]ClO4 (species 1), where (PaPy2QH) is N,N-bis(2-
pyridylmethyl)-amine-N-ethyl-2-quinoline-2-carboxamide was synthesized with only 
slight modifications from a published protocol,1 as detailed in Chapter 2.  When photolyzed 
with a 500 nm, ~3 mJ, 5 ns laser pulse, in a 0.15 cm  0.15 cm fluorescence cell, species 1 
yielded as much as 180 µM NO. 
 One potential limitation of species 1 (which ironically is also one of its strengths) 
is that, being so sensitive to visible light of all wavelengths out into the near-infrared, it is 
almost impossible to prevent it from releasing small amounts of NO prematurely.  This was 
not a problem for the studies presented herein, in which protein concentrations were always 
in large excess of NO concentrations, but could pose problems in other studies.  The 
complexes [RuIII(EDTA)H2O] and [RuIII(MEDTA)H2O], where EDTA is 
Ethylenediaminetetraacetate and MEDTA is methylethylenediaminetriacetate,2-5 were 
synthesized for possible future use as scavengers of prematurely released NO, and crude 
samples were shown to bind nitric oxide at around the expected kinetic values.6 
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 Once its photochemical properties were established, species 1 was first used in a 
study of the dioxygenation of NO by horse heart oxyMb.  This reaction has been proposed 
to be important for NO detoxification in muscle tissue;7 however, recent stopped-flow 
UV/Vis studies by Su and Groves of the metMb-catalyzed isomerization of peroxynitrite 
to nitrate called this hypothesis into question.  These studies indicated that the 
isomerization proceeded through a caged NO2 – ferrylMb intermediate, but with about 10% 
NO2 cage escape.8  A heme-bound peroxynitrite was long a presumed intermediate on the 
pathway of NO’s conversion to nitrate, but escape of 10% NO2 from the intermediate’s 
fragmentation would lead to a build-up of ferrylMb and NO2, which are arguably more 
deleterious to cell health than the NO that the reaction was originally meant to detoxify.  
The authors pointed to this as evidence that nitric oxide dioxygenation by Mb was likely 
not a physiologically relevant means of nitric oxide detoxification in vivo.   
The exceptionally high concentrations of NO produced per laser pulse by photolysis 
of 1 allowed the rapid reaction between NO and oxyMb to be initiated in quantities high 
enough that the buildup of 10% ferrylMb predicted by Su and Groves should have been 
readily detectable.8  Furthermore, numerical simulation using kinetic parameters available 
in the literature indicated that, under the reaction conditions employed in our experiments, 
10% ferrylMb represented a lower boundary of a range that could go as high as 16%.  
Contrary to prediction though, fitting of the UV/Vis spectrum obtained immediately after 
the laser pulse with the known extinction coefficient spectra of the expected products 
indicated that at most ~4% ferrylMb was being produced. Further reactions in the presence 
of ascorbate, which should have reacted with any available ferrylMb over several seconds 
and generated a characteristic spectral signature, proved that no more than 1 µM ferrylMb 
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was produced during these experiments.  This result has important implications for 
bioinorganic chemists and physiologists alike.  Peroxynitrite rearrangement to nitrate 
catalyzed by metMb cannot go through the same intermediate as NO dioxygenation by 
oxyMb, which calls into question the long-held assumption that NO dioxygenation begins 
with the formation of a bound peroxynitrite intermediate.  Not including such an 
intermediate would require a complete rethinking of the mechanism by which NO 
dioxygenation occurs.  Physiologists should likewise take note that the decreased 
production of ferrylMb (1% at most instead of 10%), and consequently also of NO2, means 
that NO dioxygenation by oxy-Mb may be an important pathway for in vivo NO 
detoxification after all.  Both of these implications will require further study. 
TrHbN is capable of the same NO dioxygenation reaction as Mb, but is over an  
order of magnitude more efficient (the rate constant calculated herein for the reaction of 
oxy-trHbNWT with NO was 1.4109 M1 s1, compared to 4107 M1s1 for oxyMb).9  
Crystal structures of trHbN had previously revealed a tunnel system connecting the protein 
surface to the active site, which provides the simplest explanation for trHbN’s superior 
efficiency compared to Mb.  However, over the years theoretical and experimental studies 
had brought up a number of other possibilities.10-20  The methodology for generating NO 
from photoprecursor 1 allowed these possibilities to be investigated in unprecedented 
detail. 
Kinetic results on trHbN variants showed an incredible robustness of the NO 
dioxygenase activity in the face of mutations.  Two active site variants showed either no 
(trHbNY33A) or minimal (trHbNQ58A) decreases in NO dioxygenation rates, consistent with 
theoretical predictions by Crespo et al.13  On the other hand these changes, and the very 
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slight changes in nitrosylation rates of trHbNF62A and trHbNF62W mutants, were inconsistent 
with predictions that NO preferentially accesses the active site via the long tunnel during 
dioxygenation.12,14,16,21  The mutations of Phe 62 in particular should have had profound 
effects on the topology of the long tunnel, and these should have affected the observed 
reaction rates accordingly.  Instead, the results of our experiments suggest that during 
dioxygenation NO can readily access the heme via the short tunnel, which remains open at 
all times. 
Perhaps the most interesting trHbN mutant studied in this work was trHbNdelN, in 
which the so-called “Pre-A” N-terminal sequence of 12 amino acids17 was deleted.17  This 
mutant exhibited a remarkable change in nitrosylation kinetics, becoming zero order with 
respect to protein concentration.  By contrast its NO dioxygenation kinetics remained 
unchanged.  The pre-A sequence is remote from the trHbN active site, so this finding 
indicates that the mutation is affecting the general dynamics of the protein in such a way 
that NO can still enter the protein, but is now blocked from binding to the heme for an 
extended period of time.  A high priority area of future study should be to determine the 
mechanism for this blocking phenomenon.  One promising hypothesis, founded on a prior 
theoretical study,21 is that a water tightly bound in the active site (but not directly to the 
heme) can no longer be dislodged as efficiently without the pre-A initiated dynamics.  This 
hypothesis could be tested by mutating the amino acids that hold the water in place (see 
below). 
Finally, the comparison between the second-order rate constant governing 
nitrosylation in wild type trHbN (2.2108 M1 s1) and the literature values governing 
dioxygen binding (2.5107 M1 s1 5.6107 M1 s1)10,21 deserves special mention.  It 
139 
 
seems surprising that NO binding is an order of magnitude more efficient than O2 binding, 
in a protein that should benefit from preferential dioxygen binding when faced with a 
choice between the two gases. 
 Several further studies with trHbN are currently in the works at the Pacheco lab.  A 
photo-activated dioxygen donor is being developed for use in laser photolysis studies, and 
this should greatly simplify testing of the hypothesis that the delN mutant of red-trHbN 
affects not only the pathway through which NO travels, but also that of dioxygen.  
Theoretical analysis suggested that the amino acids Tyr33 and Gln58 hold in place the 
water that blocks access to the heme in red-trHbN (see above),21 so a new triple mutant 
Y33F+Q58V+delN will be used to test if the decreased nitrosylation rate that we observed 
for the delN mutant is due to dynamic changes that affect this water’s exit.  A final line of 
investigation planned for the near future is to test the effects of mutations near the heme’s 
proximal ligand.  For example, Met77 is hydrogen bonded to the proximal His81, and 
computational studies have suggested that it should have a significant effect on the 
character of the bound oxygen,13 which in turn could affect NO dioxygenation.  This 
avenue of investigation was only briefly touched on in this work, but could prove very 
interesting. 
 We hope that the insights presented herein will help inform further theoretical 
studies of the fascinating trHbN protein that operates at rates on the cusp of what is possible 
in solution.  It is even possible that future studies of trHbN could lead to new treatments 
for the causative agent of tuberculosis, and some forays in this direction were recently 
reported by Ascenzi et al.22  In this regard, the profound sensitivity of the rates for gas 
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binding to heme on the mobility of the pre-A region may be a particularly attractive 
candidate for future study. 
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Appendix 1 Supplementary Material to Chapter 3 
A1.1.  Determination of the rate constant for the reaction of metMb with ascorbate 
 
 
 
 
 
 
 
A1.2.  The reaction of oxyMb with ascorbate.   
The reaction of approximately 280 µM oxyMb with 0.2 M ascorbate was followed 
by UV/vis spectroscopy.  Spectra were collected every 12s for 1h in the spectral range from 
450 - 800 nm, in the same 1.5 mm × 1.5 mm micro-cuvette that were used in the laser 
photo-initiation experiments.  In addition a spectrum of the mixture was obtained 
approximately 8h after the reaction was initiated.  SVD analysis of the data revealed 4 
Figure A1.1.  A plot showing the dependence of V0/[metMb] on total 
ascorbate concentration, where V0 is the initial rate at which metMb is reduced 
to oxyMb.  OxyMb was shown to be the only reaction product by fitting the 
changes in the complete difference spectra as a function of time using the 
extinction coefficient spectra of metMb and oxyMb.  The red trace is a linear 
fit to the data, whose slope (0.053 ± 0.002 M1s1) is the second-order rate 
constant for the reaction of ascorbate with metMb. 
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distinct spectral components.  Figure A1.2a shows 
the time trace obtained at 582 nm, which is one of 
the absorbance maxima for oxyMb.  The trace 
gives an idea of the complexity of the spectral changes: after a brief lag A582 decreases over 
a 590s time period, then briefly increases before decreasing again.  Despite the complexity, 
individual spectra can be well fitted using the known extinction coefficient spectra of 
oxyMb, metMb and Mb, plus contributions from a rising baseline and from an artificial 
extinction coefficient spectrum constructed from the UV/Vis spectrum obtained after 8h.  
Figure A1.2.  (a) UV/Vis spectral changes observed at 
582 nm after 0.2 M ascorbate were mixed with ~280 
µM oxyMb.  (b) product distribution as a function of 
time after reaction initiation, as determined by fitting 
the spectra at the given time points with the extinction 
coefficient spectra of oxyMb, metMb, Mb, an 
extinction coefficient spectrum determined for a 
putative reaction product present after 8h (Fig. A1.3a), 
and an adjustable baseline.  
Figure A1.3.  (a) An extinction coefficient 
spectrum calculated for the product(s) of 
the reaction between 0.2 M ascorbate and 
280 µM oxyMb, that were still present 8h 
after reaction initiation.  The spectrum was 
obtained by dividing the absorbance at 
each wavelength by pathlength and the 
total Mb concentration (i.e. 280 µM, the 
concentration of oxyMb at t0).  (b) UV/Vis 
spectra observed at selected times after 
mixing 0.2 M ascorbate with 280 µM 
oxyMb, and the best fits to the spectra that 
were obtained using the extinction 
coefficient spectra of oxyMb, metMb, Mb, 
the spectrum of part (a) and an adjustable 
flat baseline. 
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Figure A1.2b shows how the concentration of each species changes with time, while Fig. 
A1.3b shows the spectral fits at selected times.  Figure A1.3a shows the synthetic extinction 
coefficient spectrum used to correct the data for appearance of the unidentified final 
product.  The need to adjust the baseline and contribution from the “final product” 
independently introduced an extra degree of freedom that is not warranted from SVD 
analysis, and thus precluded an automated least-squares fit to the data.  Nonetheless 
individual spectra could be readily simulated if the concentration parameters were adjusted 
by hand.  The contributions from the final species and the baseline constitute nothing more 
than an empirical correction; however, the contributions by oxyMb, metMb and Mb all 
show very narrow least-squares tolerances, and are thus deemed reliable.  
 The results of this experiment confirm that in the cuvette used for the laser photo-
initiated experiments described in the main text and below, both Mb and metMb can be 
generated when oxyMb reacts with ascorbate, as proposed in Scheme 3.4.  In particular 
Equilibrium (2) of Scheme 3.4 can shift to form Mb from oxyMb, because molecular 
oxygen is consumed sufficiently rapidly that it can’t be replenished from the surrounding 
atmosphere by diffusion.  In the experiments presented here Mb begins to appear only after 
a lag time of about 100s, because at time zero the solution concentration of O2 is very 
nearly that predicted by Henry’s law for equilibrium of a solution with air.  By contrast, 
immediately after the laser pulse in the laser photo-initiated experiments, ~100 µM of 
oxyMb had already been converted to metMb, with concomitant consumption of ~100 µM 
Mb-bound O2 (e.g. Fig. 3.1).  As a consequence Mb would begin to appear much sooner, 
within less than 10s after the laser pulse.  
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A1.3.  The reaction of ferrylMb with ascorbate. 
Given the importance of the reaction between ferrylMb and ascorbate to the 
interpretation of our results, we deemed it imperative to ensure that this reaction is not 
affected by our specific reaction conditions.  Accordingly the reaction was carried out in 
the presence of species 1, in the presence of 1 and oxyMb, and in a solution containing no 
other species.  The precise reaction conditions are listed in Table A1.1.  In each case 
ferrylMb was reduced to metMb in an apparent first-order process, as judged by monitoring 
spectral changes in the 560-580 nm region, and fitting these with the known spectral 
components from ferrylMb and metMb.  The apparent rate constants are listed in Table 
A1.1 as kobs.  Using the derivations of Kroger-Ohlsen and Skibsted3 we calculated the 
theoretical values of the pseudo-first order rate constants that govern the reaction of 
ferrylMb with ascorbate, given the reaction conditions listed in Table A1.1; these are listed 
in the table under the heading kasc.  Now recall that we showed, in the main part of the 
paper, that the NO photo-precursor 1 can also effect ferrylMb reduction, in a process 
Reaction conditions kobs (s−1) kasc (s−1)a k1 (s−1)b ktheor = (kasc+k1) ktheor/kobs 
130 µM ferrylMb, 1 mM 
ascorbate 
0.006 0.015 0 0.015 2.5 
65 µM ferrylMb, 500 µM  
ascorbate, 500 µM 1 
0.005 0.0081 0.0035 0.012 2.4 
65 µM ferrylMb, 500 µM  
ascorbate, 250 µM 1, 250 µM 
oxyMb 
0.004 0.0081 0.0018 0.0099 2.5 
Table A1.1.  Reduction by ascorbate of ferrylMb to metMb at pH 7.35 and 25° C; comparison of 
observed vs theoretical apparent rate constants. 
a. Calculated from Eq. 2 of ref. 3.    b. Based on the second-order rate constant of 7 M−1s−1, obtained in the 
main manuscript. 
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governed by a second-order rate constant with a value of ~7 M−1s−1.  Using this value we 
calculated k1, the pseudo first-order constant that would be observed for this process given 
the reaction conditions listed in Table A1.1.  Finally, the expected rate constant ktheor 
governing reduction of ferrylMb to metMb for each set of reaction conditions was 
calculated as the sum of kasc and k1.  From Table A1.1 it is clear that the theoretical value 
ktheor consistently over-estimates the calculated value kobs of the rate constant governing 
reduction of ferrylMb by ascorbate.  However, the ratio ktheor/kobs is completely unaffected 
by the presence or absence of 1 and/or oxyMb, showing that these species do not affect the 
reaction. 
 In their paper Kroger-Ohlsen and Skibsted showed that at low pH the dependence 
of the apparent rate constant for reduction of ferrylMb by ascorbate is quite non-linear, but 
that it becomes linear with a limiting value of 2.7 M−1s−1 at high pH and 25° C.3  At pH 
7.35 the non-linear contributions are estimated to be minor, but still significant when using 
low ascorbate concentrations such as those listed in Table A1.1 (see Fig. A1.4a).  
Accordingly, for the experiments of Table A1.1 the value of kasc was calculated using Eq. 
2 from Kroger-Ohlsen and Skibsted’s paper.  As mentioned earlier the kasc values so 
obtained lead to over-estimates of the experimentally derived constants (kobs); indeed, the 
kobs values all lie about mid-way between those that would have been predicted by the 
Kroger-Ohlsen/Skibsted equation and those predicted from the high pH limiting value of 
2.7 M−1s−1.  However, the ratios ktheor/kobs that are calculated from the formula are 
significantly more invariant than those calculated by deriving ktheor from the limiting value.  
From this we conclude that, while overestimated by the Kroger-Ohlsen/Skibsted equation, 
some non-linear contributions to kasc are still present at pH 7.35.  At higher ascorbate 
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concentration the non-linear contributions to kasc become progressively less significant by 
comparison with the limiting value of 2.7 M−1s−1, as seen in Fig. A1.4b.  Therefore, in order 
to simplify the discussion, the limiting value was used to calculate the theoretical trace of 
Fig. 3.3a in the main text, and in the other experiments described below, in which mixtures 
of oxyMb, 1 and various ascorbate concentrations were exposed to laser pulses.  This 
approach is especially justified given that the Kroger-Ohlsen/Skibsted equation appears to 
overestimate the non-linear contributions at this pH.  Note that our conclusions would in 
no way be affected by changing the value of kasc by 2×, or even 3× in either direction.  In 
all cases the presence of ferrylMb would have left a readily detectable kinetic fingerprint, 
which was absent in our experiments. 
 
 
Figure A1.4.  Dependence on [ascorbate] of the pseudo-first order rate constant of the reaction between 
ascorbate and ferrylMb, as calculated from equation 2 of ref. 3 (blue traces), or from the second-order rate 
constant 2.7 M−1s−1 that becomes dominant as pH increases (red traces):  (a) at low ascorbate 
concentrations, and (b) at the ascorbate concentration ranges used in the experiments with oxyMb, 
ascorbate and 1. 
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A1.4.  Laser photo-initiated fragmentation of species 1 in the absence of protein 
A1.5.  Expected result of mixing 100 µM NO with 272 µM oxyMb, if the reaction of 
oxyMb with NO shared a common intermediate with the metMb-catalyzed 
isomerization of peroxynitrite: a numerical simulation of the product distribution’s 
evolution during the first 3 ms. 
Scheme 3.3 of the main text summarized the reactions that would be expected if 
the reaction between NO and oxyMb resulted in formation of a peroxynitrite intermediate, 
that then further reacted as shown in Scheme 3.1 Path 2, recently proposed by Su and 
Groves.4  The differential equations used to model this process and arrive at the plots of 
Fig. 3.2 are given below and on the following pages.  The variable names used to represent 
the reactant species in these equations are provided in Scheme A1.1, which is otherwise 
identical to Scheme 3.3. 
Figure A1.5.  Results of irradiating a 1.8 mM solution of 1, in pH 7.4 Hepes buffer, with a 500 nm laser 
pulse.  (a) Changes in absorbance immediately following the pulse (t160 ms) and after 10s, 20s, 30s, 40s, 
50s and 60s; the arrow indicates the direction of the absorbance displacement.  The blue traces were 
experimentally determined, the red ones were calculated by least-squares using a matrix form of Beer’s 
law and the independently determined extinction coefficient spectrum of 1.  No other components were 
required to obtain a good fit.  (b)  The amount of 1 consumed as a function of time, which also 
corresponds to the amount of NO generated.  The red trace is a linear least-squares fit.  The laser pulse 
generated 132±1 µM NO from 1.  Photolysis by the probe beam subsequently generated more NO at a 
constant rate of (0.846±0.003) µM/s.  The amount of NO generated could be controlled by varying the 
initial [1] or by changing the intensity of the laser pulse. 
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Scheme A1.1. oxyMb + NO reaction summary 
 
 
 
 
 
 
Eq. A1.1 
Eq. A1.2 
Eq. A1.3 
Eq. A1.4 
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The differential equations were modeled using Mathcad 13's “RKadapt” algorithm, 
which performs a numerical integration using the procedure of Runge-Kutta with adaptive 
stepsize.  The graphs of Fig. 3.2 were obtained using 1000 steps in an interval from 0 to 
0.02s, but identical results were obtained when 10000 steps were used.  All of the rate 
constants are exactly those provided in literature references (see main text, Scheme 3.3) 
except for k6 which is not known with certainty.  Goldstein et al. provide a range of (104 
M−1s−1 < k6 < 107 M−1s−1) for this parameter,5 and we arbitrarily chose the upper bound.  A 
smaller value of k6 is unlikely to change the conclusions; if ferrylMb+∙ reacts more slowly 
with oxyMb, then it’s probably still converted to ferrylMb by another competing process, 
such as reduction by ascorbate. 
A1.6.  Laser photo-initiated reaction of NO with excess oxyMb in the presence and 
absence of ascorbate: analysis of the data. 
 A1.6.1. 0.200 M ascorbate.  This is the reaction presented in Figs. 3.3 and 3.4 of 
the main text.  Figure A1.6 shows the difference spectrum obtained immediately after 
irradiating a solution of 272 μM oxyMb, 1.72 mM 1 and 200 mM ascorbate with a 500 nm 
laser pulse, and was used to obtain the rough upper bounds on possible ferrylMb and/or 
Mb concentrations present immediately following the laser pulse, as described for Fig. 3.1 
Eq. A1.5 
Eq. A1.6 
Eq. A1.7 
Eq. A1.8 
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of the main text.  The double-difference spectra obtained by subtracting the Fig. A1.6 
spectrum from spectra obtained during the subsequent 45s were initially processed using 
SVD analysis, which unambiguously 
revealed two components above the 
noise (Fig. A1.6).  Visual inspection of 
absorbance vs time traces at various 
wavelengths showed that at some 
wavelengths the absorbance varied 
virtually linearly with time, whereas at 
others it varied non-linearly (see for 
example Fig, 3.3b).  We therefore 
constructed a Mathcad program to fit 
the SVD-processed data with a 2-
component system, in which one 
component varied exponentially with 
time, while the other varied linearly The time-dependence was incorporated into a matrix 
T, defined in Eq. A1.9, in which i represents the number of time points, 
 
 
and k1 is a parameter that can be adjusted within the program.  The corresponding 
wavelength dependence of the two components was incorporated into a second matrix Λ, 
which is defined in Eq. A1.10.  In this equation ΔA is the SVD-processed matrix of 
Figure A1.6.  Difference spectrum obtained 
immediately after irradiating a solution of 272 μM 
oxyMb, 1.72 mM 1 and 200 mM ascorbate with a 500 
nm laser pulse.  Solid blue trace: experimentally 
obtained data; dashed red trace: calculated by least-
squares fit using the extinction coefficient spectra of 
oxyMb, metMb, ferrylMb and 1; dashed green trace: 
same as red trace but using the Mb extinction coefficient 
spectrum instead of the ferrylMb one.  The fitted 
experimental spectrum was the average of the first 20 
raw spectra collected every 16 ms using the Olis 
spectrophotometer. 
Eq. A1.9 
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absorbances.  Finally, a matrix of theoretical absorbance values (ΔAcalc) was calculated 
using Eq. A1.11, and the sum of squares for ΔA−ΔAcalc was computed.    
 
 
This sum of squares was minimized by varying the adjustable parameter k1, which yielded 
the excellent fits shown in Fig. 3.3 of the main text. 
 Up to this point the fitting procedure provides no indication of the actual chemical 
species contributing to the spectra; this information was obtained by analyzing the 
components of Λ.  In this matrix the values of the first row (Λ1,j) represent the absorbance 
amplitudes of the exponentially varying component at wavelengths λj as t →∞ (i.e., they 
represent the maximum spectral amplitude reached by this component).  By contrast, the 
values of the second row (Λ2,j) represent the absorbance changes per second at λj of the 
linearly varying component.  The two components are plotted against wavelength in Fig. 
A1.6, together with theoretical overlays obtained by fitting each component using the 
known extinction coefficient spectra of oxyMb, metMb, Mb, 1, a flat baseline, and the 
matrix form of Beer’s law.6-9 In the case of the first component the fitting procedure 
provides the concentration of each myoglobin species that is produced by the exponential 
process as it goes to completion.  For the second component the fitting procedure provides 
the concentration of each species that is generated every second by the linear process.  In 
both cases we applied the constraint that ΔCoxyMb=  −(ΔCmetMb + ΔCMb).  The net 
concentration change of each species as a function of time is thus given by Eqs. A1.12 –
A1.15, which combine the contributions by the linear and exponential processes.  These 
Eq. A1.10 
Eq. A1.11
153 
 
equations were used to construct the Fig. 3.4 graphs. 
 
 
 
 
A1.6.2.  No ascorbate added.  The double-difference spectra obtained by 
subtracting the Fig. 3.1 spectrum from spectra obtained during the subsequent 45s were 
initially processed using SVD analysis, which unambiguously revealed a single component 
above the noise.  The SVD-processed data could be fitted in a way similar to that described 
for the 0.2 M ascorbate data (Section A1.6.1), this time revealing that the one component 
varies virtually linearly with time (Fig. A1.9a).  The fitting procedure yielded a matrix Λ, 
as described by Eqs. A1.9 and A1.10, with a single row that represents the changes in 
absorbance per second of the linearly varying component.  The component Λ1, plotted 
against wavelength, is shown in Fig. A1.9b (blue trace), together with a least-squares fit of 
the data using Beer’s law, the known extinction coefficient spectra of Mb, metMb, oxyMb, 
1, and a flat baseline(red trace of Fig. A1.9b).  The analysis shows that the major change 
observed on the timescale of tens of seconds is oxidation of oxyMb to metMb, presumably 
by NO photogenerated from 1 by the probe beam (the fit was constrained such that the 
amount of 1 consumed each second matched the amount of metMb generated).  In all, our 
calculations show that about 35 μM metMb were generated during the 45s that the reaction 
was monitored, compared to the ~90 μM generated in less than a ms by the initial laser 
pulse.  The best fit suggests that a very small amount of Mb is also consumed every second: 
Eq. A1.12
Eq. A1.13
Eq. A1.14 
Eq. A1.15 
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~5% compared to the amount of oxyMb consumed.  This may represent some of the Mb 
generated during the initial laser photo-initiated process.  
A1.6.3.  0.100 M ascorbate.  
Figure A1.10 shows the spectrum 
obtained immediately after 280 μM 
oxyMb and 1.79 mM 1 were irradiated 
with a laser pulse in the presence of 0.100 
M ascorbate.  The results are comparable 
to those obtained either in the absence of 
ascorbate (Fig. 1) or in the presence of 0.2 
M ascorbate (Fig. A1.6): about 105 µM 
oxyMb have been oxidized by photo-
generated NO to yield primarily metMb 
(100 µM), though small amounts (~4-5 
µM) of either ferrylMb or Mb are also 
Figure A1.7.  SVD-analysis of the double-difference spectra obtained after irradiating a solution of 272 
µM oxyMb, 1.72 mM 1, and 200 mM ascorbate with a 500 nm laser pulse.1,2 (a) The three U components 
corresponding to the highest ranked singular values, and their associated autocorrelation values Cu.2  (b) 
The corresponding V components and associated autocorrelation values Cv, and (c) the singular values 
of the first 6 components.  Note the very low autocorrelation value U3, and the fact that the values of S3 
onwards vary linearly and are much smaller than S1 and S2.  Based on these factors we conclude that two 
spectral components give rise to the observed changes in ΔA. 
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generated.  This experiment confirms 
that addition of any amount of 
ascorbate has no effect on the initial 
photo-initiated reaction between 
oxyMb and NO. The double-
difference spectra obtained by 
subtracting the Fig. A1.10 spectrum 
from spectra obtained during the 
subsequent 45s were initially 
processed using SVD analysis, 
which unambiguously revealed a 
single component above the noise.  
The SVD-processed data could be 
fitted in a way similar to that 
described for the 0.2 M ascorbate data 
(Section A1.6.1).  This time the single 
component could be fitted 
satisfactorily using an exponential 
function (Fig. A1.11a); however, the 
reaction was followed for less than 
two half-lives (kcalc = 0.0258 s−1, t0.5 = 
27 s), so the exponential fit should be viewed as purely empirical.  The fitting procedure 
yielded a matrix Λ, as described by Eqs. A1.9 and A1.10, with a single row that represents 
Figure A1.8.  (a) The first row of Λ, representing the final 
absorbance spectrum of the exponentially varying component as 
t→∞, plotted against wavelength.  (b) The second row of Λ, 
representing the changes in absorbance per second of the linearly 
varying component, plotted against wavelength.  The red traces 
are the least-squares fits of the data using Beer’s law, the known 
extinction coefficient spectra of Mb, metMb, oxyMb and 1, and 
a flat baseline.  The concentrations and concentration changes of 
each species were obtained from the fitting procedure.  The 
shifting baselines in the components are most likely due to the 
same reactions that give rise to the nearly featureless spectrum 
of Fig. A1.3a when mixtures of oxyMb and ascorbate are 
allowed to interact for extended periods of time. 
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the changes in absorbance that 
would be expected after infinite time 
if the reaction were to continue to 
evolve exponentially.  The 
component Λ1, plotted against 
wavelength, is shown in Fig. A1.11b 
(blue trace), together with a least-
squares fit of the data using Beer’s 
law, and the known extinction 
coefficient spectra of Mb, metMb, 
oxyMb and 1 (red trace of Fig. 
A1.11b).  One sees that the major 
change observed on the timescale of 
tens of seconds is net reduction of 
metMb back to oxyMb (and possibly 
a very small amount of Mb), as 
expected in the presence of ascorbate 
(Scheme 3.4).  The predicted final 
concentration of metMb is not zero, 
presumably because oxyMb is also 
being re-oxidized to metMb by the 
NO generated via photolysis of 1 in 
the probe beam, so that the two processes eventually balance out.  Note that for this 
Figure A1.9.  (a) ΔA vs t slice at 580nm for the double-
difference spectra obtained by subtracting the Fig. 3.1 
spectrum from subsequent spectra that followed the laser 
pulse.  The calculated trace was obtained by fitting all of 
the data to a linear function in a manner analogous to that 
described in Section A1.6.1.  (b) Row of the matrix Λ 
obtained as described by Eqs. A1.9 and A1.10, which 
represents the changes in absorbance per second of the 
linearly varying component, plotted against wavelength.  
The red traces are the least-squares fits of the data using 
Beer’s law, the known extinction coefficient spectra of 
Mb, metMb, oxyMb, 1, and a flat baseline.  The 
concentration changes of each species were obtained from 
the fitting procedure.  The shifting baseline, as calculated, 
would lead to a total absorbance change of less than 0.002 
AU during the 45s that the reaction was monitored. 
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experiment the contributions to Λ1 by 1 and a shifting baseline could not be deconvoluted 
from each other.  For convenience contributions of ΔC1 = 10 μM and zero baseline were 
used to fit the trace in Fig. A1.11b, but multiple combinations of [1] and baseline gave 
comparable fits.  In contrast, when fitting the results obtained in the absence of ascorbate, 
or in the presence of 0.200 M ascorbate Fig. 3.9b and Fig. A1.8), the sums of squares were 
quite sensitive to the choices made for these parameters. 
 Figure A1.11a shows fitted absorbance changes at both 580nm and 596nm.  
Notably, a very small 
absorbance increase is seen at 
the latter wavelength, whereas 
a much more substantial 
absorbance decrease (short 
solid green trace in Fig. 
A1.11a) should have been seen 
if 5 μM ferrylMb had been 
present, as predicted by one 
analysis of Fig. A1.10.  
Furthermore, the results from 
the Groves group predict that 
even more ferrylMb (> 15 μM) 
should have accompanied 
Figure A1.10.  Difference spectrum obtained immediately after 
irradiating a solution of 280 μM oxyMb and 1.79 mM 1 with a 
500 nm laser pulse, in the presence of 0.100 M ascorbate .  
Solid blue trace: experimentally obtained data; dashed red 
trace: calculated by least-squares fit using the extinction 
coefficient spectra of oxyMb, metMb, ferrylMb and 1; dashed 
green trace: same as red trace but using the Mb extinction 
coefficient spectrum instead of the ferrylMb one.  The fitted 
experimental spectrum was the average of the first 20 raw 
spectra collected every 16 ms using the Olis 
spectrophotometer. 
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formation of 100 μM metMb from oxyMb and NO, if the reaction had proceeded via the 
intermediate formed when metMb isomerizes peroxynitrite.4 
 A1.6.4.  Other ascorbate concentrations.  In addition to the experiments 
described in the main text and in sections A1.5.1-A1.5.3 above, we also carried out similar 
experiments in the presence of 0.3M and 0.6M ascorbate.  The results were similar to those 
reported, except that with the higher ascorbate concentrations a significant amount of Mb 
was generated by reduction of oxyMb, even before the sample was irradiated with a laser 
pulse.  This Mb reacted with the photo-generated NO to yield nitrosomyoglobin (MbNO), 
which further complicated the analysis.  The data are not included here as they shed no 
new light on the problem of interest in this report, but they were analyzed and are available 
from the Pacheco lab upon request.   
  
Figure A1.11.  (a) ΔA vs t slices at 580 and 596 nm for the double-difference spectra obtained by 
subtracting the Fig. A1.10 spectrum from subsequent spectra that followed the laser pulse.  The 
calculated traces were obtained by fitting all of the data to an exponential function in a manner analogous 
to that described in Section A1.6.1.  The short green trace shows the absorbance change at 596 nm that 
would accompany the reduction of 5 μM ferrylMb to metMb by 0.1 M ascorbate.  (b) Row of the matrix 
Λ obtained using Eqs. A1.9 and A1.10, which represents the difference spectrum that would arise after 
infinite time if the reaction were to continue to evolve exponentially.  The red traces are the least-squares 
fits of the data using Beer’s law and the known extinction coefficient spectra of Mb, metMb, oxyMb and 
1.  The concentration changes of each species were obtained from the fitting procedure. 
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It should be noted that in no other cases did we see evidence for MbNO 
accumulation.  Indeed, when fitting the spectra of Figs. 3.1, A1.6 or A1.10 the sum of 
squares invariably increased if even small contributions from this species were added in 
the fits.  Given the low precision of the single-spectrum analyses this is not conclusive 
evidence for the complete absence of MbNO, but it does show that any contributions from 
this species must be minimal. 
A1.7.  Monitoring the reaction of oxyMb with NO on the microsecond timescale 
 A1.7.1.  Using 1 to generate NO.  In addition to the experiments presented above, 
the reaction of oxyMb with NO was also monitored on the microsecond timescale.  A series 
of absorbance vs. time traces were collected 5 nm apart in the wavelength range from 480 
- 630 nm, and combined to generate a set of time-resolved spectra.  This set of time-
resolved spectra were subjected to SVD analysis as described in Section A1.6.1, which 
revealed 5 components with featured time traces but only three with spectral  
 
Figure A1.12.  (a) Selected spectral changes observed on the µs timescale after a solution containing 
250 µM oxyMb and 1.75 mM 1 is irradiated with a 500 nm, 5 ns laser pulse. (b) time trace at 584 
nm.  In both cases the experimental data are shown in blue, while the best fits using Eq. A1.16 are 
shown in red. 
Eq. A1.16
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features.  Figure A1.12a shows the spectral 
changes observed at some representative 
times in the SVD-processed data set, while 
Fig. A1.12b shows the time trace obtained 
at 584 nm in the same set.  The complete 
data set was fitted to Eq. A1.16, which is 
the analogue of Eq. 3.1 in the main text, 
using the same methodology as described 
in Eqs. A1.9 and A1.10.  This equation has 
two exponential terms with initial 
amplitudes Λ1λ and Λ2λ that decrease to 
zero over time, and which arise from a 
transient response by the photomultipliers 
to the laser flash (they are featureless in the 
wavelength domain).  More interestingly it 
also has two components that increase 
exponentially from zero with amplitudes 
Λ3λ and Λ4λ, and a constant background 
component Λ0λ.  These three components 
are presented in Fig. A1.13. Component 
Λ3λ, which increases with apparent rate 
constant 1.15×104 s−1, is fitted very well 
with the known extinction coefficient 
Figure A1.13.  Three spectral components obtained 
by fitting the time-resolved spectra of Fig. A1.12 to 
Eq. A1.16.  Λ1 and Λ2 were featureless as they 
reflected the photomultiplier response to the laser 
flash. 
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spectra of oxyMb and metMb (Fig. A1.13a), and shows that in this phase about 50 µM 
oxyMb is converted to metMb.  If we assume that the apparent rate constant k3obs depends 
linearly on [oxyMb]0, then the value of the true second-order rate constant k3 is 4.6×107 
M−1s−1, which almost exactly matches the expected value of k11+k12 (Schemes 3.3 and 
A1.1) reported by Herold et al.10  To some extent such a good match must be coincidental, 
since the experimental conditions were not strictly pseudo-first order (hence we should 
have underestimated k3).  However, the closeness of the match does suggest that we are 
observing the same reaction as Herold et al (OxyMb + NO), despite the fact that NO was 
generated in an unusual way.  Interestingly, the component Λ4λ, which increases with 
apparent rate constant 4.2×103 s−1, is also well fitted with the same known extinction 
coefficient spectra of oxyMb and metMb (Fig. A1.13b), this time showing that ~16 µM of 
oxyMb are being converted to metMb.  Finally, the time-independent component Λ0λ (Fig. 
A1.13c) is very well fitted with the known extinction coefficient spectrum of species 1, 
and reflects the fact that ~65 μM of 1 were photolyzed to produce NO within the dead time 
of the experiment.  Reassuringly, this value for NO generated matches the total amount of 
oxyMb subsequently converted to metMb. 
 It is unclear why two components Λ3λ and Λ4λ are observed here.  Even if the 
oxidation of oxyMb to metMb by NO is biphasic, a single reaction type should only give 
rise to a single spectral component.  And yet, if only one spectral component is used to 
multiply both exponentials in the analysis, the fit is substantially worse.  Most of the 
differences in the fast and slow components can probably be attributed to differential 
admixing of noise (the smaller amplitude component A4λ is substantially noisier than the 
higher amplitude A3λ).  However, it may be that distinct processes are in fact being 
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observed in the two kinetic phases, but that the spectral changes are subtle enough to allow 
both to be fitted adequately with the same two extinction coefficient spectra.  In this regard 
a promising hypothesis is that the fast exponential phase actually reflects conversion of 
oxyMb to metMb(ONO2) (Scheme 1), while the second phase reflects substitution of NO3− 
by H2O at the heme center.  Such a biphasic process is indeed observed at high pH,5,10-12 
but is too fast to be observed by rapid-mixing at lower pHs.  Ours is the first analysis of 
the oxyMb + NO reaction on the µs timescale, and thus presents the first opportunity to see 
evidence of the process at pH 7.4.  
A1.7.2.  Using an alternative NO photo-precursor.  During the review process 
for chapter 3 as an article the point was made that because oxyMb is photo-labile, the laser 
pulse might be leading to O2 dissociation.  The reviewers asked what effect this might have 
on the article’s conclusions.  The results shown in Section A1.7.1 exhibit no evidence of 
oxyMb photolysis.  Such photolysis would have at first generated Mb from oxyMb, which 
would have been revealed during analysis of the Fig. A1.13 spectral components.  Even if 
free Mb had formed though, it would have either re-combined rapidly with O2, or it would 
have reacted with free NO to generate the kinetically inert MbNO.†  As an example we 
now present an early experiment in which oxyMb photolysis was observed.  In this 
experiment N,N’-bis(carboxymethyl)-N,N’-dinitroso-p-phenylenediamine8 was used as the 
NO photo-precursor.   This photo-precursor is activated by 308 nm light, which is 
                                                 
† The inertness of MbNO is well known, and discussed in Eich, R. F., Ph.D Thesis, 
Rice University, Houston, TX, 1997, and references therein. 
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substantially more energetic than the 500 nm light used to activate 1.   
 Figure A1.14a shows the spectral changes observed at representative times after 
irradiating a solution of 40 μM oxyMb and 40 μM N,N’-bis(carboxymethyl)-N,N’-
dinitroso-p-phenylenediamine with a 308 nm laser pulse, while Fig. A1.14b shows 
representative time traces at 408 nm and 418 nm, respectively.  The spectra were 
reconstructed from individual absorbance vs time traces, and subjected to SVD, as 
described in Section A1.7.1.  The SVD analysis revealed 3 components.  The data were 
fitted to a model in which a species X0 present immediately after the laser pulse decays 
first to species X1 and then to species X2, via successive first-order processes. The 2-step  
 
 
 
Figure A1.14.  (a) Selected spectral changes observed on the s timescale after a solution containing 45 
M oxyMb and 40 M N,N’-bis(carboxymethyl)-N,N’-dinitroso-p-phenylenediamine was irradiated with 
a 308 nm laser pulse.  (b) Time traces at 408 nm and 418 nm.  In both panels the best fits using Eqs A1.17, 
A1.18 are in red, while the experimental data are in either blue or green. 
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fitting process was analogous to 
that described in Section A1.6; 
in the first step a time-
dependent matrix T was 
generated according to Eq. S17 
below, and then in the second 
step the matrix of spectral 
components  was evaluated 
using Eq. A1.10.  The least-
squares best fits to the data are 
given by the red traces in Fig. 
A1.14.  Figure A1.15 shows the 
three spectral components 
corresponding to the species X0, 
X1 and X2 in the kinetic fit.  The 
first (t=0) component (Fig. 
A1.15a) is very well fitted using 
only the spectra of oxyMb and 
Mb, and shows that 0.31 μM of 
oxyMb was photolyzed by the 
laser pulse.  The second 
component (Fig. S15b) requires 
the extinction coefficient Figure A1.15.  Three spectral components obtained by fitting the time-resolved spectra of Fig. A1.14 to Eqs. A1.17 and 
A1.10. 
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spectra of oxyMb, metMb and Mb to obtain a good fit, and shows that during the first 
exponential phase the Mb generated from oxyMb photolysis recombines with O2.  MetMb 
generated by the reaction of oxyMb with NO during the first exponential phase also 
contributes to this component.  Finally, the third component (Fig. A1.15c) can be well fitted 
using only the spectra of oxyMb and metMb, and reflects purely oxidation of NO by 
oxyMb. 
 The results of the experiment with N,N’-bis(carboxymethyl)-N,N’-dinitroso-p-
phenylenediamine are consistent with the known reactivity of Mb with O2 and NO.  The 
literature rate constant for the reaction between O2 and Mb is (1.4×107 M−1s−1),13 
comparable to that for reaction of NO with Mb (1.7×107 M−1s−1).14 In this experiment [O2] 
>> [NO] (~300 μM for O2 in an air-saturated solution, compared to ~2.1 μM for NO), so 
given the comparable second-order rate constants O2 will vastly out-compete NO for the 
free Mb.  In the other experiments presented in the article, including that shown in Section 
A1.7.1, the amount of NO generated by the laser pulse was substantially greater (80-100 
μM), so NO would compete more effectively for free Mb if this were generated.  However, 
as mentioned above, MbNO is kinetically inert and would play no active role in the 
chemistry of interest in the main text.  This was observed in the experiments with high 
ascorbate concentration (>300 mM) mentioned in Section A1.6.4. 
A1.8.  Stability of ferrylMb in the presence of species 1 after laser irradiation: 
stoichiometric analysis.   
 The experiments described in this section were designed to test whether the 
Mn(PaPy2Q)H2O+ generated by laser photolysis of 1 is capable of reducing ferrylMb on 
the s timescale.  To address this possibility the amount of ferrylMb reduced and the 
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amount of NO generated by photolysis 
of a given amount of 1 were 
determined independently, in a set of 
experiments outlined in Fig. A1.16.   
The blue circles in Fig. A1.16 show 
how much ferrylMb was reduced 1s 
after solutions containing 150 M 1 
and varying concentrations of 
ferrylMb were irradiated with a 500 nm 
laser pulse.  The concentrations of 
ferrylMb in each case are given in 
parentheses, while the abscissa reports 
the fraction of photons absorbed by 1 
relative to the total absorbed by the 
solution at a given concentration (as defined by f1 in Eq. A1.18).  The value of f1 decreases 
smoothly as [ferrylMb] increases, which leads to a decrease in the amount of ferrylMb 
reduced at fixed [1] (the 150 M point is an outlier, probably resulting from a laser miss-
fire).  Self-screening is a common phenomenon in photochemical experiments, and must 
always be accounted for. 
 
 To accurately determine the amount of NO being generated from a solution 
containing 100 M of 1, solutions containing this amount of 1 and 100 M Mb were 
Figure A1.16.  Blue circles: amount of ferryl reduced 
1s after irradiating solutions containing 150 µM 1 and 
varying amounts of ferrylMb (given in parentheses) 
with a 500 nm laser pulse.  The abscissa represents the 
fraction of photons absorbed by 1 in each case, as 
determined using Eq. A1.18.  Red squares: amount of 
Mb nitrosylated 1s after irradiating solutions containing 
150 µM 1 and 100 µM Mb with a 500 nm laser pulse.  
Here, fraction of photons absorbed by 1 is given by Eq. 
A1.19.  Experiments with Mb were done before and 
after those with ferrylMb, and serve to quantify the 
amount of NO generated from 150 µM 1, given the 
laser energy on the given day. 
Eq. A1. 18 
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photolyzed to generate MbNO, whose spectral signature is substantially stronger, and thus 
more accurately quantified, than that from the simple disappearance of 1.  This experiment 
was repeated before and after the experiments with ferrylMb, and the amounts of MbNO 
generated in each case are shown as red squares in Fig. A1.16.  Once again the total 
concentration of Mb in solution is reported in parentheses in Fig. A1.16, while the abscissa 
in this case is the fraction f2 of light absorbed by 1 relative to the total absorbed by the 
solution of Mb and 1 (Eq. A1.19).   
 
  Figure A1.16 shows that, provided the values of f1 and f2 are comparable, 
the amount of ferrylMb reduced 1s after irradiation of a solution of ferrylMb and 1 matches 
the amount of Mb nitrosylated in a solution initially containing the same amount of 1 and 
Mb.  From this one can conclude that the only species capable of reducing ferrylMb on the 
s timescale after photolysis of 1 is NO itself;  Mn(PaPy2Q)H2O+ will not reduce ferrylMb 
on this timescale.  A separate set of experiments that used higher concentrations of 1 and 
ferrylMb provided the same results (data not shown).  Therefore, in the experiments in 
which solutions of oxyMb and 1 were irradiated to generate NO, any free ferrylMb 
generated by homolytic fragmentation of a metMb(OONO) intermediate should have still 
been present 16 ms after photolysis, and thus detectable. 
 
 
 
Eq. A1.19 
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Appendix 2 Supplementary Material to Chapter 4 
A2.1.  trHbN variant NO dioxygenation and nitrosylation kinetics table 
 
 
Table A2.1 Tabular form of kinetic results presented in bar graph form in Fig. 4.4 
 
A2.2.  Effect of a laser-induced artifact on laser-initiated time-resolved UV/Vis 
spectroscopy experiments 
Laser-induced artifacts are often a problem when working at faster timescales, and our 
system is no different.  Figure A2.1 shows the layout for the photolysis and spectroscopic 
experiments done in Chapter 4 of the main text.  Light from the laser pulse randomly 
scattered into the sample photomultiplier tube causes an artifact which can last 50-100 s, 
as the photomultiplier tube is “blinded” by the incredible laser intensity.  Further 
experiments suggest that the sample itself may also add to this effect, perhaps due to 
fluorescence (figures not included).  Figure A2.2 shows an example of the artifact from an 
experiment containing 38.9 M oxy-trHbN.  Pump-probe experiments that do not take this 
into account can often show exponential fits with non-zero A0, which is not included in 
analysis.  For example, prior to correcting for the artifact, Fig. 4.6a from the main text 
exhibited a significant non-zero A0.  Figures A2.3a and A2.3b show the exponential fits of 
this experiment with and without subtracting the artifact as an exponential equation 
Variant NO dioxygenation 2nd order rate 
constant 
Nitrosylation 2nd order rate 
constant 
Wild type (1.37  0.07)109 M1s1  (2.2  0.3)108 M1s1 
Q58A (5.8  0.5)108 M1s1 (2.6  0.4)108 M1s1 
Y33A (1.44  0.07)109 M1s1 (4.6  0.9)108 M1s1 
DM (Y33F+Q58V) (7.5  0.7)108 M1s1 (9  2)108 M1s1 
F62A (4.7  0.7)108 M1s1 (1.2  0.1)108 M1s1 
F62W (6.8  0.3)108 M1s1 (1.6  0.3)108 M1s1 
Pre-A Deletion (1.03  0.09)109 M1s1 N/A 
V80A (2.0  0.3)109 M1s1 (4.7  0.6)108 M1s1 
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calculated from the fit of Fig. A2.2.  Fortunately, while the difference in the rate constants 
calculated before and after artifact subtraction (5900 s1 vs. 7050 s1) is significant in this 
experiment, most of the experiments exhibited much smaller artifact effects.  
Consequently, when corrected and uncorrected data are used to calculate the second-order 
rate constant (Figs. A2.4a and A2.4b) the differences are minimal: (2.30 ± 0.17)108 
M1s1 compared to (2.16 ± 0.17)108 M1s1.  Given this result, while the rate constant for 
red-trHbN + NO in Fig. 4.4 and the experimental trace in Fig. 4.6a have been adjusted in 
this way, none of the other kinetic analyses in this work have been similarly edited. 
 Fig A2.1. Schematic of the system 
used in the Pacheco lab for 
photolytic creation of NO and 
UV/Vis measurements within a 
solution  
Fig A2.2. Spectral changes at 412nm that 
accompany 500 nm laser pulse irradiation 
of a solution initially containing 38.9 µM 
oxy-trHbNWT in a 50 mM Tris, 0.5 mM 
EDTA buffer adjusted to pH 8.  Red trace: 
single exponential fit of the data.  Under 
these conditions the apparent rate constant 
kobs for the spectral change was 
10,5001,000 s1.   
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Fig A2.3. Spectral changes observed after a solution initially containing 21.2 μM red-
trHbNWT and 40 μM photo-precursor 1 was irradiated with a 500 nm laser pulse to 
produce ~4 μM NO.  (a) With exponential equation of artifact subtracted, and a fitted 
kobs of 7050s; (b) original data with a fitted kobs of 5900s1  
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Fig A2.4. Dependence of kobs on the concentration of red-trHbNWT; concentrations of 
photo-precursor 1 were varied from experiment to experiment so that the amount of 
NO generated was always ~0.1 that of red-trHbNWT.  (a) Original data: from the linear 
fit to the data the second-order rate constant for reaction of NO with red-trHbNWT was 
determined to be (2.30.2)108 M1s1. (b) data with artifact subtracted from each 
individual experiment: from the linear fit to the data the second-order rate constant for 
reaction of NO with red-trHbNWT was determined to be (2.20.2)108 M1s1. 
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A2.3.  Derivation of rate law for trHbNdelN nitrosylation (Equation 4.3) 
 
 
NO Pseudo – 1st order, protein in excess 
 
at time t    
 
 
 
  
  
  
  
Let: 
Scheme A2.1.  Reaction sequence that could explain the lack 
of dependence on protein concentration of the interaction 
between red-trHbNdelN and NO.  In species B NO is within 
the protein tunnel system, but not bound to the heme. (also 
see Scheme 4.3) 
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 Then: 
 
 
 
 
If HbNT  K11 then kobs  k2 as observed experimentally for trHbNdelN at all 
concentrations investigated (5 M) 
 
A2.4.  NO titration experiments with oxy-trHbNdelN 
In reference 1 the authors describe a series of experiments in which oxy-trHbNwt and 
oxy-trHbNdelN are both titrated with equivalents of NO.  In the case of oxy-trHbNwt the 
oxidized met-trHbNwt was generated instantaneously as expected.  However, the authors 
reported that after addition of NO to oxy-trHbNdelN, conversion to the met form took as 
long as 30 – 40 minutes.  We found this finding surprising given the results presented in 
Fig. 4.4, which showed that the second-order rate constant governing the interaction of  
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Figure A2.5. Difference spectra of 47.5 M oxy-trHbNdelN and 176.7 M 1 photolysed 
with 500nm (a) 1 (b) 2 or (c) 3 laser pulses. Experimental absorbance differences are 
fit with (a) 24 M (b) 39 M or (c) 47.5 M oxy-trHbNWT converting to an equimolar 
amount of met-trHbNWT.  
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oxy-trHbNdelN with NO was comparable to that of the wild type.  One possible 
explanation for the discrepancy could arise from our use of large excesses of protein 
relative to NO, necessary to maintain pseudo-first order conditions.  Under such 
conditions we could not rule out the possibility that we were monitoring a small fraction 
of active protein in equilibrium with a much larger fraction of protein present in an 
inactive conformation. 
This hypothesis was tested in a series of experiments in which a solution initially 
containing 47.5 M oxy-trHbNdelN and 170 M of photoprecursor 1 was irradiated with 
laser pulses in quick succession.  The results are shown in Figs. A2.5, and A2.6, and 
summarized in Fig. A2.7.  Under these conditions a single laser pulse led to immediate 
oxidation of over half (24 M) of the 
oxy-trHbNdelN (Figs. A2.5a and A2.7), 
and within three pulses all of the oxy-
trHbNdelN was fully oxidized; we found 
no evidence of a slowed NO 
dioxygenation.   
The amount of oxy-trHbNdelN converted 
to met-trHbNdelN after each laser pulse 
was calculated using the independently 
obtained extinction coefficient spectra 
for the wild type versions of the two 
species, and did not incorporate the 
contributions from photolysis of 1. 
Figure A2.6. Difference spectrum of 47.5 
M oxy-trHbNdelN and 176.7 M 1 
photolysed with four 500 nm laser pulses.  
The experimental difference is fit using the 
extinction coefficient spectrum of 47.5 M 
oxy-trHbNWT converting to an equimolar 
amount of met-trHbNWT, but an obvious 
deviation occurs at ~422nm, which is likely 
caused by excess NO nitrosylating met-
trHbNdelN. 
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Nevertheless the fit after the first laser 
pulse is reasonably good.  The fits get 
progressively worse after more laser 
pulses, and is very poor after the fourth 
pulse (Fig. A2.6).  This is because 
excess NO is now present, and can 
nitrosylate the met-trHbNdelN after it has 
been generated. 
To summarize, our experiments in which 
large amounts of NO are added to oxy-
trHbNdelN are consistent with our 
experiments done under pseudo-first order conditions in showing that the deletion mutant’s 
reactivity with NO is comparable to that of the wild type.  It is not clear why our results 
differ so significantly from those of Lama et al.1   
 
 
 
 
 
 
 
Figure A2.7. Summary of the [met-trHbN] 
produced when 47.5 M oxy-trHbN and 
176.7 M 1 were photolysed with 500nm 
laser pulses, as calculated in figures A2.5 
and A2.6
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A2.5. Results of SVD Analyses in Sections 4.4.5. and 4.4.6. 
 
 
A2.6 Reference 
 
  (1) Lama, A.; Pawaria, S.; Bidon-Chanal, A.; Anand, A.; Gelpí, J. L.; Arya, 
S.; Martí, M.; Estrin, D. A.; Luque, F. J.; Dikshit, K. L. Journal of Biological Chemistry 
2009, 284, 14457. 
 
 
 
Figure A2.8. Results of SVD analysis of 
photolysis experiments containing 19.3 
M red-trHbNWT and 20.4 M 1.  (a) The 
three U components above noise, and (b) 
the associated V components.  Note only 
one V component appears to be a real 
signal 
Figure A2.9. Results of SVD analysis of 
photolysis experiments containing 30.6 
M oxy-trHbNWT and 73.8 M 1.  (a) The 
three U components above noise, and (b) 
the associated V components.  Note only 
one V component appears to be a real 
signal 
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